Generation and fitness of transgenic Anopheles gambiae and the impact of multiple feeding on anti-malarial properties of the vida3 transgene by McArthur, Clare
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work is protected by copyright and other intellectual property rights and 
duplication or sale of all or part is not permitted, except that material may be 
duplicated by you for research, private study, criticism/review or educational 
purposes. Electronic or print copies are for your own personal, non-
commercial use and shall not be passed to any other individual. No quotation 
may be published without proper acknowledgement. For any other use, or to 
quote extensively from the work, permission must be obtained from the 
copyright holder/s. 
 
  
 
Generation and fitness of transgenic Anopheles gambiae 
and the impact of multiple feeding on anti-malarial 
properties of the vida3 transgene 
 
Miss Clare McArthur 
 
 
In consideration for the degree of Doctor of Philosophy 
 
September 2011 
 
Keele University 
 
 
 
 2 
 
 
 
SUBMISSION OF THESIS FOR A RESEARCH DEGREE 
 
Degree for which thesis being submitted  Doctor of Philosophy 
 
Title of thesis Generation and fitness of transgenic Anopheles gambiae and the 
impact of multiple feeding on anti-malarial properties of the vida3 
transgene   
 
 
This thesis contains confidential information and is subject to the protocol set down for the 
submission and examination of such a thesis. 
     
NO  
 
 
Date of submission    Original registration date 01.10.2007 
 
(Date of submission must comply with Regulation 2D) 
 
Name of candidate  Clare McArthur   
 
Research Institute  Institute for Science and Technology in Medicine 
 
Name of Lead Supervisor Professor Paul Eggleston  
 
DECLARATION by the candidate for a research degree 
 
I certify that: 
 
(a) the decision to submit this thesis has been taken following consultation 
with, and having received advice from, my academic and (where appropriate)  
non-academic (e.g. industrial) supervisor(s)  
(b) The thesis being submitted for examination is my own account of my own 
research 
(c) My research has been conducted ethically. Where relevant a letter from the 
approving body confirming that ethical approval has been given has been bound in 
the thesis as an Annex 
(d) The data and results presented are the genuine data and results actually 
obtained by me during the conduct of the research 
(e) Where I have drawn on the work, ideas and results of others this has been 
appropriately acknowledged in the thesis 
(f) Where any collaboration has taken place with one or more other researchers, I 
have included within an „Acknowledgments‟ section in the thesis a clear statement of 
their contributions, in line with the relevant statement in the Code of Practice (see 
Note overleaf). 
 3 
(g) The greater portion of the work described in the thesis has been undertaken 
subsequent to my registration for the higher degree for which I am submitting for 
examination 
(h) Where part of the work described in the thesis has previously been 
incorporated in another thesis submitted by me for a higher degree (if any), this has 
been identified and acknowledged in the thesis 
(i) The thesis submitted is within the required word limit as specified in the 
Regulations 
 
Total words in submitted thesis (including the text and footnotes, but excluding references 
and appendices) ______68, 379_______ 
 
 
Signature of candidate ………………………………… Date ………………… 
 
 
I have read the thesis*/I have read part of the thesis*/I have not read the thesis*, and I am 
aware that the student intends to submit. 
 
 
Signature of lead supervisor ………………………………… Date ………………… 
 
Please print name ............................................. 
 
 
 
 
 
 
Note 
 
Extract from Code of Practice: If the research degree is set within a broader programme of work 
involving a group of investigators – particularly if this programme of work predates the candidate‟s 
registration – the candidate should provide an explicit statement (in an „Acknowledgments‟ 
section) of the respective roles of the candidate and these other individuals in relevant aspects of 
the work reported in the thesis. For example, it should make clear, where relevant, the candidate‟s 
role in designing the study, developing data collection instruments, collecting primary data, 
analysing such data, and formulating conclusions from the analysis. Others involved in these 
aspects of the research should be named, and their contributions relative to that of the candidate 
should be specified (this does not apply to the ordinary supervision, only if the supervisor or 
supervisory team has had greater than usual involvement). 
 
 
Cc: Director of Postgraduate Research 
 
 
 
 
 4 
Abstract 
Malaria, the leading cause of death due to vector-borne disease. is responsible for around 
250 million cases and 1 million deaths annually, mostly in sub-Saharan Africa where 
Anopheles gambiae is the major vector. 
 Novel approaches to malaria control include theoretical use of transgenic mosquitoes to 
suppress or replace wild type populations.  Generation of mosquitoes carrying either a 
conditional lethal gene (RIDL), or one encoding a molecule able to kill malaria parasites, is 
a key component of this strategy.  Detailed genetic and physiological knowledge of 
transgenic mosquitoes is important for epidemiological models to accurately determine the 
outcome of putative field releases.  This includes testing the potential for post-integration 
remobilisation of transgenes in the host genome and testing the reproductive fitness of 
transgenic mosquitoes in comparison to wild type. 
Complex plasmids, designed to create both RIDL strains and strains within which 
piggyBac remobilisation could be tested, were injected into the Keele strain of An. 
gambiae.  Ultimately, although microinjection techniques were optimised and efficiencies 
improved over time, generation of such transgenic strains was unsuccessful.   
A previously established transgenic strain (EVida3), expressing the Vida3 peptide which is 
active against ookinete stages of Plasmodium, was subsequently investigated with respect 
to multiple feeding and relative fitness. 
Multiple feeding experiments indicate that complex interactions take place between Vida3 
and the natural immune system when mosquitoes are infected with the murine malaria P. 
yoelii nigeriensis.  Vida3 production appears to impact on parasite intensity and mosquito 
fecundity in both positive and negative ways dependent on factors such as gonotrophic 
cycle and parasite-stage.  Analysis of three life-table fitness parameters, comparing EVida3 
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hemizygotes to the KIL wild type laboratory strain, indicate no fitness cost associated with 
transgene presence or expression.  Analysis of a further two parameters indicates a possible 
fitness cost associated with inbreeding rather than transgenesis alone. 
 
List of Abbreviations 
AAPP   Anopheline Anti-Platelet Protein 
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DCE   Dopachrome Conversion Enzyme 
DDT   Dichloryldiphenyltrichloroethane 
DHI   5,6 – dihydroxyindole 
EU   Engineered Underdominance 
GMO   Genetically Modified Organism 
HE   Homing Endonuclease 
iNOS   inducible Nitric Oxide Synthase 
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NLS   Nuclear Localisation Signal 
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NO   Nitric Oxide 
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PLA2   Phospholipase (from bee venom) 
PO   Phenyloxidase 
PPO   Prophenyloxidase 
RIDL   Release of Insects with a Dominant Lethal 
ROS   Reactive Oxidative Species 
SIT   Sterile Insect Technique 
TE   Transposable Element 
TSS   Transgenic Sexing Strain 
tTA   tetracycline-dependent Transcriptional Activator 
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Chapter One 
1. Introduction 
1.1. Introduction to Malaria 
Malaria, a disease caused by protozoan parasites of the genus Plasmodium and carried by 
anopheline mosquitoes, is one of the most important parasitic infections of man with 
around 50% of the world‟s population living in areas where malaria is transmitted (CDC 
website).  On a worldwide scale there were 216 million cases of malaria in 2010 resulting 
in the deaths of 655 000 deaths.  The majority of these were children under the age of 5 in 
sub-Saharan Africa (WHO World Malaria Report 2011).  More recent findings suggest, 
however, that the malaria burden is larger than previously thought, especially with respect 
to adults (Murray et al., 2012). 
Malaria is also thought to be a major cause of anaemia in pregnant women in sub-Saharan 
Africa, especially among those women who are pregnant for the first time (Savage et al., 
2007).  It has also been documented that these women are more susceptible to Plasmodium 
falciparum infection than those who have been pregnant before (Savage et al., 2007).  The 
consequences of pregnancy-associated malaria are not only the risk of maternal anaemia 
but also an increased incidence of low birth weight and infant mortality (Ndam and 
Deloron, 2007). 
The morbidity and mortality caused by malaria are problematic, however the economic and 
social losses the disease causes within those countries in which it is endemic are also a 
major issue.  Sachs and Malaney, 2002 review article published in Nature makes the 
remark “where malaria prospers most, human societies have prospered least”, which seems 
to be a fair reflection on the situation.  Average growth in per-capita GDP (Gross Domestic 
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Product) for countries without P. falciparum malaria between 1965 and 1990 was, on 
average, 2.3% per year whereas in those countries with such malaria infections the average 
was just 0.4% per year thus showing a substantial difference in economic growth (Gallup 
and Sachs, 2001).  Malaria-endemic countries have also been shown to be poorer than their 
non-malaria-endemic counterparts (Gallup and Sachs, 2001), and as such can little afford 
the preventative measures used to control malaria infections among their citizens.  It is a 
vicious cycle. 
 
1.1.1. Species of parasite causing malaria infection 
Malaria is caused by the apicomplexan protozoan Plasmodium, of which there were 
originally four recognised species that cause the disease in humans; P. falciparum, P. 
vivax, P. malariae and P. ovale (Greenwood et al., 2005).  Of these four species of malaria 
parasite, P. falciparum and P. vivax are the most prevalent in causing infection around the 
world (Mendis et al., 2001). 
Although infection with any of these four species causes malaria, the pathology of the 
disease varies slightly depending on the species responsible.  The most severe disease and 
mortality is caused by P. falciparum which is responsible for the majority of infections in 
Africa (Greenwood et al., 2005). 
P. ovale and P. vivax are however notable due to their ability to form hypnozoites in the 
liver of the infected person.  Hypnozoites are resting or quiescent stages of the parasite that 
can become re-activated many months after initial infection thus causing a relapse 
(Greenwood et al., 2005). 
Interestingly, a fifth species of the malaria parasite, which was thought to cause disease 
solely in simians (most common in two macaque species found in Southeast Asia), is now 
recognised as causing disease in humans (White, 2008).  Plasmodium knowlesi has, in the 
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past, been misdiagnosed as P. malariae due to their morphological similarities.  It is thus 
deemed useful to use molecular screen methods alongside traditional blood smears in areas 
of Southeast Asia where P. knowlesi infections are known to exist in order to determine the 
exact species of parasite causing the disease (Lee et al., 2009). 
1.1.2. Geographical Distribution of Plasmodium species 
Of the five species of Plasmodium which cause human malaria infection, P. vivax is the 
most widespread.  It is present not only in the tropics and sub-tropics, but also in some 
temperate areas (Martens et al., 1999). 
P. ovale, a similar parasite to P. vivax, replaces it in West Africa (Martens et al., 1999). 
P. falciparum is the most common species found in tropical areas and P. malariae is the 
least common of the four malaria parasites, being found mainly in tropical Africa (Martens 
et al., 1999). 
P. knowlesi is found to be most common in forested areas of Southeast Asia (White, 2008). 
Limitations on the distribution of the human disease caused by the genus Plasmodium in 
general are due to climate and vector distribution.  Temperature affects the distribution of 
the host mosquito itself and also affects replication of the parasite within the insect host 
(Martens et al., 1999).  For P. falciparum and P. vivax, the minimum temperature required 
for replication of the parasite within the mosquito host is approximately 18°C and 15°C, 
respectively (Patz and Reisen, 2001). 
 
1.1.3. Life cycle and stages of Plasmodium falciparum with reference to pathology 
The life cycle of P. falciparum involves two hosts. Namely a human host and an 
intermediate vector host, the anopheline mosquito.  Its lifecycle is complicated and 
includes both asexual and sexual reproduction, as well as different stages within each host 
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species (Figure 1).  Although the life cycle has been documented and explored for many 
years, some mechanisms are still not fully understood. 
An infected mosquito, whilst taking a blood meal from a human, injects sporozoites from 
the salivary glands into the dermis (Kappe et al., 2003).  After entering the blood stream, 
sporozoites migrate rapidly to the liver where they leave the bloodstream and invade 
hepatocytes.  It is here that they develop into the exo-erythrocytic forms and thus undergo 
the first round of asexual replication, in the human host, to produce vast numbers of first 
generation merozoites (Kappe et al., 2003).  
The journey from hepatocyte to sinusoid (blood vessel) is a „dangerous‟ one for the 
parasite due to patrolling macrophages (Kupffer cells) within liver sinusoids.  Sturm et al., 
2006, have shown, using a variety of techniques both in vitro and in vivo, that P. berghei 
parasites are capable of causing the detachment of host hepatocytes and the formation of 
membrane-bound vesicles called merosomes.  The detached cells, and the merosomes 
which form from them, contain infective merozoites in large numbers.  The authors 
conclude that it is these merosomes which ensure the safe release of such merozoites 
directly into live sinusoids thus protecting the parasite from being recognised by Kupffer 
cells of the host immune response (Sturm et al., 2006). 
The merozoite stage is briefly extra-cellular prior to invasion of erythrocytes, and is 
therefore of immunological importance (Bannister and Mitchell, 2003).  It is the release of 
merozoites into the bloodstream that causes the classical fever symptomatic of a malarial 
infection.  The merozoites of P. falciparum are probably the smallest of all the 
Plasmodium species.  They are ovoid in shape and possess all the cellular machinery 
required not only for invasion of, and feeding on, red blood cells, but also for escaping 
what remains of the previous old red blood cell (Bannister and Mitchell, 2003).  Due to its 
invasive nature, the merozoite has developed features or structures which aid in the 
 20 
invasion of erythrocytes.  It has, on its surface, clumps of filaments known as bristles, 
which capture an erythrocyte but which are cleaved upon entry into the host erythrocyte 
(Bannister and Mitchell, 2003).  The P. falciparum merozoite has an low, flat-ended 
projection at one end known as the apical prominence.  It is within this structure that dense 
granules, rhoptries and micronemes are found.  These vesicles are bound by membranes 
and are thought to release their respective contents during invasion, by the merozoite, of 
the red blood cell, thus altering the shape and composition of the erythrocyte membrane 
(Bannister and Mitchell, 2003).  Fowler et al. (1998) have also demonstrated that 
dinitroaniline drugs inhibit invasion of merozoites into red blood cells in assays by de-
polymerising f-MAST (falciparum merozoite assemblage of subpellicular microtubules); 
thus indicating that microtubules may be implicated in P. falciparum merozoite invasion of 
red blood cells (Fowler et al., 1998). 
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Figure 1.1 (opposing page):  A diagrammatic representation of the lifecycle of 
Plasmodium species 
The life cycle of Plasmodium is complicated and involves different stages and rounds of 
replication within each of it‟s two hosts. 
A) The infected mosquito takes a blood meal; sporozoites are injected with the saliva 
into the dermis of the human host. 
B) Sporozoites migrate to the liver where they invade hepatocytes. 
C) In the hepatocytes the parasite undergoes several rounds of asexual reproduction or 
schizogony which produces vast numbers of merozoites. 
D) The number of merozoites within the hepatocyte causes the cell to burst releasing 
the merozoites into the bloodstream 
E) The merozoites invade red blood cells where they undergo morphological changes 
and become ring stages (early trophozoites) and trophozoites which are feeding 
stages, taking nourishment from the erythrocyte the parasite has invaded.  The 
trophozoite stage become a schizont and undergoes further schizogony to form 
erythrocytic cycle merozoites that burst out of the red blood cell and are free to 
either invade other red blood cells to continue the erythrocytic cycle indefinitely, or 
continue the life cycle. 
F) Some merozoites differentiate into gametocytes which are essentially male and 
female forms of the parasite. 
G) These gametocytes are ingested by an anopheline mosquito when a blood meal is 
taken from an infected human host. 
H) Various mosquito factors cause the micro- and macro-gametocytes to exit the 
ingested erythrocytes in the insects mid-gut.  It is here that the gametocytes fuse to 
form a zygote. 
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I) The zygote transforms into a stage known as an ookinete and exits the remnants of 
the blood meal and enters the midgut epithelial cells where it migrates to the basal 
sub-epithelial space 
J) The parasite is now known as an oocyst.  It undergoes further rounds of asexual 
reproduction (known as sporogony) to produce thousands of sporozoites which, 
after bursting out of the oocyst, migrate through the haemolymph and into the 
mosquito salivary glands.  From there they can be injected by the act of blood 
feeding into a human host, and thus the life cycle of Plasmodium begins again. 
Figure adapted from http://www.dpd.cdc.gov/dpdx,  accessed 19/09/11) 
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Once it has invaded the erythrocyte, the parasite becomes the flattened, ring-like shape, 
which has become a characteristic of malaria parasite infection in the human hosts‟ blood.  
The middle of this ring-stage parasite becomes thin and contains very few organelles.  
These are pushed towards the outer edge of the parasite and are surrounded in thick 
cytoplasm (Bannister and Mitchell, 2003).  The ring-stage is a feeding stage (early 
trophozoite). It uses a small dense ring at its surface, called a cytostome, through which it 
feeds on the surrounding red blood cell, converting haemoglobin into inert haemozoin 
crystals that build up in the pigment vacuole of the parasite (Bannister and Mitchell, 2003).  
The surface area of the parasite relative to the erythrocyte, becomes greatly increased as 
the parasite feeds on the erythrocyte itself.  The endoplasmic reticulum of the parasite 
becomes enlarged and the number of free ribosomes increases, indicating increased protein 
synthesis (Bannister and Mitchell, 2003). 
It is at this point that bulges and clefts appear at the surface of the parasite.  Indeed some of 
these protrusions extend deep into the cytosol of the red blood cell and may even come into 
contact with the membrane itself (Bannister and Mitchell, 2003).  Trelka et al. (2000) have 
used transmission electron microscopy to detect the formation of electron-dense vesicles 
on the erythrocytic side of the parasite.  These are similar to secretory vesicles in mammals 
and appear to bind with and fuse to the erythrocyte membrane.  These vesicles could be 
responsible for the movement of parasite proteins into the cytosol of the red blood cell and 
could also be a precursor in knob structure formation, which occurs from the trophozoite 
stages through to the schizont stage of the parasite (Trelka et al., 2000). 
It has been documented that a protein known as PfEMP1 (P. falciparum erythrocyte 
membrane protein 1) is exposed on the surface of infected red blood cells causing them to 
become „sticky‟.  This occurs at around 16 hours into the asexual cycle (Newbold et al., 
1999).  These surface „knobs‟ are involved in mediating adhesion to blood vessel 
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endothelial cells and also can result in „rosetting‟ whereby the infected red cell becomes 
bound to non-infected red blood cells (Newbold et al., 1999).  Both „rosetting‟ and the 
binding of an infected erythrocyte to the blood vessel endothelium can result in blocking of 
blood vessels thus causing severe pathology in an infected person (Newbold et al., 1999).  
Horrocks et al. (2005) have shown, using cytoadhesion assays, that both static and flow 
adhesion is reduced in all P. falciparum clones that do not possess „knobs‟ on their surface, 
and that PfEMP1 displayed on the surface of such infected erythrocytes is reduced by 50% 
(Horrocks et al., 2005). 
Work undertaken by McMorran et al., 2009, indicates that whilst platelets are responsible 
for major pathology associated with later stages of malarial infections caused by 
sequestering of infected red blood cells, they also form part of the hosts‟ protective 
response in early stages of red blood cell infection.  This was indicated by work in vivo 
using P. chaubaudi within a mouse model, as well as in vitro whereby human platelets 
killed P. falciparum parasites cultured in erythrocytes (McMorran et al., 2009).  A review 
by Pleass, 2009, discusses implications of this finding and plausible mechanisms behind it. 
After the trophozoite stages the parasite changes to become a form known as a schizont 
and undergoes asexual replication (schizogony).  The nucleus divides four times to 
produce 16 nuclei and the individual merozoites are formed (Bannister and Mitchell, 
2003).  These are then released into the bloodstream, free to invade other red blood cells; 
again causing the classical fever which is typical of a malaria infection.  This fever occurs 
with each round of merozoite release into the bloodstream, approximately every 48 hours 
in a P. falciparum infection and correlates with an immune response to the merozoites 
present in the bloodstream (Ramasamy, 1998).  A rise in serum levels of tumour necrosis 
factor α (TNF-α) occurs 30 minutes before the onset of fever in P. vivax (Pv) malaria, 
which is thought to be stimulated by T cells and macrophages.  This initiates the release of 
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interleukin 1 (IL-1), which is a fever-inducing cytokine (Ramasamy, 1998).  This intra-
erythrocytic cycle can continue indefinitely through rounds of multiplication within the 
bloodstream (Lampe et al., 1999). 
It is not, however, the merozoite form of P. falciparum (or indeed other Plasmodium 
species) that provides the link between vertebrate and invertebrate host.  This link is 
provided by two specialist forms of the malaria parasite, the gametocytes. These stages are 
present in the peripheral blood of the human host and are taken up by the mosquito as it 
takes a blood meal (Lampe et al., 1999).  The environment that they are in alters 
significantly as their host changes.  A temperature drop, a rise in pH and the presence of 
xanthurenic acid are what trigger the gametocytes to exit the red blood cells ingested by 
the mosquito (Billker et al., 1998; Lampe et al., 1999; Carter et al., 2007).  The female 
gametocyte exits the red blood cell as a round-shaped macrogamete.  The male gametocyte 
undergoes three rounds of genome replication, which take place extremely quickly, and are 
shortly followed by nuclear division and axoneme assembly, after which eight motile 
microgametes are formed (Lampe et al., 1999).  Fertilisation takes place within the insect 
midgut, and a zygote is formed. 
The mechanisms behind the decision for a merozoite to commit to sexual differentiation as 
opposed to the continuation of the erythrocytic cycle are not completely understood.  Kariu 
et al., 2006, have shown, by disruption of the gene coding for TPx-1 in P. berghei, that in 
the mouse host, the TPx-1 gene is required for gametocyte development.  It is most likely 
that gene expression regulates parasite differentiation to the gametocyte stages; however 
the trigger behind this „decision‟ is not known in P. berghei or indeed P. falciparum (Kariu 
et al., 2006). 
It is now known that co-infection with different genotypes does not necessarily induce P. 
chabaudi to alter its gametocyte conversion rate, however this rate is increased in response 
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to increasingly hostile host conditions such as in the case of drug application (Babiker et 
al., 2008). 
It is reported that parasite virulence, according to genotype as opposed to species, also has 
an effect on gametocyte conversion rates, but it is not thought that coexisting in itself, 
within a host alongside another genotype, has an effect on conversion rates (Babiker et al., 
2008). 
Furthermore, sex allocation of gametocytes within a P. chabaudi infection has been shown 
to correlate with factors such as gametocyte density, i.e. a male bias is seen when total 
gametocyte numbers are low (Babiker et al., 2008). 
Many observations have been recorded from experimental data looking at gametocyte 
development.  Definite advances have been made to further our understanding of this 
subject.  However, many of the mechanisms behind the observations remain poorly 
understood thus far. 
Within 24 hours of the gametocytes being taken up by the mosquito during its blood meal 
the zygote transforms into a motile ookinete.  The ookinete exits the remnants of the blood 
meal (bolus) and travels across the midgut epithelium to rest in the space between the 
midgut epithelium and the basal lamina, known as the basal subepithelial space (Carter et 
al., 2007).  The parasite, now known as the oocyst, within which several rounds of asexual 
reproduction (sporogony) occur, is responsible for the production of sporozoites that are 
released into the haemolymph when the mature oocyst bursts and migrate to the salivary 
glands of the mosquito (Kappe et al., 2003).  Upon arrival at the salivary gland, 
sporozoites attach to the gland cells, invade these cells and move through the cytoplasm 
exiting into the lumen of the gland where they await injection into the human host when 
the mosquito takes a blood meal (Kappe et al., 2003).  These sporozoites are the stage of P. 
falciparum infective to the human host, thus the life cycle becomes complete. 
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1.2. The anopheline mosquito: vector of malaria 
Mosquitoes belonging to the genus Anopheles are the only vectors of human malaria.  
They belong to the subfamily Anophelinae which in turn is a member of the family 
Culicidae, or the „true mosquitoes‟.  The Culicidae have many morphological features that 
enable them to be recognised as different from other members of the order Diptera.  They 
are a relatively primitive family more closely related to midges (Ceratopogonidae) and 
crane flies (Tupilidae) than to houseflies (Muscidae) or blowflies (Calliphoridae) 
(Clements, 2000). 
Mosquitoes are found in all parts of the world except those that are permanently frozen, 
with the tropics and sub-tropics being home to the most species as conditions in these areas 
favour development and survival of the mosquito (Clements, 2000). 
Of the 430 species of Anopheles found worldwide, only around forty are important malaria 
vectors (Meek & Hill, 2007).  It is interesting also to note that although there are a good 
number of species able to transmit malaria, it is unusual to find more than four different 
vector species in any particular geographic region, probably due to requirements in 
breeding and feeding habitats and their availability in a given location (Chandramoban, 
2007).  Figure 2 shows the distribution of 34 species of dominant vector over 260 endemic 
or potentially endemic regions (Kiszewski et al., 2004).  It can be seen from this figure that 
some countries have more than one dominant species of vector dependent on the 
geographical location within the country.  This reflects the diversity of habitats within the 
country (Kiszewski et al., 2004). 
Figure 2 also demonstrates that the sibling species complex, Anopheles gambiae sl, is very 
commonly found in Afro-tropical regions and as such are responsible for a large proportion 
of malaria transmission in sub-Saharan Africa (Scott et al., 2002).  Anopheles gambiae 
sensu stricto is highly anthropophilic, which increases its potential as a malaria vector 
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(Scott et al., 2002).  An. gambiae ss and An. funestus are also both endophagic and tend to 
bite after 11pm, meaning they are more likely to come into regular contact with humans 
than other anophelines, thus increasing their competency as vectors (Githeko et al., 1996).  
An. albimanus, the malaria vector in South and Central America, is largely exophagic and 
less likely to rest indoors, which means that outside workers and those who sleep outside 
due to the hot weather in these areas are subjected to being bitten by this species, hence 
malaria spreads between humans in these areas (Curtis and Lines, 2007).
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Figure 1.2 (opposing page):  The distribution of dominant or potentially important 
malaria vectors across the world (Robinson projection).   
Dominant vectors were selected for by looking at longevity and feeding rate on humans.  
Keszewski et al. (2004) identified 260 endemic or potentially endemic regions which were 
infested by 34 species of dominant anopheline vector.  
Figure adapted from Kiszewski et al., (2004). 
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The preferential biting habits of the different anopheline species in the various areas where 
malaria is endemic can have significant effects on the epidemiology of the disease.  For 
example,  Bockarie et al., 1996, show that in Sierra Leone, parous females belonging to the 
species An. punctulatus bite later than nulliparous females.  They also indicate that 
infection with the Plasmodium parasite in sporozoite form may alter biting behaviour 
depending on species of the mosquito (Bockarie et al., 1996).  It is useful to study these 
biting habits in order that preferences can be noted among the species in different 
locations.  Such information could be critical in the implemented control of these vectors 
depending on the major vector present, amongst other factors. 
The preferential breeding habitats of different species of Anopheles also impact on the 
epidemiology of the disease and need to be seriously considered when determining control 
strategies for a particular geographic region.  The water used by the female anopheline on 
which to lay her desiccation-prone eggs can be permanent, such as a marsh, or temporary, 
such as a hoof print, puddle or water storage container (Service, 2004).  The practical 
importance of permanent and semi-permanent habitats in controlling aquatic stages of An. 
gambiae sl is discussed with reference to their study in Mbita, Kenya in the paper by 
Fillinger et al. (2004).  Their 20 month study shows that An. gambiae sl, identified using 
morphological characteristics, is found across many types of habitat whether they are man-
made or natural, permanent or semi-permanent (Fillinger et al., 2004).  Therefore it is 
possible to suggest that their lack of preference in breeding habitat makes An. gambiae sl 
an undoubtedly good vector of malaria due to its ability to breed in any waterlogged 
habitat.  If such habitats are man-made, this will certainly bring the mosquito into close 
proximity to humans, therefore increasing its competency as a vector.  Fillinger et al. 
(2004) suggest that targeting the aquatic stages in areas such as Mbita would be necessary 
for sufficient malaria control programs.  
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1.2.1. Life cycle of the anopheline mosquito 
Anopheline mosquitoes undergo a complete metamorphosis (holometabolism) during their 
life cycle as do other members of the Diptera.  Female mosquitoes lay between 50 and 200 
eggs at a time, and deposit them on the surface of clean oxygenated water.  The anopheline 
egg is laid individually, (not in rafts like Culex) and its flattened upper surface is not 
covered with water whilst its lower part is submerged.  It floats due to two air-filled 
extensions of exochorion on either side of the egg (Clements, 2002). 
In tropical climates, eggs hatch within two to three days and aquatic stage larvae emerge. 
In temperate climates, development time of the mosquito takes longer.   The larvae are 
filter feeders, feeding on micro-organisms, detritus and biofilm and, as with all mosquitoes, 
there are four larval instars (Clements, 2002; Service, 2004).  During respiration, 
anopheline larvae utilise the pair of spiracles in the 8
th
 abdominal segment only.  The other 
nine pairs are responsible only for withdrawal of tracheae at ecdysis when the cuticle is 
shed (Clements, 2002).  Anopheline larvae lie parallel to the waters‟ surface and are held 
to the surface membrane by a series of structures so the spiracles have direct contact with 
the air (Clements, 2002). 
The larvae, dependent on food and temperature, usually pupate in tropical climates within 
7 to 10 days after hatching.  The pupae do not feed, however, they are mobile and need to 
respire, and do so by using a respiratory trumpet, within which short tracheal trunks 
connect the dorsal longitudinal tracheal trunks with the spiracles (Clements, 2002). 
Adult anophelines emerge in a tropical climate within around 24 to 48 hours as a fully 
formed adult with the long legs, body and proboscis found in all mosquitoes (Clements, 
2002).  Male and female anophelines can be distinguished morphologically from each 
other.  Males have plumose antennae and long clubbed palps, whereas females have pilose 
antennae and long simple palps (Service, 2004). 
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Both males and females of the Anopheles genus have the long proboscis associated with 
the Culicidae and both sexes feed on sugar from nectaries, rotting fruit and honeydew 
(Clements, 2002).  It is only the female that requires a blood meal in order that she obtains 
enough protein so she can develop a batch of eggs (Clements, 2002).  An. gambiae 
reportedly takes its first blood meal 12 hours after emerging, and will take multiple meals 
throughout its gonotrophic cycle (Briegel and Horler, 1993).  The muscles at the base of 
the females‟ mandibles and maxillae, which are flattened and toothed, drive these 
mouthparts through skin tissue thus making a channel for the labrum and hypopharynx 
(Clements, 2002; Service, 2004).  When taking a blood meal, saliva is pumped down the 
hypopharynx from the salivary glands and the blood is sucked up into the space formed by 
the relative positioning of the labrum and other piercing mouthparts and enters the midgut 
(Service, 2004).  Around 70 possibly secreted proteins have been identified which may 
assist sugar and blood meals in An. funestus (Calvo et al., 2007).  Salivary proteins serve to 
prevent platelet aggregation, blood clotting and vasoconstriction as well as preventing 
some of the actions of the immune response (Calvo et al., 2007).  The combination of 
proteins evolved to do this clearly serve to ensure a blood meal can be taken from a host 
with minimal effort from the insect. 
If a female mosquito has mated, it is the protein from a blood meal which will then enable 
a batch of oocytes to mature in the ovaries. The female will thus locate herself in a suitable 
environment where her eggs can be laid (Clements, 2002). 
 
1.2.2. Life cycle of Plasmodium species within the anopheline vector 
It is the adult female mosquito that is responsible for the transmission of Plasmodium 
species and it is within the adult that the malaria parasite undergoes developmental 
changes.  It is the female mosquito‟s blood-feeding habit that allows uptake of the 
 35 
gametocyte form of the parasite.  This developmental stage of Plasmodium is the only 
stage infective to the anopheline mosquito host (Smith et al., 2002).  The trigger for the 
differentiation from the asexual reproductive cycle, which takes place in the blood of the 
vertebrate host, to the sexual reproductive stages remains unclear, but is thought to be 
partly a genetic response as loss of certain genes such as the Pfg27 gene leads to a loss of 
the sexual phenotype in P. falciparum (Talman et al., 2004).  The Pfs16 gene has also been 
shown to be vital for male microgamete exflagellation and therefore mosquito infectivity 
(Berry et al., 2009).  Differentiation is also thought to be partly triggered by a response to 
environmental factors whereby commitment to the sexual stage is increased when 
conditions in the host become unfavourable to the parasite (Talman et al., 2004).  However 
it is clear that this change is necessary in order to allow formation of male and female 
gametocytes and as such genetic recombination becomes possible which is a definite 
advantage for the parasite (Smith et al., 2002).  In the vertebrate host, sexually committed 
merozoites break out of red blood cells, invade new red blood cells and become 
trophozoites but instead of forming schizonts, they become gametocytes (Baton and 
Ranford-Cartwright, 2005).  It has been shown that all merozoites from one schizont 
develop into gametocytes or continue the erythrocytic asexual cycle and all those that are 
committed to sexual development from one schizont become either male or female 
gametocytes (Talman et al., 2004).  As sexual development proceeds, the male and female 
forms of the parasite become increasingly dissimilar.  Microgametes possess little synthetic 
apparatus and few cell organelles and assume a motile role lasting for only a short period 
of time.  Conversely, macrogametes are packed with cellular organelles and apparatus and 
are capable of rapid stage-specific protein synthesis following fertilisation and are well 
adapted for survival within the hostile environment of the mosquito mid-gut (Baton and 
Ranford-Cartwright, 2005).  The gametocytes within the vertebrates‟ red blood cells are 
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ingested by the mosquito during a blood feed and the change in environment triggers 
gametocytogenesis within the midgut of the female mosquito, whereby a drop in 
temperature, and rise in pH and the presence of a gametocyte-activating factor 
(xanthurenic acid) trigger the gametocytogenesis through calcium- and cGMP-dependent 
signalling pathways (Baton and Ranford-Cartwright, 2005; Muhia et al., 2001). 
Xanthurenic acid is part of the tryptophan oxidation pathway in mosquitoes, which protects 
the central nervous system from being over-stimulated by excitatory neurotoxins (Han et 
al., 2007).  The metabolites belonging to this pathway also influence the colour of 
compound eyes in mosquitoes with 3-hydroxykynurenine (3-HK) being the initial 
precursor for ommochrome production that contributes to pigment production in mosquito 
eyes (Han et al., 2007).  This pigmentation step occurs mainly in the pupal and adult stages 
of mosquito development and thus the conversion of 3-HK to the chemically stable 
compound xanthurenic acid  is down-regulated in these stages to allow for transportation 
of some 3-HK to the compound eyes (Han et al., 2007).  Due to the production of 
xanthurenic acid being implicated in gametocytogenesis of Plasmodium spp., the 
tryptophan oxidation pathway and the proteins involved may provide a novel target for 
control of malaria especially given that parts of the pathway differ in mammals (Han et al., 
2007). 
Macrogametes emerge from the red blood cells within the mosquito midgut and 
subsequently microgametes undergo exflagellation and produce eight product genomes 
that attach to axonemes rapidly assembled in the parasite cytoplasm (Baton and Ranford-
Cartwright, 2005).  Up to eight haploid microgametes break free and attach themselves to 
uninfected erythrocytes possibly enabling increased movement through the blood meal 
(Baton and Ranford-Cartwright, 2005).  Fusion of micro- and macro-gametes forms 
diploid zygotes within the blood meal and endomeiotic replication follows producing a 
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single tetraploid zygote nucleus that is assumed to contain four haploid meiotic products 
(Baton and Ranford-Cartwright, 2005). 
The sessile zygote gradually transforms into a banana-shaped motile ookinete present 
within the midgut of the mosquito (Barillas-Mury and Kumar, 2005).  It is an extra-cellular 
stage of the parasite meaning that it is open to attack by gut digestive proteases and has 
therefore developed various defence strategies against such attack (Baton and Ranford-
Cartwright, 2005).  Two membranes, the outer zygote plasma membrane and the parasite 
plasma membrane, together are part of the Inner Membrane Complex (IMC) which forms 
the ookinete pellicle which is surrounded by a dense coat providing protection against 
digestive proteases (Baton and Ranford-Cartwright, 2005).  The anterior portion of the 
IMC is capped by a rigid cone-shaped collar forming an apical prominence typical of the 
apicomplexan group of parasites when in their invasive stages (Baton and Ranford-
Cartwright, 2005).  This apical complex containing various cellular apparatus allows the 
parasite to penetrate and migrate through host tissues by the release of chitinases.  These 
digest the peritrophic membrane surrounding the bolus (blood meal) and allow entry into 
the midgut epithelium (Barillas-Mury and Kumar, 2005; Baton and Ranford-Cartwright, 
2005).  This was demonstrated using P. berghei knockout parasites for the chitinase gene 
PbCHT1 (Dessens et al., 1999).  This study showed that invasion of the parasite into An. 
stephensi midgut epithelium was reduced by 90% when compared to wild type parasites.  
The role of another key gene encoding membrane-attack ookinete protein was determined 
by Kadota et al. (2004). Parasites with null mutations of this gene lost infectivity to the 
midgut and were unable to rupture the cell membrane (Kadota et al., 2004).  This suggests 
a major role for this protein in invasion of the midgut by the Plasmodium ookinete.  The 
ookinete must enter and traverse the midgut epithelial cells in order to reach the basal 
lamina.  It has been observed that some ookinetes will cross a single cell in order to reach 
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the basal lamina, however in some cases the parasite performs extensive lateral movements 
crossing as many as six cells before the basal lamina is reached (Han and Barillas-Mury, 
2002).  Han et al. (2000) proposed a model of invasion they termed „The Time Bomb 
Model‟.  It is based on observations of damage and repair systems occurring in the midgut 
at the time of parasite invasion whereby damage to the midgut epithelium is controlled so 
as to avoid contact between contents of the midgut and the haemolymph (Han and Barillas-
Mury, 2002).  Essentially, invaded epithelial cells are destined for destruction and, once 
the cascade of events leading to cell death is initiated, the parasite must leave the cellular 
compartment within a limited time window, before the „bomb‟ detonates, to escape 
unharmed (Han and Barillas-Mury, 2002). 
More recent studies indicate that it is not only insect cells invaded by Plasmodium species 
that undergo programmed cell death (PCD) (Arambage et al., 2009).  P. berghei and P. 
falciarum ookinetes show markers of apoptosis (similar to those shown by mammalian 
cells), expressed even in the absence of stressors.  It is possible that PCD is used by the 
parasite to control its numbers in order to limit any host immune response (Al-Olayan et 
al., 2002).  
A study by Carter et al (2007) indicates the presence of an intermediate stage in the 
transformation between the ookinete form of P. berghei and the oocyst, which they have 
named a „took‟ (transforming ookinete).  They propose that the transformation, in vitro, of 
P. berghei ookinetes to young oocysts is not a time dependent transformation but is 
dependent on environmental stimuli.  These stimuli, however, are not provided by basal 
lamina components (Carter et al., 2007).  It is thus proposed that transformation is initiated 
through bicarbonate stimulus and that full transformation requires nutrients and a suitable 
pH.  This provides a better  insight as to the requirements of the parasite system invaluable 
to further in vitro studies (Carter et al., 2007). 
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Upon reaching the basal lamina, the ookinete is no longer motile and becomes surrounded 
by a thick extracellular capsule (Baton and Ranford-Cartwright, 2005).  New basal lamina 
is secreted below the developing oocyst thus separating it from the midgut epithelium and 
within the oocyst itself, DNA-replicating machinery is up-regulated as is protein-making 
machinery, in order that sporogony can occur (Baton and Ranford-Cartwright, 2005). 
The four presumed haploid products of meiosis that occurred in the zygote stage of the 
parasite within one nucleus now each undergo multiple rounds of endomitosis.  Eventually 
the nucleus becomes lobular and divides into individual nuclei, followed by sporoblast 
formation after the oocyst cytoplasm becomes separated by clefts of subcapsular space 
(Baton and Ranford-Cartwright, 2005).  During these rounds of asexual reproduction, the 
oocyst endures a massive increase in size of around 1000-fold and protrudes into the 
haemocoelic cavity of the mosquito.  This size increase causes a tear in the basal lamina 
overlying the oocyst itself and as a result it becomes directly exposed to the haemocoel 
(Baton and Ranford-Cartwright, 2005). 
A study by Aly and Matuschewski (2005) made use of targeted gene disruption and reverse 
genetic techniques to show that the gene encoding ECP1 (a cysteine protease) is 
responsible for Plasmodium sporozoite emergence from the oocyst.  This indicates that 
oocyst rupture is an active developmental event, rather than a passive result of sheer 
numbers of sporozoites (Aly and Matuschewski, 2005). 
Once the sporozoites have entered the mosquito haemolymph they begin their migration to 
the salivary glands in order that the Plasmodium life cycle can be completed.  It has been 
suggested that sporozoites isolated from the haemolymph of a mosquito are less infectious 
than those found in salivary glands, which suggests that they undergo important changes as 
they migrate (Barillas-Mury and Kumar, 2005).  A study by Myung et al. (2004) confirms 
previous findings that Plasmodium circumsporozoite protein (CSP) found on the surface of 
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sporozoites binds to salivary glands and not other haemolymph organs.  A peptide from the 
N-terminal third of the CS protein is also shown, in the same study, to inhibit sporozoite 
invasion of salivary glands in vivo so together with previous evidence suggests CSP plays 
an important role in attachment and invasion of mosquito salivary glands (Myung et al., 
2004). 
Engelmann et al., 2009, identify that the siap-1 gene is essential for sporozoite 
transmission from the mosquito to the mammalian host.  In this study, targeted gene 
deletion experiments gave rise to P. berghei parasites which were able to form sporozoites 
but could not fully egress from oocysts and consequently were unable to establish an 
infection of An. stephensi salivary glands (Engelmann et al., 2009). 
The sporozoites enter the salivary gland cells by formation of a parasitophorous vacuole 
(PV) that dissolves once the parasite is internalised leaving the sporozoite in direct contact 
with the cytoplasm of the cell (Baton and Ranford-Cartwright, 2005).  Once the 
sporozoites have reached the apical membrane of the cell the surrounding membranes 
disintegrate and the parasite is left exposed in the cavity of the salivary gland.  Here they 
gather in high numbers in tightly packed bundles and are secreted into a bite wound when 
the mosquito feeds (Baton and Ranford-Cartwright, 2005). 
 
 
 
 
 
 
 
 
 41 
1.3. Mosquito Immune Response to Infection 
An immune response is mounted in an organism when its cells or tissues are invaded by 
„foreign‟ matter, i.e. something not recognised as „self‟.  When a pathogen enters the body 
of an organism it is recognised as a potential threat and is attacked by the immune system 
of this organism.  The form of defence used by the immune system is dependent upon both 
the host and the attacking organism.  Immune reactions within the host are complicated but 
it is necessary to understand, as much as possible, the interactions between host and the 
attacking organism if we are to in any way aid the immune system in fighting infection.  
Not only is this the case for the human immune system and its many diseases, but it also 
holds true when it comes to interactions between haematophagous insects, such as 
mosquitoes, and the parasitic diseases they transmit.  Knowledge of the steps involved in 
immune processes when mosquitoes are infected with parasites may lead to the creation of 
opportunity to aid the mosquito in preventing parasite development and thus halt or at least 
decrease transmission to a human host (Yassine and Osta, 2010). 
When anopheline mosquitoes are infected with the malaria parasite Plasmodium after 
taking a blood meal from an infected host, they mount an immune response against this 
invading parasite.  This determines the outcome of the parasites‟ development within the 
mosquito host and ultimately whether the life cycle of Plasmodium can be completed and 
consequently infection passed to another mammalian host (Yassine and Osta, 2010). 
The lifecycle of Plasmodium is such that it must cross the midgut epithelium.  In doing so 
it encounters an immune response which is capable of vastly reducing parasite numbers 
(Yassine and Osta, 2010).  The ookinete stage can be melanised in the basal labyrinth of 
the midgut or lysed in the cytosol of the midgut epithelial cells it is traversing.  A genetic 
basis for these traits has been shown (Collins et al., 1986; Vernick et al., 1995). 
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A study by Vlachou et al., 2005, has shown that of the transcripts analysed from half the 
genome of An. gambiae, 7.1% (650 genes in total) are differentially regulated upon 
invasion of the midgut by P. berghei 18 to 44 hours post-blood meal.  This 7% was shown, 
by reverse genetic techniques, to include the most prominent regulators of actin and 
microtubule dynamics thus providing more evidence that actin cytoskeleton reorganisation 
occurs as a response to parasite invasion (Vlachou et al., 2005).  Further reverse genetic 
analysis also indicated that the lipid transporter RFABG plays a role in the development of 
both parasite and mosquito-egg development (Vlachou et al., 2005).  This study 
demonstrates the incredibly complex link between host response at a genetic level and 
parasite survival in the midgut.  It further highlights the need for knowledge regarding the 
mosquito immune response to Plasmodium invasion should we wish to adapt this response 
with a view to creating refractory mosquitoes. 
Lehmann et al., 2009, looked at a variety of mosquito species including anthropophilic An. 
gambiae/An. arabiensis and zoophilic An. quadriannulatus to determine molecular 
evolution of immune genes by looking at polymorphism across these species.  The authors 
suggest that purifying selection is the most common selection pressure acting on the 
immune genes in their study (SP14D1, GNBP, defensin, and gambicin), operating on all 
genes at the contemporary time scale, and indicate a presence of balancing selection on at 
least gambicin (Lehmann et al., 2009).  Their study also suggests that a diverse array of 
pathogens mediates balancing selection to maintain several alleles of immune genes and 
that positive selection may be associated with speciation following exposure of mosquito 
species to new pathogens (Lehmann et al., 2009).  Patterns of genetic variability were 
homogeneous across all mosquito species, whether anthropophilic or zoophilic, so 
consequently the conclusion was drawn that exposure to human pathogens does not 
mediate selection on immune genes (Lehmann et al., 2009). 
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1.3.1. Melanisation 
The Plasmodium ookinete traverses the midgut epithelium and becomes the oocyst, 
containing many sporozoites which are the infectious stage of the parasites (Collins et al., 
1986).  Surrounding the ookinete stage in a capsule of an electron-dense melanin-type 
substance prevents development and thus causes death of the parasite (Collins et al., 1986).  
The encapsulation reaction takes place in the refractory mosquito at about 16 hours post 
blood meal with the melanin-like substance appearing on the ookinete once it has traversed 
the gut wall as indicated by electron microscopy.  These encapsulated parasites are located 
between the midgut epithelial cells and the basal lamina (Collins et al., 1986).  This space 
is permeated by haemolymph serum but is kept separate from mosquito haemocytes by the 
basal lamina (Volz et al., 2006).   
This melanisation response, part of the innate immune reaction to many invading 
organisms, is apparently unique to arthropods and involves at least 14 genes and a complex 
set of regulatory reactions within An. gambiae (Christensen et al., 2005; Volz et al., 2006). 
The encapsulation process involves three Plasmodium encapsulation genes, Pen1, Pen2 
and Pen 3 of which Pen1 is the main locus of these three mapped quantitative trait loci 
(Kumar et al., 2003).  Various experiments using micro arrays as well as physiological and 
morphological data have indicated that reactive oxygen species (ROS), levels of which are 
elevated in a refractory strain of An. gambiae especially after blood feeding, are involved 
in the melanisation pathway (Kumar et al., 2003).  It may be that the ROS themselves 
cause damage to the parasite thus triggering an immune response or increased levels of 
ROS directly stimulate an immune response.  Both scenarios are possible though not 
confirmed, but the fact that ROS are involved in the encapsulation of ookinetes is likely 
(Kumar et al., 2003). 
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Phenylalanine hydroxylase (PAH) catalyses the hydroxylation of phenylalanine to form 
tyrosine (Christensen et al., 2005).  Phenoloxidase (PO) then is able to catalyse the 
hydroxylation of the formed tyrosine molecule to produce dopa which is the start of the 
pathway leading to eumelanin production (Christensen et al., 2005). 
The proteolytic serine protease cascade responsible for the activation of PPO 
(prophenoloxidase) to PO is involved in the melanisation process (Volz et al., 2006).  
Activation of the serine proteases responsible for converting PPO to the active PO is 
thought to be regulated by serpins (Christensen et al., 2005). 
Sequential activation of several serine proteases eventually leads to activation of  PPO-
activating protease (PAP) which cleaves PPO to the active molecule PO, ultimately leading 
to the production of eumelanin (Michel et al., 2006).  Conversion of PPO to PO is 
probably the rate-limiting step in eumelanin production (Michel et al., 2006). 
Michel et al., 2006, report that the An. gambiae recombinant serpins (SRPNs), 1 and 2 are 
capable of binding and inhibiting a heterologous PAP (PAP3 from the moth Manduca 
sexta) in vitro.  In vivo, a reduction of SRPN2 causes an increase of melanin laid down on 
introduced negatively charged sulphadex beads as well as causing a 90% loss of P. berghei 
ookinetes.  This suggests that knockdown of SRPN2 causes a greater melanisation 
response, indicative that it is a down-regulator of a mosquito PAP (Michel et al., 2006).  
Similar in vivo studies using a P. falciparum infection did not however result in an increase 
in melanisation of ookinetes which the authors explain by suggesting that melanisation is a 
consequence of, rather than the cause of, the killing of P. berghei ookinetes (Michel et al., 
2006). 
SRPN2 seems to down-regulate immune responses across the insect group, as do many 
other SRPNs which play a role in the serine protease cascade.  However, studies on 
SRPN6 in both An. gambiae and An. stephensi indicate a difference in the function of this 
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particular serpin between these closely related species, possibly due to interaction with 
other genes responsible for an antiparasitic immune response (Abraham et al., 2005).  
RNAi experiments to knock down SRPN6 function from An. stephensi (AsSRPN6) lead to 
a significant increase in the number of oocysts present on the midgut thus meaning that the 
gene has a role, either direct, or indirect, in parasite killing as knock down increased 
vectorial capacity (Abraham et al., 2005).  On the other hand, knock down of the  An. 
gambiae SRPN6 (AgSRPN6) did not have an effect on oocyst load in the midgut, but did 
have an effect on clearance of dead parasites indicating that its function lies with 
promoting lysis of dead parasites in the midgut (Abraham et al., 2005). 
The clip-domain serine proteases (CLIPs) are key components of this protease cascade 
with five subfamilies identified in mosquitoes, two of which are non-catalytic and three of 
which are catalytic (Yassine and Osta, 2010).  CLIPB17 (catalytic) and CLIPA8 (non-
catalytic) are positive regulators of the melanisation process in An. gambiae and have 
suggested roles in activation of PPO (Volz et al., 2006).  CLIPs acting as negative 
regulators in the melanisation process are all non-catalytic (Volz et al., 2006).   
Once dopa is formed from the hydroxylation of tyrosine, PO then catalyses the oxidation 
of dopa to dopaquinone (Christensen et al., 2005).  Dopachrome is formed spontaneously 
from dopaquinone which is, in the presence of dopachrome conversion enzyme (DCE), 
decarboxylated to form 5,6-dihydroxyindole (DHI) which subsequently undergoes 
oxidation to become indole-5,6-quinone (Christensen et al., 2005).  It is these 
indolequinones which polymerise to form brown eumelanin without the requirement of 
enzymes (Christensen et al., 2005).  These melanisation reactions, though complex, are 
specific against various pathogens including sympatric, but not allopatric, Plasmodium 
species, and can occur within minutes of exposure to haemolymph (Christensen et al., 
2005). 
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1.3.2.  Lysis 
Vernick et al., 1995, reported that the laboratory infection of An. gambiae with the bird 
malaria parasite, Plasmodium gallinaceum, indicated a refractoriness to infection not 
involving parasite encapsulation.  Parasite death was seen to be occurring, by use of 
ultrastructural studies, in the midgut epithelial cell cytosol within 27 hours of midgut 
invasion thus showing, by microscopy, a lack of oocyst development on the mosquito 
midgut (Vernick et al., 1995).  The same study indicated that, by crossing of susceptible 
and refractory lines, a simple genetic basis existed for refractoriness to infection due to 
parasite lysis in the epithelial cell cytosol (Vernick et al., 1995; Yassine and Osta, 2010). 
Blandin et al., 2004, knocked down the TEP1 gene (which codes for a haemocyte-specific 
complement-like protein) in An. gambiae mosquitoes by RNAi techniques.  This caused 
the abolition of the refractory phenotype in a refractory strain of An. gambiae and caused 
an increase in the number of developing parasites in a susceptible strain of this mosquito 
species.  The authors suggest that the TEP1-dependent killing of parasites is immediately 
followed by TEP1-independent lysis and/or melanisation of ookinetes (Blandin et al., 
2004).  However, although it is known that TEP1 binds to P. berghei ookinetes egressing 
from the midgut epithelial cells on the basal side, the mechanism behind the killing of 
these parasites remains unclear (Blandin et al., 2004).  TEP1 is however both structurally 
and functionally similar to mammalian complement factor whilst having several distinct 
features, all of which require further investigation in order to understand the role that 
mosquito complement protein has in the immune defence against malaria parasites.  
However, there is now increasing evidence that TEP1 is almost certainly responsible for 
lysis of parasites in midgut epithelial cells (Vlachou and Kafatos, 2005; Volohonsky et al., 
2010).  A leucine-rich immune factor (LRIF1), containing structural motifs similar to those 
found in immune related molecules such as Toll and Toll-like receptors, is also involved in 
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lysis of Plasmodium ookinetes.  Moreover, by means of gene silencing techniques, LRIF1 
is known to be an antagonist on development of ookinetes to oocysts (Osta et al., 2004). 
 
1.3.3. Nitric oxide and its role in immunity 
Several cell types are capable of expressing an inducible nitric oxide sythase (iNOS) which 
converts L-arginine to citrulline and nitric oxide.  The latter is toxic to a variety of 
pathogens including Plasmodium in both murine and human hosts (Mellouk et al., 1994).  
In vitro studies with human hepatocytes have shown that gamma interferon and P. 
falciparum act together to increase the production of NO by 33% compared to the presence 
of P. falciparum alone (Mellouk et al., 1994).  The same studies indicate that NO synthesis 
plays a role in anti-malarial activity (Mellouk et al., 1994).  It seems that as well as playing 
a role in defence against the malarial parasite in both murines and humans, iNOS activity is 
known to limit Plasmodium development in Anopheles stephensi mosquitoes (Luckhart et 
al., 1998).  An. stephensi NOS levels were shown to be elevated 1 day post blood-meal, 
when P. berghei invasion of the midgut is maximal, and also later whereby enzyme 
activity would correlate with sporozoite release (Luckhart et al., 1998).  It is suggested that 
the midgut is the first line of defence against Plasmodium (and other invading organisms) 
with carcass induction of AsNOS acting as a signal-mediated secondary response to 
mediate those pathogens crossing the midgut barrier (Luckhart et al., 1998). The same 
study also showed that mosquitoes fed an L-arginine supplemented diet had a 28% 
reduction in infection rates, and a significant reduction in infection when fed a thousand-
fold dilution of the same supplement.  This indicates that parasite killing is dependent on 
the NOS substrate, L-arginine (Luckhart et al., 1998).  However, supplements of the NOS 
inhibitor, L-NAME, significantly increased Plasmodium oocyst infections.  When looked 
at together, the evidence from this study suggests strongly that nitric oxide is capable of 
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limiting Plasmodium in An. stephensi mosquitoes (Luckhart et al., 1998).  More recent 
studies both in vitro and in vivo (using An. stephensi) also indicate that NO has a direct 
effect on Plasmodium berghei, inducing apoptosis in the ookinete stage of the parasites 
development prior to invasion of midgut epithelial cells (Ali et al., 2010). 
 
1.3.4. Antimicrobial Peptides (AMPs) 
Antimicrobial peptide production is hugely important in terms of the innate immune 
response mounted by both vertebrates and invertebrates to combat attack by various 
pathogens.    In Drosophila, production of AMPs is regulated by either the Toll or Imd 
immune pathways, and involves various members of the NF-κB/Rel family of transcription 
factors which regulate expression of these AMPs in the fat body of the insect (Luna et al., 
2006).  In the mosquito, An. gambiae, there are three families of AMPs reported.  These 
are the defensins, cecropins and gambicins (Luna et al., 2006).  Molecules similar to 
defensins have been found in various members of the invertebrate group including the 
Mollusca and Arthropoda, as well as in the vertebrate group.  However, there is little 
homology in terms of sequence or structure, only in terms of mode of action, between 
these two groups (Froy and Gurevitz, 2003).  Cecropins have been found in some members 
of the phylum Nematoda and in various members of the Arthropoda (Luna et al., 2006).  
Defensins and cecropins found in Ae. aegypti as well as An. gambiae are expressed in 
naïve mosquitoes in the thorax and abdominal tissues as well as in the anterior part of the 
midgut (Vizioli et al., 2001a).  Gambicin has also been found in Ae. aegypti and Culex 
pipiens pipiens (Luna et al., 2006). 
In Anopheles, the mature peptide gambicin, containing 61 amino acids including eight 
cysteines in four disulphide bridges, shows an expression pattern similar to that of the 
defensins and cecropins.  In its mature form, it is active against the ookinete stage of the 
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Plasmodium parasite and is a novel AMP, not sharing homology with other database 
entries, which could possibly suggest that it evolved as to be active specifically against 
Plasmodium parasites  (Vizioli et al., 2001a). 
Defensins in insects all contain six cysteine residues engaged in three disulphide bridges, 
with the An. gambiae defensin being similar in sequence to other insect peptides belonging 
to this family (Vizioli et al., 2001b).   Defensin RNA had been detected in various 
mosquito tissues but the mature peptide had only been isolated from haemolypmph of adult 
Ae. aegypti and larval An. gambiae prior to the study by Vizioli et al., 2001b.  In this study, 
MALDI-TOF-MS and RP-HPLC indicated the presence of mature defensin in adult An. 
gambiae hamolymph as well as in the midgut.  An ELISA was used to quantify this 
amount (Vizioli et al., 2001b).  In a study by Dixit et al., 2008, a novel defensin was 
identified and characterised after selective enrichment during extraction from Plasmodium-
infected salivary glands of the An. stephensi mosquito.  The exact nature and 
transcriptional activity of this protein is yet to be assessed (Dixit et al., 2008) .   
Cecropins were first isolated from the moth species, Hyalophora cecropia, and have since 
been identified in other members of the Lepidoptera and also from dipterans including 
Drosophila, and more recently, the mosquito group (Ekengren and Hultmark, 1999).  The 
highly basic cecropin protein, usually around 3-5 kDa in size, is secreted into the 
haemolymph of the insect after it is induced upon infection, and is active as a broad-
spectrum antibiotic against both Gram negative and Gram positive bacteria (Ekengren and 
Hultmark, 1999).  Drosophila cecropins are also known to have antifungal properties 
(Ekengren and Hultmark, 1999).  In a study by Sun et al., 1999, three isoforms of cecropin 
were characterised from cDNA from the Ae. albopictus cell line, C7-10.  These were 
shown to bear only 40% similarity to Drosophila cecropins when taking into consideration 
the overall sequence, with the N-terminus bearing a 71% homology in terms of amino acid 
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sequence when direct comparisons were made with this region of the mature peptide alone 
(Sun et al., 1999).  Lowenberger et al., 1999, have shown that a cecropin isolated from the 
haemolymph of bacterially-challenged adult Ae. aegypti, whilst being effective against the 
same species of bacteria and filamentous fungi, is less active than its Drosophila 
counterpart.  The authors suggest that differences between the two peptides can be 
explained by the lack of tryptophan residue and C terminus amidation in the Ae. aegypti 
cecropin A (Lowenberger et al., 1999).  It has been documented that cecropin RNA from 
the malaria vector An. gambiae is up-regulated in response to Plasmodium infection, and 
where expressed in the midgut, is seen solely in the anterior part (Vizioli et al., 2000). 
 
1.3.5. Infection and immune response in relation to mosquito fitness 
It has been documented that infection with Plasmodium reduces the fecundity of the 
mosquito vector both in the lab and in the field even though a reduction in blood meal size 
is not seen (Hogg and Hurd, 1995a; Hogg et al., 1996).  Carwardine and Hurd, 1997, using 
An. stephensi mosquitoes infected with P. yoelii nigeriensis, show that the reduction in 
fecundity observed when comparing mosquitoes fed on infected blood with those fed on 
non-infected blood, is due to resorption of the follicles within the mosquito ovaries.  In this 
study, assessment of follicular development using Christopher‟s stages indicated that 
follicular resorption takes longer than 12 hours post-blood meal to begin, and affects more 
follicles in infected mosquitoes than in their non-infected counterparts (Carwardine and 
Hurd, 1997). 
Ahmed et al., 2002, stimulated the humoral immune response of An. gambiae mosquitoes 
by a post-blood meal injection of LPS (lipopolysaccharide) from Gram-negative bacteria.  
Up-regulation of the immune response, possibly via the NF-κB/Rel pathway, was gauged 
by measurement of antimicrobial activity in the mosquito haemolymph against 
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Micrococcus luteus, and this immune stimulation was compared against two fitness 
parameters (Ahmed et al., 2002).  Egg production was measured by counting eggs laid plus 
eggs retained and accumulation of yolk protein (vitellin) was also measured (Ahmed et al., 
2002).  The study indicates that the stimulation of the mosquito immune response leads to 
fewer resources being made available for reproduction thereby reducing fecundity of these 
mosquitoes (Ahmed et al., 2002).  A similar study showed that stimulation of AMPs by the 
method described by Ahmed et al., 2002, as well as stimulation of the melanisation 
pathway by injection with Sephadex beads gave rise to caspase activity in follicular cells 
within the ovaries of An. gambiae (Ahmed and Hurd, 2006).  Caspase activity is an 
indicator of apoptosis, and was seen to be up-regulated in An. gambiae infected with P. 
yoelii nigeriensis in a more pronounced manner than with injection of beads of LPS 
(Ahmed and Hurd, 2006).   It can therefore be concluded that up-regulation of the immune 
response in An. gambiae by a variety of methods is costly in terms of reproductive fitness 
(Ahmed and Hurd, 2006).  It is possible therefore that the lack of refractoriness to 
Plasmodium in field populations of anophelines is because the cost of immunity in terms of 
reproductive fitness would outweigh the benefits (Schwartz and Koella, 2001).  
Interestingly, Ae. aegypti injected with Sephadex beads also showed reduced fecundity 
associated with an increased melanisation response, but only when the beads were 
positively charged (Schwartz and Koella, 2004).  No reduction in fecundity was observed 
with neutral beads even though the melanisation response was still strong, thus suggesting 
that re-allocation of reserves is not the underlying mechanism for fecundity-reduction, or at 
least the underlying mechanism is not at all simple (Schwartz and Koella, 2004).  It has 
also been documented that dietary resources, namely blood and sugar, are a requirement 
for development of an active melanisation immune response, and as field populations are 
often malnourished, this may have an impact on released transgenic refractory mosquitoes 
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(Koella and Sorensen, 2002).  Transgenic mosquitoes, refractory to Plasmodium, may 
struggle when released, in competing with field populations if their immune response to 
the infection is hindered by malnourishment.  This may only prove to be problematic if 
expression of anti-Plasmodium effector genes is driven by immune-specific promoters 
which may have altered expression patterns at times of malnourishment.  If driven by, for 
example, blood feed-specific gene promoters such as the carboxypeptidase promoter, then 
although it is effectively an immune response, expression of such a gene would not be 
affected by malnourishment in the same manner.  
 
1.3.6. Multiple blood feeding habits 
It has been noted that An. gambiae mosquitoes given an initial infected blood feed, upon 
receiving a second blood meal, show an increased sporozoite load in comparison to those 
not given a second blood meal (Beier et al., 1989).  It is suggested that the increase in 
sporozoite load is due to an increased stimulation of oocyst maturation (Beier et al., 1989).  
Lopes et al., 2007, suggest that this occurs due to a higher availability of nutrients for the 
parasite due to a second blood meal, and also may trigger a diversion of energy resources, 
within the mosquito, from an immune reaction against the parasite to digestion and protein 
production for egg development.  The same study also showed that the oocyst burden was 
higher in those mosquitoes given a second blood meal when compared to those only given 
the initial infected feed, and that this effect was blocked when the second feed contained 
rat immune serum (Lopes et al., 2007).  Briegel and Horler, 1993, show that Anopheles 
mosquitoes will take more than one blood meal per gonotrophic cycle.  A study by Nirmala 
et al., 2005, supports this finding, and suggests that even when fully engorged, a female 
will seek blood every 24 hours.  The authors suggest, after looking at the accumulation of 
mRNAs post-blood feed, that this multiple feeding behaviour can be used to an advantage 
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when creating transgenic mosquitoes whereby an effector molecule is linked to a blood-
meal-specific promoter such as the carboxypeptidase promoter (Nirmala et al., 2005).  It is 
important to consider the biting behaviour of An. gambiae when looking to create 
transgenic mosquitoes which are effective against Plasmodium, especially where there is a 
possibility that blood meals taken after the initial infected feed may cause an increase in 
parasite burden within the mosquito, due to a divergence of resources from an immune 
response, as this may have an impact on an effector molecule.  Further clarification will be 
required before any release of mosquitoes containing anti-Plasmodium effector molecules 
is deemed feasible. 
Clearly, an understanding of insect immunity and host-parasite interactions is imperative, 
especially when considering future work aiming to control diseases such as malaria by the 
introduction of transgenic mosquitoes which express novel anti-Plasmodium peptides. 
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1.4. Vector control 
Control of the vector is regarded as one of the most effective ways of preventing malaria 
transmission and as such has become one of the four implemented elements of the Global 
Malaria Control Strategy (WHO, 2006). 
In order that control of the vector is successful, several factors must be considered in 
relation to the vector that is to be controlled.  A knowledge of the local species of 
Anopheles responsible for malaria transmission in that area is vital, so it can be gauged as 
to their feeding and breeding habits which will have an impact on the best type of control 
method to be used (Walker and Lynch, 2007).  Eradication of invading populations of An. 
gambiae has been possible even before the invention of insecticides, such as DDT, 
whereby extensive high profile political programs in places such as Egypt and Brazil were 
sustained by community involvement (often enforced by legislation) and were concerned 
with targeting larval populations requiring detailed knowledge of species breeding habitats 
(WHO, 2006). 
The introduction of DDT meant that adult mosquitoes could be targeted either instead of, 
or as well as, the larval stages and Indoor Residual Spraying (IRS) with DDT was thought 
to be able to provide a good chance of eradication of malaria if continued until malaria 
infection died out (WHO, 2006).  Certainly, this seemed to be the case from early reports 
in southern Europe, north America and Taiwan and as such IRS with DDT, and later with 
other insecticides, became the backbone to malaria control (WHO, 2006).  However IRS 
relies on mosquitoes resting on walls indoors either before or after feeding and also relies 
on human shelters having walls and that these walls are accessible for spraying and are not 
likely to be re-plastered (WHO, 2006).  The IRS strategy wasn‟t adhered to in terms of 
logistics, human resources and funding and as such the eradication effort, especially in 
Africa, was abandoned as it was no longer deemed possible (WHO, 2006). 
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It was decided that vector control was important in order to reduce transmission of malaria, 
thereby reducing the number of cases requiring treatment and easing pressure on health 
services (WHO, 2006).  However it was also recognised that vector control can only be 
most successfully undertaken when measures are taken to properly plan the methods to be 
used in particular areas and ensure that they are implemented properly by making certain 
that costing is accurate and the plan is feasible given the biology of the vector in that area 
(WHO, 2006; (Walker and Lynch, 2007). 
Insecticide-treated bed nets (ITNs) and IRS are now the more common methods of vector 
control directed at adult Anopheles populations as they are more applicable to different 
areas than larval based control programs which require a more in-depth knowledge of both 
the biology of the local vector and the geography of the local area (WHO, 2006). 
Smith et al., 2009, discuss the use of mathematical models to map malaria endemicity 
following the distribution of ITNs using Plasmodium falciparum parasite rate (PfPR) 
measured in children over two and under ten years of age.  Such models indicate that high 
levels of ITN ownership would alter malaria epidemiology, thus reliable models could 
prove useful as a tool when considering ITN distribution as a control measure across 
various parts of Africa (Smith et al., 2009). 
The insecticides used to treat bed nets are currently pyrethroids however there is evidence 
to suggest that primary malaria vectors such as An. gambiae sl and An. funestus have 
developed resistance across many parts of Africa over the past few years (N'Guessan et al., 
2003).  Culex quinquefasciatus, the vector of lymphatic filariasis caused by Wuchereria 
bancrofti and Brugia malayi, also shows high levels of resistance to pyrethroids and as 
such it is concerning that as local inhabitants are aware the C. quinquefasciatus are not as 
highly affected by ITNs then they may deem them as pointless, although they may still 
offer protection against Anopheles spp (N'Guessan et al., 2003). 
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Koella et al., 2009, suggest that emergence of insecticide resistance to those used in the 
treatment of bed nets and for IRS has been exacerbated by legislation such as that put in 
place by WHO.  Their Pesticide Evaluation Scheme for Laboratory Testing states that 
potential insecticides for ITNs and IRS must kill 80% of 2-5 day old female Anopheles 
within 24 hours of exposure (WHO, 2005).  It is thought that this places great evolutionary 
pressure on mosquitoes which serves only to increase probability of emerging resistance 
amongst mosquito populations.  This is because younger females have not yet completed a 
gonotrophic cycle and thus haven‟t been able to successfully reproduce and it is also 
thought that insecticides which have a delayed effect place less evolutionary pressure on 
insects (Koella et al., 2009).  The authors suggest ways of providing protection using an 
approach that would decrease the risk of resistance developing. 
Two main mechanisms confer resistance to pyrethroids.  The kdr (knock-down resistance) 
mutation involves alterations at the site of action in the sodium channel.  Both DDT and 
pyrethroids act by altering the gate kinetics of the sodium channel causing them to remain 
open for prolonged periods of time and thus causing paralysis and therefore death (Davies 
et al., 2007).  Two base substitutions in the kdr gene confer resistance and each is found in 
different populations of An. gambiae in different parts of Africa (Davies et al., 2007).  In 
resistant West African An. gambiae, leucine is substituted for phenylalanine in the S6 
hydrophobic segment of domain II of the sodium channel (Davies et al., 2007).  In Kenyan 
populations of An. gambiae the same leucine molecule is replaced with serine, which 
confers a decreased resistance to pyrethroids than in the west African An. gambiae 
populations but an increased resistance to DDT (Davies et al., 2007).  An increase of 
detoxification and/or metabolism through high levels of multi-function oxidase (MFO) and 
non-specific esterase (NSE) is the alternative mechanism of resistance to pyrethroids and 
DDT (N'Guessan et al., 2003).   Matambo et al. (2007) used An. arabiensis from the 
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Sennar region of Sudan in a resistance study whereby it was indicated that a colony 
selected for DDT resistance showed an elevated level of glutathione-S-transferase in both 
sexes and elevated levels of esterases in males only when compared to a colony which had 
not been subjected to selection for DDT resistance.  In both cases the colonies were 
subjected to all four classes of commonly used insecticides.  Where both mechanisms are 
functional, resistance can reach extremely high levels (Davies et al., 2007). 
Donnelly et al., 2009, review work undertaken by various groups to monitor resistance 
among Anopheles populations in order to determine whether kdr genotyping does show a 
real correlation with a resistance phenotype.  They conclude that kdr screening, at the 
present time, is the best molecular diagnostic tool for predicting sensitivity of mosquito 
populations to pyrethroids (Donnelly et al., 2009).  However, the authors do consider that 
other mechanisms conferring resistance, such as the metabolic resistance mechanism 
discussed above, may play a bigger role than previously thought, but is momentarily hard 
to screen for due to a lack of diagnostic tools (Donnelly et al., 2009). 
The malaria eradication programs of the 1950‟s and 1960‟s are thought to have been major 
contributors to the selection of pyrethroid and DDT resistance in An. gambiae populations 
(N'Guessan et al., 2003).  However it has been noted that insecticide use in agriculture is 
much more extensive than its usage in vector control with insecticide resistance levels 
being higher in mosquito populations found around urban vegetable growing areas in 
which insecticides against crop pests are used more extensively than in rice field areas 
where insecticide usage is much lower (N'Guessan et al., 2003).  The study by Matambo et 
al. (2007) indicates that selection pressure for resistance by DDT especially causes a high 
movement from susceptibility of a colony to resistance.  This has particularly worrying 
consequences for control measures especially in The Sudan where the colonies of An. 
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arabiensis used in this study were from and indicates that the mosquito is highly adaptable 
when placed under selection pressure. 
A study by N‟Guessan et al. (2007) shows that an insecticide marketed for controlling 
agricultural pests and termites known as Chlorfenapyr has the potential to be used as part 
of a malaria control program.  The study shows that strains of An. gambiae resistant to 
pyrethroids, by means of the kdr resistance gene mutation, and organophosphates, as a 
result of the Acel
R
 insensitive acetylcholinesterase mechanism, gave no indication of cross 
resistance to Chlorfenapyr (N'Guessan et al., 2003).  A more recent eight-week study in 
Benin, West Africa, whereby M-form An. gambiae were tested for susceptibility to 
chlorfenapyr, indicated that although resistance to pyrethroids is well-documented in this 
area, chlorfenapyr had a distinct knockdown effect (N'Guessan et al., 2009).  However, this 
insectide reduced efficacy over time as it has only a short „shelf life‟ of around four weeks.  
The authors suggest that, if longer-lasting formulations become available, this insecticide 
shows promise for malaria control programs, however selection pressure will be placed 
upon mosquito populations, and given that resistance can occur rapidly (Matambo et al., 
2007) it must be taken into consideration that it may not be long before populations of 
mosquitoes become resistant by some mechanism to this insecticide too (N'Guessan et al., 
2009).  Other more sustainable methods of vector control must be given some serious 
thought. 
The creation of genetically modified mosquitoes has been suggested as a way of 
controlling malaria by either of two general methods; population replacement or 
population suppression (Marrelli et al., 2006).   Sparagano and De Luna, 2008, discuss 
both methods of control with reference to population structure amongst disease systems 
which is, of course, a huge consideration when looking at these systems for vector and 
therefore disease control. 
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1.4.1. Population Suppression 
A mechanism which causes a reduction in numbers of vector insects present within an area 
would thereby reduce the transmission of the malaria parasite.  This could be achieved by 
techniques such as the Sterile Insect Technique (Knipling, 1959), or RIDL (Release of 
Insects with a Dominant Lethal) technology (Thomas et al., 2000; Alphey, 2002) or a 
combination of both (Marrelli et al., 2006). 
 
1.4.1.1. Sterile Insect Technique (SIT) 
Sterile Insect Technique (SIT) has been used with well documented success as a method of 
controlling pest insects and disease vectors.  The technique involves release of a large 
number of irradiated sterile males across a wide geographical area, often following a 
program of insecticide use (Alphey, 2002).  Over whole areas in the USA and Central 
America, SIT has been used with some success to control the New World Screwworm fly 
Cochliomyia hominivorax, and in Latin America SIT has been used to combat the 
Mediterranean fruit fly Ceratitis capitata, also a pest insect (Alphey, 2002).  SIT has been 
previously used to suppress the population of Glossina species, the tsetse fly vector of 
African sleeping sickness (trypanosomiasis).  In 1994, Zanzibar initiated a tsetse 
eradication program which was to make use of SIT on the island of Unguja, Zanzibar.  
Sufficient time for six generations of tsetse was allowed to elapse after the last recorded 
catch of male and female flies before release of sterile males was stopped.  The area has 
since been considered free of the insect (Vreysen, 2001). 
Although SIT has been deemed successful in several areas with a variety of insects, it does 
have several limitations as a control method.  SIT requires mass rearing of insects, and 
therefore a huge space in which to keep them.  Only the males are irradiated and released, 
thus the reared population needs sexing and males retaining which is a laborious and time 
 60 
consuming process.  Methods used are seldom completely effective in separating sexes 
(Alphey, 2002).  The process of irradiating males is expensive, and poses a fitness cost to 
the insect, whereby it has been shown that irradiated C. hominivorax males are at a 
disadvantage when compared to wild type males of the same species (Mayer et al., 1998).  
Thus mass release is required in order that the sheer number of these irradiated males 
outweighs the fitness cost and therefore means that they can compete with the wild type 
population for females.  The laboratory-reared males have this decreased fitness due to 
their being smaller than their wild type relations and interruption of physiological 
processes, both caused by the irradiation process itself (Spradbery, 1994).  This is partly 
demonstrated by Helinski and Knols, 2009, by collection of An. arabiensis sperm from 
male reproductive organs to determine both sperm quality and length as a measure of male 
„fitness‟.  This was done using non irradiated lab strain males, field-collected males (from 
the same region as the lab strain was originally collected), as well as pupal-stage radiated 
males and adult-stage irradiated males.  Those males irradiated at pupal stage were seen to 
produce fewer and smaller sperm when compared to unirradiated and those irradiated at 
adult-stage (Helinski and Knols, 2009).  This suggests that whilst natural variation exists, 
as seen in other species and indicated by the results from the males collected from wild 
populations, irradiating males does have an effect on sperm quality when done at certain 
life stages (Helinski and Knols, 2009). 
Different methods of sterilising males have been used to generate flies to be used in SIT 
programs where population reduction was not necessarily the intended outcome (Benedict 
and Robinson, 2003).  In the studies where release of males was intended for population 
reduction there have been varying levels of success, dependent on both the species of 
mosquito and the area in which the study took place (Benedict and Robinson, 2003).  In 
Pensacola, Florida, USA, 4.6 million sterile male Aedes aegypti sterilised by using gamma 
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radiation were released between 1960 and 1961.  Despite good ratios of released males to 
wild males, no reduction in the population was observed (Benedict and Robinson, 2003).  
In 1967 the population of C. quinquefasciatus in Okpo, Myanmar (Burma) was eradicated 
by release of 5000 sterile males daily for 9 weeks.  In this case sterilisation was achieved 
by Cytoplasmic Incompatibility (CI) known to be caused by the presence of Wolbachia 
bacteria (Benedict and Robinson, 2003).  In Burkina Faso, 240,000 sterile male An. 
gambiae were released over a period of 9 weeks.  However, it was seen that male 
competitiveness was poor compared to wild type males, and no significant reduction in 
population numbers was observed (Davidson et al., 1970).  The more successful large-
scale releases of mosquitoes (whereby population suppression, or in some cases 
eradication, was achieved) have tended to occur in populations which are isolated and 
therefore migration effects are not seen (Benedict and Robinson, 2003). 
 
1.4.1.2. Release of Insects with a Dominant Lethal (RIDL) 
Thomas et al (2000) describe a modification to SIT whereby transgene integration 
technology is utilised in order to create an insect which has a dominant gene incorporated 
into its genome causing lethality to insects at a specific life stage.  RIDL is designed to be 
repressible using the tetracycline-repressible expression system as described by Alphey 
(2002) meaning that the action of the lethal gene in the homozygous insects can effectively 
be „switched off‟ in order that the population can be reared in the laboratory under 
conditions used for wild type strains.  When access to tetracycline is removed from the 
population this activates the lethal system, and causes lethality at the intended life stage 
(Figure 3).  The RIDL system ensures that any released homozygous male mating with a 
wild type female passes on the lethal gene to all the offspring and due to the gene‟s 
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dominance, the lethal phenotype is apparent in all female offspring thus reducing the insect 
population. 
The RIDL system can be used, not only to create an insect line containing a gene which, 
when activated, causes life-stage-specific death, but can also use sex-specific splicing of a 
promoter in order that the lethal action of the system is active in only one sex (Thomas et 
al., 2000, Gong et al., 2005, Fu et al., 2007, Morrison et al., 2009). 
In most cases the sex-specific lethality is targeted at females as it is often this sex which 
causes the damage in terms of both crop-pests (oviposition) and vector insects (biting).  
Consequently it is beneficial, should such strains be released as a population control 
method, that females do not survive to reproduce.  With this system it also follows that any 
wild-type females mating with homozygous RIDL males have offspring which survive to 
breed only if they are male.  These males will all carry a copy of the dominant gene and 
will subsequently pass on this gene to a proportion of the next generation following the 
usual Mendelian heritability patterns (Thomas et al., 2000, Gong et al., 2005, Fu et al., 
2007).  In terms of RIDL as a direct modification of SIT, release of a huge number of 
males is reliant on efficient sexing mechanisms.  Morrison et al., 2009, present this lethal 
system in terms of the creation of a transgenic sexing strain (TSS) of Mediterranean Fruit 
Fly (Ceratitis capitata) which would allow for initial mass rearing and, once the colony is 
large enough and a release required, the production of males only.  Following competition 
studies, the authors suggest that these TSS strains are competitive enough against wild-
type strains to allow for further research prior to eventual release (Morrison et al., 2009). 
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Figure 1.3:  An illustration of the tetracycline-repressible expression system. 
Expression of the tetracycline-repressible transcriptional activator (tTAV) is under the 
control of a promoter of choice (in this case the Ae. aegypti Actin4 promoter which drives 
expression of Act4 primarily in female flight muscle).  The translated tTAV protein binds 
to the tetO operator DNA sequence, resulting in activation of a minimal promoter.  This 
leads to expression of an effector protein, which results in the flightlessness of the insect.  
In the system represented above, VP16 from the Herpes simplex virus is the effector 
protein which builds up in the flight muscle of the mosquito causing flightlessness and 
consequently, death.  Presence of a low level of tetracycline prevents binding of tTAV to 
tetO by itself binding to the tTAV protein.  Adapted from Alphey, 2002. 
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Effector protein causes 
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This system has certain advantages over traditional SIT in that it doesn‟t require facilities 
for sex separation or irradiation.  RIDL males do not undergo irradiation therefore released 
RIDL males would be fitter in terms of sperm competition than released SIT males 
(Alphey, 2002).  Other fitness costs associated with the irradiation step involved in SIT as 
discussed by Mayer et al. (1998) for the new world screwworm fly C. hominivorax would 
also be removed, however the RIDL system is not problem-free. 
Mayer et al. (1998) discuss, with reference to SIT, the reasons why factory-reared C. 
hominivorax males are less competitive for females than wild type males.  Some of the 
reasons are SIT-specific, for example due to irradiation effects, however some are 
applicable to any laboratory-reared species and would also pose a problem for the RIDL 
system.  Handling of and dispersal of flies can cause damage to wings and legs, for 
example, thus reducing fitness.  Laboratory reared strains are under very different natural 
selection pressures to those placed upon natural populations.  As such, they may possess 
different behaviours not suitable to successful release into a wild population which may 
cause a reduction in competitive mating compared to the wild type males (Mayer et al., 
1998). 
RIDL also poses a further problem which is irrelevant in SIT.  Release of genetically 
modified organisms (GMOs) is always a cause for concern for both the public and 
governing bodies.  A good example of this has been given by the ongoing arguments for 
and against release of genetically modified or altered crops as discussed by Dlugosch and 
Whitton (2008).  This paper also highlights a possibility that transfer of the transgene to 
neighbouring plants via gene flow mechanisms is occurring in the absence of direct 
selection pressure favouring the transgene (Dlugosch and Whitton, 2008).  Although this 
finding occurs in plants, it only serves to concern the scientific community as well as 
regulatory bodies about the action of releasing any GMOs including insects.  It would be 
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wise, as suggested by Alphey (2000), to ensure that any RIDL gene introduced into an 
insect should not be linked with resistance to insecticide or antibiotic, therefore incurring 
no selective advantage under those selection pressures. 
Stability of the transgene involved in the RIDL system is a major concern given that 
transformation of insects such as mosquitoes involves the use of transposable elements 
such as minos, Hermes, mariner and piggyBac  (Lobo et al., 2006; Alphey, 2002).  The 
involvelment of mobile DNA elements poses a theoretical risk that a transgene may alter 
its location within a genome or even transfer horizontally to other individuals or species. 
Knols et al., 2007, discuss the implications of using genetically modified mosquitoes to 
control malaria.  They suggest that the use of these transgenic mosquitoes, whilst being 
(theoretically at least) a promising control strategy, requires careful management in terms 
of not only overcoming difficulties with public perception of GMOs in general, but also 
ensuring proper consideration of release (Knols et al., 2007). 
 
1.4.2. Population Replacement 
If a population of vector were to be replaced by insects of the same species but which were 
refractory to the malaria parasite then a reduction in transmission of malaria would also be 
noted.  There are many issues with this method of reducing transmission of a disease, such 
as the release of GMOs which is part of an ongoing debate, stability of the transgene 
associated with refractoriness to the disease within the population of released insects 
(Sethuraman et al., 2007; Scali et al., 2007, Woods et al., 2007, Franz et al., 2009), as well 
as relative fitness of the transgenic insect in comparison to the wild type (Marrelli et al., 
2006). 
Marelli et al. (2006) discuss the associated fitness costs related to the creation of transgenic 
mosquitoes and examine the issues which surround the need for a drive mechanism to push 
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the transgene through the population thus creating a refractory strain.  The creation of 
transgenic mosquitoes has been made possible by fine tuning of transformation techniques, 
and the invention of site-specific transformation systems (Lobo et al., 2002; Nimmo et al., 
2006).  Fluorescent markers and appropriate promoters are now also known to work in 
mosquito species and so the creation of refractory lines of various different species of 
mosquito vectors to their respective diseases has been made possible (Horn et al., 2003). 
 
1.4.2.1. Effector genes and their promoters 
The mobile ookinete stage of the parasite develops in the midgut and traverses the mid gut 
epithelium becoming an oocyst which then encounters the haemocoel of the mosquito.  
After a certain length of time, the oocyst bursts to release sporozoites which invade the 
salivary glands.  The ideal transgenic anopheline mosquito would therefore express an 
appropriate effector gene expressed in the gut, haemocoel or salivary glands which would 
target the developing or migrating Plasmodium parasite (Jacobs-Lorena, 2003). 
Several research groups have successfully created transgenic strains of mosquito that carry 
genes associated with refractoriness to a particular parasite.  Jacobs-Lorena (2003) 
describes transformation of An. stephensi, a malaria vector, whereby the transgenic strain 
expresses a tetramer peptide known as SM1 (Salivary-binding and Midgut-binding protein 
1).  The protein was found by screening a phage display peptide library for phages that 
bind to midgut and salivary gland epithelia thus preventing parasites (Plasmodium species) 
binding to these surface due to their using a common receptor (Ghosh et al., 2002).  
Expression of this peptide was linked to a carboxypeptidase promoter and infection studies 
with P. berghei showed a reduction in oocyst number of 80% when compared to the 
control (Ito et al., 2002).  Transformation of An. stephensi whereby the transgenic 
mosquito expresses bee venom phospholipase A2 (PLA2) under control of a 
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carboxypeptidase promoter from An. gambiae has also been undertaken (Jacobs-Lorena, 
2003).  Transgenic mosquitoes were challenged by a P. berghei infection and an 87% 
reduction in oocyst numbers was observed (Moreira et al., 2002).  Moreira et al. (2002) 
inhibited PLA2 enzyme activity and again looked at development of the parasite which 
continued to be impaired.  Inactivity of the enzyme suggests that the enzyme acts on the 
parasite purely by its binding action to exposed membrane lipids.  There is also further 
evidence to suggest it does not actually kill the parasite, but merely impedes its 
development Moreira et al., 2002).  The ideal situation would be that the expressed gene 
would encode a peptide which caused death of the parasite. 
A study by Yoshida et al. (2007) demonstrates that transgenic An. stephensi expressing C-
type lectin CEL-III isolated from the sea cucumber Cucumaria echinata, when challenged 
with a P. berghei and P. falciparum infection, show an impairment of development of both 
rodent and human parasites.  Expression of the effector gene was driven by the An. 
gambiae carboxypeptidase promoter therefore the protein was localised to the midgut 
(Yoshida et al., 2007).  CEL-III was seen to haemolyse red blood cells of both humans and 
rats both in vitro and in the midgut of the transgenic An. stephensi.  It is also known to 
induce apoptosis, thus causing destruction of the red blood cells before the gametocytes 
differentiate (Yoshida et al., 2007).  Although the protein was not seen to haemolyse 
mouse erythrocytes, there was still a reduction in oocyst numbers in comparison to the 
control, thus indicating that CEL-III may have a direct effect on the parasite, and may also 
possibly reduce fertilisation efficiency of the parasite (Yoshida et al., 2007). 
James (2003) reviews the use of effector genes that target the salivary gland stage of the 
malaria parasite.  He makes the point clearly that various studies have shown that there is a 
substantial difference between regions of the anopheline salivary gland lobes.  The 
sporozoites have been shown to prefer to invade the distal-lateral and medial lobes of the 
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female salivary glands (James, 2003).  This has obvious implications for the inclusion of 
salivary gland targeting peptides expressed in a transgenic mosquito. 
Catteruccia et al. (2005) expressed EGFP under the control of the ß2-tubulin promoter in 
the gonads of 3
rd
 instar larvae (and later stages) of An. stephensi in order that efficient sex 
separation be possible either manually or by automated sorting machines thus creating a 
viable sexing strain which could be used for application in vector control programs.  The 
fluorescent sperm produced by these transgenic mosquitoes was shown to be viable and the 
males were capable of mating normally (Catteruccia et al., 2005).  Following on from this 
work, Windbichler et al., 2008, transformed An. gambiae with the EGFP marker expressed 
as a fusion protein with the homing endonuclease, I-Ppol, in the hope that this enzyme 
would behave as it does in An. gambiae cell lines and selectively cleave ribosomal rDNA 
repeats exclusive in An. gambiae to the centromeric region of the X chromosome thus 
rendering this chromosome unable to function properly and thus distorting the sex ratio 
with a male bias.  The experiments showed that distortion of the sex ratio towards a male 
bias is possible though embryonic lethality occurred as well which in itself is an interesting 
observation, again in terms of mosquito control, but both areas require further study 
(Windbichler et al., 2008). 
For an effector gene to be successful it has to be expressed at the right time and in the right 
place to target the particular parasite stage.  Several promoters have been discovered which 
can be linked to the effector gene to ensure it is transcribed at the correct time.  Yoshida 
and Watanabe (2006) describe the discovery and use of a salivary gland-specific promoter 
driving expression of anopheline anti-platelet protein (AAPP).  The authors constructed a 
cDNA expression library from mRNA collected from female An. stephensi at 6 hours post 
blood meal.  After cloning a cDNA, sequence analysis showed that the gene encodes a 
homologue of an Ae. aegypti 30 kD allergen of unknown function.  The sequence of the 
 69 
cDNA was identical to the gene encoding An. stephensi GE-rich protein which inhibits 
platelet aggregation and was therefore termed AAPP (Yoshida and Watanabe, 2006).  An. 
stephensi embryos were transformed with a vector containing the 1.7 kb AAPP promoter 
region, the DsRed reporter gene and the Antryp1 polyadenylation signal.  RT-PCR analysis 
showed that an abundance of DsRed mRNA was expressed specifically in salivary glands 
of female An. stephensi and not in male salivary glands.  Maximal expression of the DsRed 
gene was found to be at 48 hours post blood meal which corresponded to maximum levels 
of the AAPP mRNA expression as confirmed by qRT-PCR analysis (Yoshida and 
Watanabe, 2006).  The authors conclude that a robust salivary gland expression system is 
viable in An. stephensi mosquitoes to drive a salivary gland-specific effector gene. 
Studies by Chen et al. (2007) indicated that the An. gambiae vitellogenin promoter can be 
used to drive EGFP marker expression in transgenic An. stephensi.  As the major yolk 
precursor, vitellogenin gene transcription is up-regulated following a blood-meal, with 
expression localised to the fat body of a female thus making the promoters of such genes 
theoretically useful for targeting Plasmodium sporozoites traversing the haemolymph 
(Chen et al., 2007b).  Initial expression of vitellogenin genes occurs earlier than the 
appearance of sporozoites in the haemolymph of the female mosquito, however the authors 
suggest that, as An. gambiae and An. stephensi are known to take multiple blood meals, 
this would cause sufficient transcription for an effector to be present at the same time as 
haemolymph sporozoites (Chen et al., 2007b).  In this set of experiments, An. stephensi 
were injected with a construct whereby EGFP was expressed under control of the An. 
gambiae vitellogenin gene, but with the 3‟ UTR from the homologous mammalian gene 
(BGH) which may account for the longer-lasting presence of EGFP mRNA in the 
mosquito than was expected, though the actual mechanism behind this requires further 
investigation (Chen et al., 2007b).  As such, it remains unclear as to whether one can say 
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for definite that the vitellogenin promoter would ideal for driving expression of an effector 
molecule targeting sporozoites in the female mosquito haemolymph, so further 
investigation is required in order to answer this question (Chen et al., 2007b). 
A recent study by Franz et al. (2009) has highlighted a problem with using the 
carboxypeptidase promoter for driving expression (in the female mid-gut after a blood-
meal) of an antiviral effector gene in Aedes aegypti.  The mosquitoes were transformed 
using a mariner vector containing containing the Aedes carboxypeptidase promoter driving 
expression of inverted repeat (IR) sequences which would eventually form dsRNA from 
IR-RNA to trigger an RNAi response targeting Dengue virus serotype 2 (DENV-2) (Franz 
et al., 2006).  The initial studies by Franz et al. (2006) on the established Carb77 line, up 
until Generation 8, indicated, by use of Northern blot analysis, IFAs and plaque assays, 
that the vast majority of individuals belonging to this transgenic line showed high 
resistance levels to infection with DENV-2.  Presence of siRNAs derived from the IR 
transgene were found to be present which is indicative that the mosquitoes were 
completely blocking virus transmission past the midgut stage by use of the RNAi 
mechanism (Franz et al., 2006). 
When testing the same Carb77 strain at later generations (G9-G17), Franz et al. (2009) 
showed that although the RNAi mechanism still provided the basis for the resistance 
phenotype, it was seen in fewer mosquitoes and had been completely lost by G17.  The 
authors conclude that mutation in either the virus or the transgene was not the cause for 
phenotype loss, however, IR effector gene expression was undetectable in G17 mosquitoes 
using Northern blot and qRT-PCR techniques, though the transformation marker was still 
present (Franz et al., 2009).  Loss of expression may just be a phenomenon unique to this 
single situation, but nevertheless is indicative that serious consideration is required when 
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designing refactory mosquitoes as transgenic insects would only be thought of as a viable 
control method if the transgene were proved to be stable over time (Franz et al., 2009). 
It is possible to drive effector gene expression in the necessary environments to reduce 
parasite transmission at the insect stage.  However there are clearly both ethical and 
scientific problems to be overcome before this method of control can be implemented.  
Jacobs-Lorena (2003) suggests the use of more than one promoter-effector gene targeting 
more than one life stage of the Plasmodium parasite in order to reduce the likelihood of the 
wild type Plasmodium overcoming the effector gene and thus becoming resistant. 
 
1.4.3. Fitness costs associated with transgenic mosquitoes 
Marelli et al. (2006) discuss the fitness costs involved in the creation of transgenic 
mosquitoes with special regard to the actual burden from the transgene product and 
insertional mutagenesis.  These studies have shown that transgenic mosquitoes capable of 
reducing their parasite burden have a clear advantage over non-transgenics with the same 
background.  This indicates that being able to kill the parasite is desirable in fitness terms 
but only when fed on mice infected with gametocyte-producing parasites (Marrelli et al., 
2007).  This advantage may not transfer well to the field as infection rates are so low and 
the advantage may be outweighed.  However many other studies looking into fitness in 
transgenic insects indicate there is a cost in reproductive fitness to transgenic insects 
possibly associated with inbreeding to a large degree and maintenance of homozygous 
lines (Marrelli et al., 2006).   
Studies by Li et al. (2008) tested three transgenic An. stephensi lines in terms of fitness 
loads of the inserted transgene as well as mating success and reproductive capacity.  All 
three lines express the SM1 peptide under control of the vitellogenin promoter but have 
differing insertion sites with one line (VD9) containing a double insertion.  In cage 
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experiments, whereby homozygous transgenic lines were competing with their non 
transgenic counterparts, the frequency of the transgene decreased over time (Li et al., 
2008).  Further study suggested that this observation was due to reduced mating success 
and mating capacity of the transgenic lines, leading to the conclusion that a driving 
mechanism would be required to overcome the fitness cost associated with the transgenic 
mosquito if they were to be released for control purposes (Li et al., 2008).  This 
replacement method of population control will only work in the field if the transgenic 
mosquito can out-compete its wild type counterparts for resources.  When considering the 
population suppression strategy using RIDL technology, whereby mass release of 
transgenic males is necessary then these released males must be able to compete 
effectively against their wild type counterparts for females in order for the strategy to have 
any chance of working.  Mating competitiveness of transgenic An. arabiensis males was 
looked at by Howell and Benedict (2009).  The transgenic strain expresses EGFP under 
control of the ß2-tubulin promoter as well as a DsRed transformation marker driven by the 
eye-specific 3xP3 promoter.  Mating experiments were conducted in small cages and 
spermathecae examination as well as blood feeding/egg laying/screening determined the 
ability of heterozygous males to mate successfully when  competing for genetically similar 
or dissimilar females with wild-type males (Howell and Benedict, 2009).  These 
experiments show that the genetic background of neither males nor females has an effect 
on male survival or frequency of mating thus indicating that, for this species, with this 
insertion, there is no cost in terms of male competitiveness.  Clearly this study does not 
provide conclusive proof that all transgenic insects are able to compete effectively with 
wild-type counterparts but does go someway to suggesting that larger scale field trials are 
worth doing (Howell and Benedict, 2009). 
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In summary, fitness of transgenic mosquitoes needs to be compared not only with non-
transgenic laboratory populations but with out-bred populations which will resemble field 
populations more closely.  Also, linking of the transgene to a drive mechanism may prove 
useful (Marrelli et al., 2006). 
 
1.4.4. Drive mechanisms 
Sinkins and Gould (2006) review various selfish genetic elements, including transposons, 
meiotic drive genes, homing endonuclease genes and Wolbachia.  All of these have a 
degree of potential for driving effector genes through a population of vector insect if they 
are more fully understood (Sinkins and Gould, 2006). 
Chen et al. (2007) report a synthetic drive mechanism first described in the beetle 
Tribolium castaneum and termed medea (maternal effect dominant embryonic arrest).  This 
triggers maternal-effect lethality of offspring that do not inherit the element-bearing 
chromosome from the maternal or paternal genome.  The authors created a synthetic 
medea-like transgene to be used in the model organism Drosophila.  A P element vector 
was used that contained a bicoid (maternal-germline specific gene expressed in early 
embryo development) promoter to drive expression of a polycistronic transcript encoding 
two microRNAs (miRNAs) designed to silence expression of myd88.  The latter is a gene 
responsible for dorsal-ventral patterning of the early embryo.  Females experiencing loss of 
function of myd88 in the germline produce embryos that do not hatch even with a wild type 
allele present (Chen et al., 2007a).  The vector, known as medea
myd88
, also coded for a 
zygotic „antidote‟ gene whereby the embryo-specific bottleneck (bnk) promoter drives 
expression of a maternal miRNA-insensitive myd88 transgene (Chen et al., 2007a).  The 
experiment showed that all surviving adult progeny carried the medea
myd88-1
 synthetic 
element, suggesting that a single copy of bcd-driven miRNAs targeting myd88 expression 
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was sufficient to induce maternal-effect lethality and a single copy of zygotic bnk-driven 
myd88 expression was adequate for rescue (Chen et al., 2007a).  If a synthetic medea 
element was constructed for use in mosquitoes and linked to one or more effector genes, 
there is evidence to suggest, if introduced into a population at a high enough frequency, it 
would rapidly transform the population into element-bearing heterozygotes and 
homozygotes.  However, these models do not take into account migration, non-random 
mating and genetic drift, which must be considered in terms of „real‟ populations 
especially where species complexes such as An. gambiae are concerned (Chen et al., 
2007a).  There is still a great deal to be discovered about these elements and their function 
in the mosquito.  In addition, little is known about the genes and promoters used during 
early embryonic development in such species.  However medea elements have definite 
possibilities as a genetic drive mechanism for anti-parasitic transgenes. 
Rasgon (2009) suggests multi-locus assortment (MLA) as a method of transgene dispersal 
among mosquito populations.  This involves release of mosquitoes carrying anti-parasite 
effector genes at multiple genomic locations.  The study indicates that only four transgenes 
at different loci are required, and, depending on fitness cost of said transgenes, they can be 
maintained within the population by sequential releases of relatively small numbers 
whereby halted release would cause transgene elimination over time (Rasgon, 2009).  
However it is not likely that transgenes would be spread across wide geographical areas 
using this method of dispersal especially if there is an imposed fitness cost associated with 
carrying the transgenes themselves, and as such, MLA would be useful only in terms of 
dispersal within defined local areas (Rasgon, 2009).  There are also limitations imposed by 
use of the mathematical models themselves as they assume parameters which are not 
necessarily a reflection on the real situation, and would need to be addressed as entirely 
separate issues (Rasgon, 2009). 
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Different gene drive systems have different properties.  For example, Engineered 
Underdominance (EU) is able to drive its two associated transgenes to high and stable 
frequencies within a population but does require the release of a larger number of insects 
than other systems would, whilst Meiotic Drive (MD) and Wolbachia systems are unable 
to maintain high frequencies, but can drive the spread of the transgene from initial low 
frequencies (Huang et al., 2007).  It has thus been suggested that a combination of gene 
drive strategies can be utilised as an improved method of driving inserted transgenes across 
insect populations (Huang et al., 2007).  The authors use statistical modelling techniques to 
determine the combination of EU, MD and Wolbachia systems which could increase gene 
drive efficiency.  The differing properties of each system indicates, via the models, that a 
combination of EU with either MD or Wolbachia may provide a plausible mechanism of 
transgene dispersal through insect populations and is certainly worthy of further thought in 
order that a combination strategy can be given a thorough assessment (Huang et al., 2007). 
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1.5. Transformation using Transposable Genetic Elements 
Transposable genetic elements are capable of promoting recombination reactions which 
result in the movement of the element from one site in the genome to another (O'Brochta 
and Atkinson, 1996).  Class I transposable elements transpose using a mechanism similar 
to that involved in retroviral integration, by reverse transcription of an RNA intermediate.  
Class II appear to transpose directly from DNA to DNA using a cut and paste mechanism 
(O'Brochta and Atkinson, 1996; O'Brochta et al., 2003).  The  P element has been used 
successfully for germline transformation of Drosophila with great success, and remains the 
transposon of choice in this insect (Rubin and Spradling, 1982;Venken and Bellen, 2007).  
It has however proved unsuccessful in transformation of non-drosophilid insects where 
class II transposable genetic elements, such as mariner, minos, Hermes and piggyBac are 
used for effective germline transformation (O'Brochta et al., 2003). 
Class II transposons such as those mentioned above are generally short to medium length 
sequences of less than 10kb, and encode the transposase enzyme which catalyses the 
transposition event through the inverted terminal repeat sequences at either end of the 
element (O'Brochta and Atkinson, 1996; Venken and Bellen, 2007).  A schematic of a 
generalised transposon is shown in Figure 4. 
Since the successful transformation of Drosophila using P elements in the early 1980s, 
progress has been made in order that it is now possible to transform several different insect 
species including vector species such as Ae. aegypti, An. stephensi and An. gambiae with 
various transposable elements (Grossman et al., 2001; Catteruccia et al., 2000; Coates et 
al., 1998; Jasinskiene et al., 1998). 
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Figure 1.4:  A generalised schematic of a Class II transposon showing the transposase 
gene flanked by inverted terminal repeat sequences 
When using transposons (A) for transformation of insects the transposase gene is replaced 
by a transgene of choice, possibly an anti-malaria effector gene (B). The transformation 
vector is injected into the embryo with a helper plasmid (C) containing the transposase 
gene sequence, or transposase mRNA  (Lobo et al., 2006; Nimmo et al., 2006). 
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The Class II transposon piggyBac is a 2.4kb long transposable element, originally isolated 
from baculovirus genomes from infected Trichoplusia ni (Lepidopteran) cells (Fraser et 
al., 1995), which has been used successfully in transformation of many insects including 
mosquitoes (Grossman et al., 2001; Kokoza et al., 2001; Lobo et al., 2002; Moreira et al., 
2002; Allen et al., 2004; Sethuraman et al., 2007).  The element terminates in 13bp perfect 
inverted repeats and also contains internal asymmetrically located 19bp internal inverted 
repeats (Cary et al., 1989).  Its open reading frame (ORF), at 1783bp in length, encodes a 
protein consisting of 594 amino acids at a predicted mass of 68kDa.  This protein, as with 
all transposons, is an enzyme which catalyses transposition of the piggyBac element itself 
at a specific TTAA target site (Fraser et al., 1995). 
Precise excision of piggyBac from the donor site is via a hairpin intermediate created at the 
donor ends and involves cleavage at the recognition site leaving TTAA overhangs on the 
ends of the donor DNA meaning a simple ligation reaction is all that is required for these 
ends to re-join (Mitra et al., 2008).  This hairpin intermediate leaves TTAA overhangs on 
the 5‟ ends of the excised linear transposon which base-pair with 5‟ TTAA single-strand 
gaps on the target-site DNA which again can be sealed by a ligation reaction (Mitra et al., 
2008).  It is suggested that piggyBac is a member of the DDC recombinase superfamily 
due to the evidence collected from studies on its transposition mechanism (Mitra et al., 
2008). 
Experiments to truncate the n and c-terminals, cause specific amino acid mutations and 
targeted gene deletions of the ORF coding for the transposase enzyme, demonstrate that a 
functional nuclear localisation signal (NLS) is present within c-terminal residues (Keith et 
al., 2008).  A NLS is necessary for the enzyme to be active in the presence of the nuclear 
envelope of a cell as this would require interaction with nuclear transport proteins allowing 
the transposase access to the nucleus of S2 cells (Keith et al., 2008). 
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Lobo et al (2006) describe a protocol pertaining to high efficiency transformation of 
mosquitoes.  This is based on micro-injection of plasmid DNA containing the required 
effector gene under transcriptional control of an appropriate associated promoter. The 
chosen transposon inverted terminal repeats flank the effector gene/promoter and marker 
sequences. The plasmid DNA requires injection with a „helper plasmid‟ containing the 
transposase gene in order that the transposon can facilitate the jumping of the effecter gene 
into the genome of the mosquito (Lobo et al., 2006).  Injection of the plasmid DNA with 
transposase mRNA is also possible for successful integration into the genome of the target 
species (D. Nimmo, personal communication). 
Transformation of mosquitoes using transposable elements has always been proved 
difficult, even with laboratories investing a large amount of time in fine-tuning techniques 
designed to improve efficiency.  Transformation frequencies are often low, for example, 
transformation of Ae. aegypti with piggyBac is typically around 8% (Handler, 2002).  
Often, laboratories experience different transformation efficiencies with a relatively large 
range between individual experiments as illustrated by Lobo et al (2002) where 
efficiencies ranged between 0% and 13%.  Catterucia et al. (2000) showed transformation 
efficiencies of 7% when using a minos element to transform An. stephensi and indicate that 
the first experiments yielded a much lower survival efficiency than later ones.  Typically, 
those experiments showing higher transformation effiencies were the same as the later ones 
which gave a greater survival rate.  Grossman et al (2001) also discuss poorer survival 
efficiencies near the beginning of their study, hypothesising that as they improved their 
protocol for microinjection and after-care of the embryos, they achieved a greater survival 
rate. 
Even when transformation is successful there are still limiting factors when using 
transposons to facilitate insertion of novel DNA into a mosquito.  There is a natural 
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limiting carrying capacity associated with transposons which limits the size of the effecter 
gene the element can insert into the host insects genome (Nimmo et al., 2006).  The 
transposition event is essentially random within the genome, and therefore can result in 
insertional mutagenesis.   This involves disruption of the function of a gene required for 
normal function of the mosquito, for example a housekeeping gene.  This results in death 
or severe deformation of the progeny of the G0 survivors.  It is also possible for there to be 
a position effect on the transgene itself due to its site within the genome causing low 
expression levels, and the gene not functioning as it should in order to be effective within 
the transgenic mosquitoes (Nimmo et al., 2006). 
Nimmo et al. (2006) discuss a site-specific system that proposes to overcome the three 
main problems associated with transposon-mediated transgene insertion into the mosquito 
germline.  This system, from a Streptomyces bacteriophage, was shown to work in both 
Eschericia coli cells and in vitro assays using purified integrase to catalyse recombination 
of attP with attB sites to generate new products (attL and attR) which are junctions no 
longer recognised by integrase thus meaning that the system is unidirectional (Thorpe and 
Smith, 1998). 
Studies using Drosophila S2 cells have indicated that recombination occurs at a rate of 
around 50%.  In embryos, the recombination rate is around 80 to 100%, producing 
transgenic Drosophila in the range of 43 to 56% of fertile adults at attP sites previously 
inserted using P element (Groth et al., 2004).  Therefore this system is seen to be an 
improvement on previously used methods of genetically modifying the fly genome, 
generating a transgenic frequency of 8% (once optimised) as opposed to 2% using the 
transposon-mediated conventional method.  The phiC31 system also produced a higher 
transformation rate than both the FLP and homologous recombination systems and requires 
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the generation of only one suitable attP-containing line which can then be used indefinitely 
for gene insertions using the phiC31 system (Groth et al., 2004). 
In Drosophila, this site-specific integrase system has been optimised whereby visual 
selection for precise attP targeting has been generated using a white-gene based 
reconstitution system, and it is demonstrated that chromosomal attP sites can be modified 
in situ thus increasing efficiency as docking sites (Bischof et al., 2007). 
In the case of Ae. aegypti, Nimmo et al. (2006) used the piggyBac transposon to 
incorporate an attP insertion site into the genome of this target species.  The authors 
characterised genomic integration sites of this construct by inverse PCR, and four 
homozygote lines were used to test the site-specific phi C31 integration system by 
microinjection of integrase mRNA and a construct containing the attB site and a DsRed 
marker linked to an eye-specific promoter.  Interaction between attP and attB sites is 
mediated by integrase and creates attL and attR junctions that are no longer recognised by 
integrase, therefore making the system unidirectional.  Transformation efficiency for this 
second phase of the experiment averaged 23%.  Southern blotting and PCR techniques 
were used to confirm site-specific integration at attP target sites at the molecular level 
(Nimmo et al., 2006). 
The site-specific integration system has, in theory, an unlimited carrying capacity, meaning 
that multiple transgenes can be incorporated into the genome of a mosquito targeting 
different life stages of the parasite.  The system also overcomes the problems of insertional 
mutagenesis and position effects by careful selection of the attP target sites. 
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1.6. Stability and re-mobilisation of transposons 
A major problem associated with the use of transposons to insert transgenes into the 
genome of mosquitoes is the potential for remobilisation.  Further transposition events 
after the element has become incorporated into the genome may lead to a lack of stability 
of the associated transgene.  This clearly has implications at the population level, and may 
cause concern were transgenic mosquitoes to be released.  It would be impossible to 
accurately describe future phenotypes of descendents of released transgenic mosquitoes 
within a population, or model the behaviour of a transgene over a period of time in 
modified species if there was instability linked to the transgene itself due to its association 
with the transposon (O'Brochta et al., 2003). 
Several studies have been undertaken to assess the potential that remobilisation occurs 
after the initial insertion of the element into the genome.  Catterucia et al. (2000) showed 
that it was possible to transform An. stephensi using the minos element.  In 2001, Kokoza 
et al were able to transform Ae. aegypti using the piggyBac element.  Although proving 
that successful germ-line integration of novel DNA using transposons is possible, these 
experiments did not test the stability of these integrations in successive generations.  Since 
then, several studies have been undertaken to assess the re-mobility potential of various 
transposons in different insect species (O'Brochta et al., 2003; Horn et al., 2003; Lorenzen 
et al., 2007; Scali et al., 2007; Wilson et al., 2003).  These studies have indicated that 
different transposons do not behave in the same manner in any one particular organism.  
They also show that the same transposon may behave differently in another organism, even 
when considering related species.  For example, Hermes transforms Drosophila with a 
frequency of over 50%, but transforms Ae. aegypti with a frequency of less than 10% 
(O'Brochta et al., 2003).  Mariner has been shown to remobilise efficiently in D. 
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mauritiana but very inefficiently in D. melanogaster, even though they are closely related 
species (O'Brochta et al., 2003). 
Remobilisation of the Hermes element is discussed by O‟Brochta et al (2003).  The 
remobilisation potential of the element in Ae. aegypti was assessed using transposable 
element (TE) display.  In this technique genomic DNA from individuals is digested with 
restriction enzymes resulting in a junction fragment between the transposon and the wild-
type DNA.  The ends of the fragment are ligated to specific adapters, and a nested PCR 
reaction follows, whereby the second reaction uses an element-specific primer labelled 
with Cy5.  The fragments are size fractionated by denaturing acrylamide gel 
electrophoresis and visualised on a phospho-imager (O'Brochta et al., 2003).  Darker bands 
(representing an abundance of product) of a different size to the expected fragment length 
indicate that remobilisation has occurred within the germline and the element has been 
inherited vertically.  Weaker bands represent transposition events occurring in somatic 
cells of an individual (O'Brochta et al., 2003).  Well isolated bands can be excised, cloned 
and sequenced to confirm the presence of the Hermes terminal sequences and the unique 
flanking genomic DNA resulting from the transposition event.  These techniques have 
demonstrated that remobilisation of the Hermes element occurs in the soma of Ae. aegypti 
however it has not been shown to remobilise in the germline of this species.  It does 
however show remobilisation potential in the germline of Drosophila (O'Brochta et al., 
2003). 
Similarly, Scali et al. (2007) have demonstrated that an X-linked minos element does not 
appear to remobilise within the germline of An. stephensi mosquitoes, but transposition and 
excision events are common within the somatic cells of males heterozygous for both the 
transposon and the transposase.  The transposon piggyBac was used to create transgenic 
helper lines expressing the minos transposase gene.  An ML10 donor line was created 
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using the minos element containing the EGFP gene under the control of the D. 
melanogaster actin5C promoter.  Both lines were characterised using southern blot 
techniques (Scali et al., 2007).  Virgin homozygous ML10 females were crossed with 
homozygous helper line males.  Male progeny were then crossed with virgin wild-type 
females and their progeny were assessed for remobilisation events using TE display (Scali 
et al., 2007). 
In Ae. aegypti it has been shown that the Mos1 mariner element is only rarely able to 
remobilise in somatic cells, and is even less likely to transpose in germline cells.  This 
study was undertaken in a similar manner to that described above, using transposase-
expressing helper strains crossed with donor strains containing a Mos1 element flanking a 
marker/promoter sequence.  TE display was again used to assess remobilisation events 
(Wilson et al., 2003).  The fact Mos1 shows a low potential for remobilisation when 
compared to Hermes indicates that it may be a useful tool for introduction of stable 
transgenes within a population of Ae. aegypti.  The authors do suggest however, that the 
lower remobilisation potential of this transposon may be due to the lack of critical 
sequences and/or sub-optimal spacing of the inverted terminal repeat sequences (Wilson et 
al., 2003).  More recent studies of the mariner transposon have demonstrated that 
transposition rates are temperature-dependent whereby higher temperatures cause a 
decreased rate possibly related to the transposase enzyme kinetic properties altering at 
higher temperatures (Sinzelle et al., 2008).  This may have an impact on not only initial 
integration events into host genomes using mariner, but also on remobilisation potential 
post-integration especially when it is considered that mosquitoes are responsive to ambient 
surrounding temperatures. 
Horn et al. (2003) reported that the piggyBac element remobilises in the presence of 
transposase in D. melanogaster at a rate similar to the P element.  This appears also to be 
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the case in the beetle T. castaneum as shown by Lorenzen et al. (2007) whereby the donor 
element containing an EGFP marker was remobilised in 84% of hybrid crosses.  
Sethuraman et al. (2007) have shown that, contrary to studies using other species, 
piggyBac is stable in the soma of Ae. aegypti and did not remobilise the reporter gene 
when the transposase source was provided by either a helper plasmid or by a transposase-
expressing helper line.  The authors have also shown no transposition events occurred in 
the germline of Ae. aegypti in the absence or presence of a transposase source.  These data 
indicate that piggyBac may indeed be a good tool for integration of effector genes into Ae. 
aegypti as these integration events would be stable and show a very low propensity for 
remobilisation thus causing less concern about excision of, or movement of the gene within 
the genome of the species concerned.  Vertical transmission may still be possible. 
 
Future work 
PiggyBac is commonly used in the transformation of many organisms (Handler, 2002).  
This includes the major African malaria vector An. gambiae (Grossman et al., 2001).  It 
would therefore be very beneficial to look at the potential for remobilisation of this 
transposon within An. gambiae as this insect species is the target for many studies 
regarding the creation of transgenic lines refractory to the malaria parasite. 
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1.7. Aims and Objectives 
The overall aim of the work undertaken here was to create a transgenic line of Anopheles 
gambiae containing an effector gene which, in the absence of tetracycline, would be 
expressed, resulting in a female-specific flightless phenotype.  Females of this line, when 
reared without tetracycline, are not able to mate or feed and thus the phenotype is akin to 
that of a line containing a dominant lethal gene.  This transgenic line, once generated, was 
to be characterised and assessed for the remobilisation potential of the piggyBac 
transposable element used in the integration process.  A further aim was to assess the 
fitness of a previously generated transgenic line, EVida3, containing an effector gene 
known to be active against Plasmodium parasites in the mosquito midgut.  Therefore the 
objectives for the work undertaken here were as follows: 
I. Creation of a transgenic RIDL strain of Anopheles gambiae using the double-ended 
piggyBac system ( Dafa‟alla et al., 2006) to insert the RIDL gene into the genome 
of An. gambiae and utilisation of this system to test the remobilisation potential of 
piggyBac in An. gambiae as well as the application of RIDL technology in An. 
gambiae 
II. Assessment of the effect of multiple blood meals on the anti-malarial properties of 
the Vida3 peptide within transgenic An. gambiae.   
III. Initial laboratory-based fitness studies on the transgenic EVida3 line of An. 
gambiae.   
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Chapter Two 
2. Microinjection of Anopheles gambiae 
2.1. Introduction 
The introduction of novel DNA into insects was documented in the model organism 
Drosophila melanogaster by Rubin & Spradling in 1982.  This work showed that, by using 
the 3Kb transposon, P element, a stable, heritable integration of a known genetic sequence 
was not only possible, but was efficient and reproducible.  The wild-type phenotype in the 
transformed strain was rescued thus indicating correct expression of the inserted gene 
(Rubin and Spradling, 1982).  Initial introduction of the plasmid carrying the wild-type eye 
colour gene (rosy plasmid) was via microinjection into Drosophila embryos.  It was co-
injected with a plasmid containing an entire P element which would provide the necessary 
enzyme for the transposition of the rosy
+
 allele into the fly genome (Rubin and Spradling, 
1982).  Since then, microinjection of constructs into insect embryos has become a standard 
technique for the introduction of novel DNA into many species (Coates et al., 1998; 
Catteruccia et al., 2000; Tamura et al., 2000; Grossman et al., 2001; Handler and Harrell, 
2001; Concha et al., 2011).  Although the microinjection technique for germ line 
transformation of insects has been pioneered in Drosophila, the transfer of this technique 
to other species has many applications.  It is possible to genetically modify insects of 
agricultural, veterinary and medical importance in order that they are less able to have a 
detrimental effect on their natural environment.  It is estimated that the tsetse-borne 
disease, trypanosomiasis, which affects cattle and humans, costs Africa US$4.5 billion per 
year (Eisler et al., 2003).  The Medfly puts the production of €5.3 million per year of 
certain subtropical and fresh fruit at risk in Madeira alone (IAEA, 2005).  The human cost 
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of the disease malaria in 2008, was estimated at 1 million deaths with more than 250 
million people contracting the disease thus having a marked effect, not only on human life 
itself but quality of human life for those who could not work due to their becoming ill 
(WHO, 2010).  Control of pest insects is therefore of significant importance and is a well 
documented control strategy for diseases such as malaria (WHO, 2010).  Due to increasing 
insecticide resistance in populations of vector insects within endemic areas, the emphasis 
on vector control strategies has been shifted away from insecticide use and towards 
alternatives such as genetic modification of the vector.  The long term goal for the use of 
these genetically modified insects would be their mass release with a view to eventually 
suppressing the vector population, or to replacing the vector insect with a modified 
alternative with impaired vectorial capacity (Marrelli et al., 2006; Sparagano and De Luna, 
2008). 
Mosquito lines have been generated which express peptides active against the stages of 
Plasmodium present within the mosquito.   This has been demonstrated for avian malaria 
(Jasinskiene et al., 2007), as well as rodent model systems (Ito et al., 2002; Moreira et al., 
2002; Yoshida et al., 2007), and now, for the human malaria parasite, P. falciparum 
(Meredith et al., 2011, Isaacs et al., 2011).  Interrupting the Plasmodium life cycle whilst 
within the vector could thus result in a total block in transmission of the parasite and 
therefore control of the disease.  Although (at least partially) refractory transgenic strains 
of An. gambiae and An. stephensi, the two major vectors of malaria exist, very stringent 
field tests would have to be completed before release can even be contemplated.  Fitness 
costs may be unavoidable when creating a transgenic strain so there may also be a 
requirement for the refractory gene to be linked to a drive mechanism in order that this 
gene is spread through a mosquito population (Sinkins and Gould, 2006; Marshall, 2009).  
Several selfish genetic elements which occur naturally, such as homing endonucleases, 
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meiotic drive genes and transposable elements themselves have been proposed as a gene 
drive mechanism as well as Wolbachia which, although not a selfish genetic element, is 
capable of driving itself through insect populations (Nolan et al., 2011; Sinkins and 
Godfray, 2004; Sinkins and Gould, 2006; Chen et al., 2007a).  Offspring produced by 
females containing MEDEA (maternal-effect dominant embryonic arrest) selfish genetic 
elements which do not inherit these elements are inviable.  Studies suggest that use of 
MEDEA elements could help drive a transgene through an insect population (Guevara-
Souza and Vallejo, 2011).  Use of MEDEA elements is reviewed by Chen et al. (2010).  
However, none of these mechanisms have proved to be a conclusive answer thus far to the 
problem of driving transgenes through vector populations. 
The problem of driving transgenes through populations is also a major factor when 
considering the population suppression strategy as a method of malaria control.  SIT has 
long been used as a species-specific method of controlling insect populations with 
documented success targeting the New World Screwworm, Cochliomyia hominivorax, in 
the Southern states of America, Mexico and parts of South America as well as Libya 
(Lindquist et al., 1993; Wyass and Society for Tropical Veterinary, 2000).  This method of 
control involves the mass-release of irradiated sterile males which mate with the 
indigenous female population thus reducing their reproductive capabilities and, after 
sufficient release, leads to suppression, and possible eradication of the target species.  Not 
only is this method of control species-specific, but it is not detrimental to the environment 
in the same way as insecticides.  A successful reduction in populations of Mediterranean 
fruit fly (Medfly), Ceratitis capitata, in Latin America has been documented using SIT.  
However, irradiation has fitness impacts, lowering mating competitiveness and reducing 
lifespan.  This has lead to estimated 4-10 fold fitness costs in Medfly (Shelly et al., 1994; 
Lance et al., 2000).  The problems associated with conferred fitness costs due to irradiation 
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as well as those brought about by mass rearing and sex-sorting has meant that 
improvements to SIT have been a necessary research focus.  This has led to the 
development of molecular genetic techniques for insect population suppression such as 
Release of Insects with a Dominant Lethal, commonly known as RIDL (Thomas et al., 
2000; Alphey, 2002; Alphey et al., 2008).  A repressible genetic sexing system which, 
under certain conditions, would cause female-specific lethality could be used simply as a 
mechanism by which insects could be sexed in mass rearing facilities.  Alternatively, such 
a mechanism could itself be used as a method of population suppression (Alphey, 2002).  
SIT requires the sorting of sexes in order to discard females which are not part of the 
release programme.  Original sex-sorting methods are expensive, as twice as many insects 
are reared than necessary before sorting can take place, and time consuming which again 
incurs an economic cost to the procedure (Alphey, 2002).  Accuracy rates of 100% are 
often not achievable which can have implications further along in the programme as 
release of females is undesirable (Alphey, 2002; Nolan et al., 2011).  Introduction, into 
target insects, of a dominant lethal gene which affects only females and at a purposefully 
chosen development stage provides a method of sex-sorting with 100% accuracy.  A 
repressible system ensures that the transgenic strain can be reared on a mass scale prior to 
release but then can be activated when only males are required (Alphey, 2002).  For 
example, in the RIDL system, the gene is lethal only in the presence of tetracycline so 
under normal field conditions this system minimises any environmental hazard due to 
accidental release from a laboratory setting (Thomas et al., 2000).  Alphey (2002) proposes 
that this repressible lethal system could not only be used as a genetic sexing mechanism as 
part of an SIT approach but could itself replace SIT as mass release of a strain of insect 
carrying a dominant lethal gene would achieve a similar outcome to that of an SIT 
program.  Eggs produced as a result of SIT males breeding with wild type females are non-
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viable.  With a RIDL system, progeny produced as a result of RIDL males breeding with 
wild type females will possess a copy of the lethal gene.  This will be switched on in 
females causing lethality prior to them being able to bite, in the case of mosquitoes, and 
before they can breed, and males receiving a copy of the gene will pass it on to a quarter of 
their offspring.  Mass release of RIDL strains would therefore incorporate the benefits of a 
SIT program in terms of vector control but would have the added advantage of reducing 
the cost of irradiation and avoiding the issue of fitness costs associated with irradiation, 
though genetic modification may bring its own fitness costs (Alphey, 2002). 
A female-specific lethal system was demonstrated in Drosophila using the pro-apoptotic 
gene head involution defective (hid) which causes lethality when expressed ectopically 
(Heinrich and Scott, 2000).  Expression of this gene was controlled by a tetracycline-
mediated switch (tTA), which in turn was regulated by a female-specific enhancer from the 
Drosophila yolk protein 1 (yp1) gene (Heinrich and Scott, 2000).  This whole system is 
inactive in the presence of tetracycline, which was fed to the flies via supplemented yeast-
based medium.  Moreover, lethality was demonstrated in females only, when tetracycline 
was removed from the diet (Heinrich and Scott, 2000).  This system, illustrated in Figure 
1.3, echoes that demonstrated by Thomas et al. (2000) whereby Drosophila were 
genetically modified to express a cytotoxic gene product under the control of tTA.  When 
reared on tetracycline-containing medium, the sex ratio of flies produced was unbiased, 
and all flies appeared to be suffering no detrimental effect.  Upon removal of tetracycline 
from the diet however, no female progeny were produced (Thomas et al., 2000).  The 
authors also demonstrated that this tetracycline-repressible system can be used to cause 
lethality in females by using it to drive expression of a gene product which itself is toxic 
only to females (Thomas et al., 2000).  Since the original studies in Drosophila, the 
tetracycline-repressible system is now considered a feasible alternative to standard SIT and 
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has been demonstrated in both pest and vector insects (Alphey, 2002; Alphey et al., 2008).  
Use of this technology has lead to the creation of genetic sexing strains in pest insects such 
as C. capitata, a previous SIT target, which have been shown to be sexually competitive 
(Morrison et al., 2009).   The pink bollworm, Pectinophora gossypiella, a destructive pest 
of economic importance within the cotton industry has also been a previous SIT target 
species.  A bollworm strain carrying a lethal gene has been developed which shows larval 
stage mortality rates of up to 92% (Simmons et al., 2007).  Field trial data for this RIDL 
strain of pink bollworm is currently awaiting publication (Derric Nimmo, personal 
communication).  The yellow fever mosquito, Aedes aegypti, has also been the target of 
RIDL strain development.  A bi-sex RIDL strain of Ae. aegypti carrying a dominant lethal 
gene causes mosquito progeny to die at late larval/early pupal stage (Phuc et al., 2007).  
Thus mass release of males of this strain would suppress the native mosquito population by 
causing progeny resulting from their mating with native females to die before producing 
offspring, or indeed becoming a biting nuisance and disease vector.  The study showed a 
95-97% reduction in survival to adulthood of the RIDL strain when compared to a wild 
type strain (Phuc et al., 2007).  A dominant, female-specific, late-acting RIDL strain of Ae. 
aegypti has also been constructed,  which gives a flightless phenotype in adult female 
mosquitoes (Fu et al., 2010).  This strain is not therefore directly lethal to the female, but 
reduces their capacity to find and attract mates, and lessens the ability to find a host and 
consequently a blood meal, thereby rendering females of this strain effectively sterile (Fu 
et al., 2010).  This technology relies on the natural alternative splicing of the Actin4 gene 
in male and female mosquitoes.  In Ae. aegypti mosquitoes Actin4 is predominantly 
expressed in the indirect flight muscles (IFM) of female pupae (Munoz et al., 2004).  The 
alternative splicing of this gene results in males having a low-abundance transcript which 
contains 244 extra nucleotides in the 5` UTR compared to that seen in females.  This extra 
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sequence contains several start and stop codons which may be responsible for premature 
initiation or termination of translation which ultimately reduces the amount of functional 
Actin4 protein present in male pupae (Fu et al., 2010).  As illustrated in Figure 2.1, 
replacement of the Actin4 gene with a tTAV gene whose expression is driven by the 
AeAct-4 promoter allows for a transgene to be engineered whereby translation of a 
detrimental protein can not only be controlled by presence of tetracycline, but can be 
differentially expressed in males and females.  Tetracycline is known to readily cross lipid 
bi-layers and enter cells by diffusion and without use of specific protein channels.  This 
process, albeit slow, means that the drug can penetrate most parts of the body and thus is 
an appropriate choice for use as a gene switch (Berens and Hillen, 2003; Lycett et al., 
2004). 
The anopheline mosquitoes, vectors of malaria, are a possible target for RIDL technology, 
and several candidate genes have been proposed which would cause sterility or female 
lethality in anophelines (Nolan et al., 2011).  Combining RIDL technology shown to be 
effective in Ae. aegypti with proven transformation techniques in anophelines may be the 
first step towards providing an integrated malaria control programme. 
A major consideration in the engineering of any genetically modified organisms is the 
stability of the insertion.  This is of particular concern for organisms which would be 
released into the natural environment.  Several studies have been undertaken which have 
assessed the re-mobility of transposons in different insect species (Horn et al., 2003; 
O'Brochta et al., 2003; Wilson et al., 2003; Lorenzen et al., 2007; Scali et al., 2007).  
These studies show that each transposon has a different re-mobility potential which also 
seems to depend on which organism they are in.  Further transposition events after the 
transposable element has become incorporated into the genome may lead to a lack of 
stability of the associated transgene.  This has clear implications at the population level.  It 
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would be impossible to accurately describe future phenotypes of descendents of released 
transgenic mosquitoes within a population, or model the behaviour of a transgene over a 
period of time in modified species if there was instability linked to the transgene itself due 
to its association with the transposon (O'Brochta et al., 2003).  Injection of constructs, such 
as OX3688 (Figure 2.3) and OX4356 (Figure 2.8), designed to assess mobility of the 
piggyBac transposon in An. gambiae, would provide a useful assessment of the re-mobility 
potential of this transposon.  This would be beneficial in downstream applications of 
transgenic insects where novel effector genes had been inserted using the piggyBac 
transposon, which is the element of choice in many laboratories (Handler, 2002). 
The microinjection technique used to insert novel DNA into mosquito embryos is itself 
both challenging and demanding in terms of skill and time.  Unsurprisingly, microinjection 
of embryos has a detrimental effect on survival, as the injection itself is quite traumatic.  
The associated handling of embryos both pre-injection and post-injection also contribute to 
lower survival rates than expected from non-injected embryos.  In mosquitoes, especially 
An. gambiae, which can be difficult to rear under laboratory conditions, optimisation of the 
whole microinjection technique is imperative to increase the likelihood of creating 
transgenic lines.  Lobo et al., 2006 outline an optimised protocol for the microinjection of 
mosquito embryos in an attempt to minimise the number of steps causing increased 
mortality.  It is this protocol which forms the basis of the microinjection of An. gambiae 
used in this chapter, though adjustments were made to maximise survival within this 
laboratory.  A summary of plasmids used for injections can be seen in Table 2.1. 
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Plasmid 
number 
(size) 
Transformation 
promoter/marker 
Effector gene Effector 
gene 
promoter 
Brief description 
OX3081 
4813bp 
N/A piggyBac 
transposase 
T7 in vitro transcription of piggyBac transposase mRNA 
OX3497 
7719bp 
N/A Mariner 
transposase 
T7 in vitro transcription of Mariner transposase mRNA 
OX3688 
18500bp 
 Hr5-IE1 DsRed2 
 
 
 
 
 3xP3 DsRed2 
 3xP3 AmCyan 
RIDL gene 
(flightless 
phenotype in 
females) 
 
Ae. aegypti 
Actin4  
 RIDL gene flanked by 2 entire piggyBac sequences 
 Insertion of entire plasmid results in larval fluorescence phenotype of 
red/blue eyes & red body 
OX4244 
13908bp 
 Hr5-IE1 DsRed2 RIDL gene 
(flightless 
phenotype in 
females) 
An. 
gambiae 
Actin4 
 RIDL gene within single piggyBac cassette 
OX4356 
13492bp 
 3xP3 AmCyan piggyBac 
transposase 
An. 
gambiae 
nanos 
 Effector gene contained within Mariner cassette 
 Entire piggyBac sequence separates a fluorescent marker from its 
promoter 
 Transposition of piggyBac within line results in change in 
fluorescence phenotype  
 
Table 2.1:  A summary of plasmids used for injections into An. gambiae 
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♀ 
♂ 
♀ 
♂ 
AeAct4 
AeAct4 
Promoter 5`UTR Intron CDS 3`UTR 
A) Native AeAct4  
B) OX3688  
Actin4 
tTA K10 
Act4 
 97 
 
 
 
Figure 2.1 (opposing page):  Native Aedes aegypti Actin4 gene splicing and gene splicing in transgenic flightless constructs (adapted from 
Fu et al., 2010). 
A) Native Actin4 gene;  B) OX3688 (OX4244).  Coding sequences (CD) and 3` UTR sequences are indicated (K10 represents the Drosophila 
gene fs(1)K10).  Short lines above and below the thicker horizontal line represent potential start (ATG) and stop codons respectively. 
Alternative splicing pathways results in the production of transcripts of differing lengths in males (826bp) and females (583bp).  Multiple ATGs 
at the 5` end are seen in male splice variants of AeAct-4 whereas in females, the first ATG is that of the Ae-Act4 coding region.  In its native 
form, Actin4 expression is seen mainly in the indirect flight muscles (IFM) of female pupae, with only low-abundance transcripts seen in the 
male.  In the transgenic construct an additional ATG was engineered adjacent to the 5` end of the male-specific exon (indicated in green).  In 
females this ATG is in frame with tTA but in males it causes a frame shift to occur and thus introduces stop codons.  This in turn results in the 
prevention of functional tTA production in males therefore the detrimental VP16 protein is not produced even if the AeAct-4 promoter is active.  
This is because tTA drives expression of VP16, a protein from the human Herpes simplex virus (Fu et al., 2010).  
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2.2. Methods and Materials 
2.2.1. Rearing of Anopheles gambiae populations 
2.2.1.1. Oviposition and traying out 
Mosquitoes of the „Keele‟ strain were allowed to lay eggs in a polystyrene oviposition pot 
placed inside a cage of adults offered a blood meal 48 hours previously.  Eggs were 
allowed to hatch in the distilled water contained within the pot.  Once hatched, around 150 
L1 larvae were counted and transferred into plastic trays (35cm x 25cm) using a disposable 
Pasteur pipette in 1 litre of distilled water (Elga Water Systems, High Wycombe, UK).  
Three drops of Liquifry (Interpret Ltd., Dorking, UK) were added to each tray. 
 
2.2.1.2. Larval maintenance and feeding 
After the initial feed of Liquifry, larvae were sustained on a diet of Tetramin fish flakes 
(Melle, Germany) until pupation at around 7 – 12 days after hatching.  Pupae were hand 
picked daily using a disposable Pasteur pipette (with the tip cut off) or with a flask linked 
to a pump.  Pupae were then placed in a weigh-boat in the bottom of a perspex cage 
(Talking Plastics, Fareham, UK) and allowed to emerge. 
 
2.2.1.3. Adult maintenance and blood feeding regimes 
All adults had ad libitum access to 10% glucose solution (containing 
Penicillin/Streptomycin at a concentration of 0.28%) and distilled water.  All stages of 
mosquito populations were kept in a purpose-built room maintained at 28
o
C with a relative 
humidity of around 75-80% with a 12h:12h cycle of light and dark.  The glucose solution 
was removed from adult cages around 12 to 24 hours prior to a blood feed being offered.  
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Distilled water was removed from cages in the morning of the feeding day.  Blood was 
offered to cages of adults using a Hemotek membrane blood feeding system (Discovery 
Workshops, Accrington, UK).  Defibrinated horse blood (TCS Biosciences, Buckingham, 
UK) was contained within metal 3ml reservoirs sealed on one side by plastic plugs, and on 
the side in contact with the adult mosquitoes, by a layer of trimmed sausage skin (Plant and 
Wilson, Newcastle-under-Lyme, UK) covered by a layer of pre-stretched Parafilm 
(Pechiney Plastic Packing, Chicago, USA).  The reservoirs were attached to heated blocks 
and placed on top of the cage of mosquitoes so females could easily probe through the 
mesh and gain access to blood.  The assembled feeders were left on the cage for 20 to 30 
minutes. 
 
2.2.2. Preparation of plasmid DNA constructs used for injection – General DNA 
techniques 
2.2.2.1. Transformation of plasmid DNA constructs into competent cells 
Manufacturer‟s protocol was followed exactly for electroporation of plasmid DNA into 
One Shot TOP10 Electro-competent E. coli (Invitrogen, Paisley, UK).  Electroporation of 
the vector into the competent cells followed the following settings:  cuvette gap: 0.2cm; 
voltage: 1.8kV; capacitance: 25μF (Bio Rad Micropulser Electroporator, Hertforshire, 
UK). 
Manufacturer‟s protocol was followed exactly for transforming XL10-Gold ultracompetent 
cells (Agilent Technologies, Santa Clara, USA) when transforming cells following a 
ligation reaction.  Changes were made to the protocol when transforming from minipreps – 
see Appendix I. 
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With both transformation procedures, cells were allowed to recover in the supplied 
medium at 37
o
C for 1 hour with vigorous shaking.  Cells were then plated onto LB-agar 
plates containing the required antibiotic and incubated overnight at 37
o
C. 
 
2.2.2.2. Picking overnight bacterial colonies 
Antibiotics were added to LB broth to a concentration of either 50μg/ml (ampicillin) or 
100μg/ml (kanamycin).  3ml of this sterile LB broth was added to a 15ml Falcon tube, and 
a sterile 200μl tip used to pick an individual colony which was inserted into the broth in 
order to inoculate it.  Each tube was labelled and placed in a shaking incubator for 12-16 
hours (overnight) at 37
o
C.  Once removed from the incubator, tubes were kept at 4
o
C until 
required for further applications. 
 
2.2.2.3. Colony PCR 
A PCR master mix was made up containing 1.25U Taq polymerase (Promega UK, 
Southampton, UK), buffer (Promega UK, Southampton, UK), 0.2mM dNTPs (Promega 
UK, Southampton, UK) and water as well as specific forward and reverse primers each at a 
concentration of 10µM.  10μl of PCR mastermix was added to each well of a 96 well PCR 
plate.  100μl of LB broth containing ampicillin (50μg/ml) was added to each well of a 96 
well flat-bottom tissue culture plate. 
Individual colonies were picked using a 2μl pipette and tips.  The end of the pipette tip was 
used to stir in the LB broth in a well of the tissue culture plate.  The pipette tip was then 
transferred to the corresponding well of the PCR plate and the mix pipetted up and down 
several times.  The tip was then discarded and the procedure repeated for an appropriate 
number of colonies.  Once inoculated, the tissue culture plate was covered and placed in a 
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shaking incubator for 2 hours at 37
o
C.  The PCR plate was placed in the thermocycler at 
the desired program, and once finished, 5μl of PCR product from each well was run on a 
1.5% agarose gel.  The gel was then visualised using a SynGene Gel Documentation 
System (Cambridge, UK). 
 
2.2.2.4. Minipreps 
Plasmids were purified from inoculated bacterial broths using the GeneJET Plasmid 
Miniprep Kit (Fermentas) following the manufacturers instructions.  Cells were 
centrifuged to form a pellet, then lysed.  Bacterial cell debris and chromosomal DNA is 
discarded whereas plasmid DNA remains adsorbed onto the GeneJET spin column.  This 
was then washed prior to eluting in GeneJET elution buffer.  The DNA in solution was 
then stored at -20
o
C until required for further applications. 
 
2.2.2.5. Endotoxin-free Maxipreps 
The Qiagen EndoFree Plasmid Maxi Kit (Qiagen, Crawley, UK) was used to purify 
plasmid DNA following manufacturers instructions.  Cells were pelleted following 
centrifugation of the overnight bacterial culture in LB broth.  Addition of an alkaline 
solution lyses cells within the pellet.  Plasmid DNA is then able to bind to the Qiagen 
anion-exchange resin under appropriate low salt and pH conditions.  A medium-salt wash 
removes impurities such as RNA, proteins and dyes  A high-salt buffer is then used to elute 
plasmid DNA which is then precipitated using isopropanol, then re-dissolved in endotoxin-
free water. 
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2.2.2.6. Rapid Phenol Preps 
Phenol preps were used for rapid evaluation of plasmid DNA.  In a 1.5ml micro-centrifuge 
tube, 30μl of overnight culture LB broth was added followed by 30μl of phenol:chloroform 
(1:1 ratio) and 12μl of 6 x Orange G loading dye.  The tube was vortexed vigorously for 30 
seconds prior to being spun at >13000g for 5 minutes.  20μl of the top aqueous phase was 
loaded into a 1% TAE-agarose gel and compared to a negative control for evaluation. 
 
2.2.2.7. Glycerol Stocks 
Glycerol stocks of bacterial cultures were made for long term storage of all plasmids.  
850μl of bacterial overnight culture was placed in a fully-labelled 2ml screw-lid cryo-vial.  
150μl of sterile 50% glycerol was then added to the culture and the solution vortexed then 
stored at -80
o
C. 
 
2.2.2.8. Restriction digests 
Plasmid DNA was cut with restriction enzymes (NEB UK Ltd, Herts, UK; Promega UK, 
Southampton, UK) in order to help confirm presence of the correct plasmid within a 
Miniprep or Endofree Maxiprep or to cut plasmid DNA prior to downstream applications.  
Restriction digests were also undertaken to linearise plasmids containing the coding region 
for piggyBac transposase prior to in vitro transcription of the mRNA.  Restriction enzymes 
used were dependent on the plasmid.  Enzymes were used in the presence of enzyme-
specific buffer and BSA to cut DNA.  Enzyme and DNA were added to an appropriate 
microcentrifuge tube in amounts suggested by the manufacturer.  DNA was digested at the 
temperature specified by the manufacturer in a heat block for the recommended time and 
the digests terminated following manufacturers‟ protocols. 
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2.2.2.9. TAE-Agarose gel electrophoresis 
In order to visualise DNA, samples were fractionated using TAE-agarose gel 
electrophoresis.  Agarose concentrations used were appropriate to the fragments of DNA to 
be separated.  Agarose was added to TAE in a glass bottle and the solution warmed in the 
microwave oven until the agarose was fully dissolved.  The solution was left to cool until it 
was possible to handle the glassware without gloves at which point ethidium bromide was 
added to a concentration of 0.5μg/ml.  The solution was then poured into a gel tank fitted 
with a comb.  Gels were run at 70v for 40min to 1.5hours depending on their size after 
which they were visualised using a SynGene Gel Documentation System (Cambridge, 
UK). 
 
2.2.3. Microinjection of Anopheles gambiae embryos 
2.2.3.1. Egg laying for microinjection 
An oviposition vessel comprising of a 30mm Petri dish base filled with moist cotton wool 
and topped with a 30mm Whatman filter paper was placed inside a cage of 4-6 day old 
adult mosquitoes 2-3 days post blood-meal.  To prevent oviposition on any other surface, 
water was provided to the cage used for laying for microinjection by means of a damp 
cotton wool ball placed on top of the cage.  The mosquitoes were given access to the 
oviposition site for between 10 and 20 minutes before it was removed so that embryos 
could be lined up prior to microinjection. 
 
2.2.3.2. Pulling microinjection needles 
Filamented aluminosilicate glass capillaries (Intracel Ltd, Royston, UK) were pulled into 
two symmetrical microinjection needles using a Sutter Micropipette Puller, model P-2000 
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(Sutter Instrument, Nevato, USA).  The capillaries were 10cm in length with an outer 
diameter of 1mm and inner diameter of 0.64mm.  They were pulled on the following two-
stage program:  Heat: 445; Fil: 120; Vel: 50; Del: 200; Pul: 140 and subsequently Heat: 95; 
Fil: 235; Vel: 235; Del: 235; Pul: 235. 
 
2.2.3.3. Lining up of embryos prior to microinjection 
Embryos were left on the filter paper oviposition surface for around 20 minutes to allow 
time for the chorion to harden slightly before manipulation.  During this period of time 
they were kept in insectary conditions; 28
o
C and around 75% relative humidity.  
Subsequently, the filter paper was viewed under a dissecting microscope (Leica 
Microsystems (Schweiz) AG, Heerbrugg, Switzerland) and aligned using a mounted needle 
so that they were in the same plane for microinjection (posterior end to the top and the 
dorsal surface resting downward) taking care to cause minimum disruption to the floats 
either side of the individual embryos.  Once manipulated and aligned the embryos were 
transferred to a cover slip using double-sided sticky tape (Sellotape, Henkel Consumer 
Adhesives, Winsford, UK) so that the dorsal surface was pointing up and posterior ends of 
all embryos were to one edge of the cover slip.  Desiccation of embryos was performed by 
eye under the microscope and embryos were covered by a layer of water-saturated 
Halocarbon oil (700 series) (Sigma-Aldrich, Dorset, UK) as soon as the embryos were at 
the appropriate stage of desiccation.  Lining up and desiccation of embryos was undertaken 
at room temperature. 
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2.2.3.4. Microinjection of embryos 
The cover slip on which the embryos were aligned was transferred to a Leica M125 
dissecting microscope (Leica Microsystems (Schweiz) AG, Heerbrugg, Switzerland) and 
secured on a glass mount on the microscope stage.  The posterior regions of the embryos 
were all facing in the direction of the micro-manipulator.  The injection needle was 
mounted on a Narishige MN-151 joystick manipulator (Narishige International Ltd, 
London, UK), itself mounted directly onto the microscope base.  It was connected to an 
Eppendorf FemtoJet Express (Eppendorf UK Ltd, Cambridge, UK) which had pressure 
supplied by a Jun-Air Condor MDR-2 compressed air pump (Gast group, Redditch, UK).  
Injection was triggered by the left-click of a mouse button whilst the facility for clearing 
the needle was via the right-click of a mouse button. 
Previously pulled needles were backfilled using an Eppendorf Microloader pipette tip 
(Eppendorf, UK Ltd, Cambridge, UK) with injection mix.  The assembled injection mix 
was cleared by centrifugation at >13000g for 5min at 4
o
C prior to backfilling. 
Embryos were pierced with the needle using the micromanipulator joystick and the 
DNA/RNA mix injected into the embryo using the mouse button.  Use of the FemtoJet 
allowed for easy control of the quantities of injection mix introduced into each embryo and 
the micromanipulator allowed for precise needle placement.  The aim was to enter the clear 
space at the posterior of each desiccated embryo and insert the injection mix here to restore 
the turgidity of each embryo, whilst also piercing the inner membrane allowing the 
injection mix contact with the syncytial mass whilst attempting to minimise injection 
trauma as much as possible.  The injection process was repeated for all embryos in the line.  
Embryos not injected for any reason were killed immediately whilst still on the cover slip.  
The cover slip was then placed at an angle into a small well filled with distilled water to 
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allow the halocarbon oil to drain off and to soften the double-sided sticky tape.  These 
wells were returned to the insectary to allow the embryos to recover. 
 
2.2.3.5. Recovery and husbandry of injected embryos 
Embryos were left immersed in distilled water attached to the cover slip for a minimum of 
1 hour.  The cover slip was removed from the water and placed face-up on to a moist 
90mm piece of Whatman filter paper.  Using a Leica M125 microscope and a mounted 
needle, each embryo was individually and carefully transferred from the cover slip to the 
filter paper.  The embryos were then rinsed into small polystyrene oviposition pots lined 
with filter paper containing distilled water and left in insectary conditions until hatching.  
From 48 hours post-injection, hatched larvae were transferred to individual wells of a 12-
well flat-bottomed tissue culture plate at a density of 1 larva per well.  Wells were filled 
with pre-conditioned water containing Liquifry (one drop per litre).  Each larva was fed a 
small individual flake of Tetramin fish flake from its second day in the culture plate.  Each 
day the old flake, and remnants of it, were removed and fresh flake added.  When possible, 
cloudy water was removed and replaced with clean distilled water.  Upon reaching 
pupation, pupae were picked, sexed using a Leica M125 microscope, and placed in a weigh 
boat within an appropriate cage ready to be backcrossed with the host strain. 
 
2.2.3.6. Screening for transient expression of fluorescent markers in G0 larvae 
Larvae were screened at the L2 or L3 stage for transient expression of the fluorescent 
marker on the injected plasmid.  Water was removed from each well containing a larva 
using a plastic pasteur pipette so each larva had only a minimum amount of water within 
the well.  This meant that screening had to be done relatively quickly and only one plate at 
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a time.  Larvae were starved of food from the day before screening to minimise auto-
fluorescence from food debris.  Individual larvae were screened for fluorescence using a 
Leica MZ FLIII microscope with the appropriate filter sets (Chroma Technology Corp., 
Rockingham, USA). ECFP filter: exciter D436/20x; barrier D480/40m and DsRed filter: 
exciter HQ545/30x; emitter HQ620/60m.  Presence or absence of transient expression in 
each larva was recorded, distilled water added to the wells containing larvae, and the larvae 
returned to the insectary after screening. 
 
2.2.3.7. Backcrossing of surviving G0 adults 
Male and female G0 pupae were kept in separate cages until eclosion.  Emerged adults 
were then allowed to become sexually mature, a process taking around 2-3 days.  At this 
time female G0 adults were mated in small groups with a surplus of sexually mature adult 
wild-type host-strain males in order that all females were mated.  Male G0 adults were 
mated in groups of no more than 4 with around 6 mature adult wild-type host-strain 
females per male in order that all males were given a chance to mate at least once.  All 
back-cross cages were allowed 2-3 days to mate and were then blood-fed.  An oviposition 
pot was placed in the cage 48 hours post blood-meal.  G1 larvae were trayed out in 
suitably-sized vessels according to the number of larvae hatched.  Their maintenance 
followed the usual husbandry routine. 
 
2.2.3.8. Screening G1 larvae for fluorescence 
Larvae were screened for fluorescence as described previously.  Preparation of L2/L3 
larvae did differ due to larvae being maintained together and not individually.  Larvae were 
chilled on ice in weigh boats with a minimal amount of water.  Once chilled, the weigh 
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boat was placed within a petri-dish containing ice to maintain the chilling during screening.  
The weigh boat had parallel lines drawn on its underside to facilitate screening in terms of 
ensuring all larvae were looked at.  Any larvae found to be fluorescing were hooked from 
the weigh boat using a mounted needle.  Once screened, larvae were returned to normal 
insectary conditions. 
 
2.2.3.9. in vitro transcription of mRNA 
A plasmid containing the coding region of the required transposase gene was linearised 
using a restriction enzyme.  This linearised template was used in the mMessage mMachine 
T7 Ultra kit (Ambion, Texas, USA) (following manufacturers instructions with some 
adaptations – see Appendix I) to generate transposase mRNA to be used in downstream 
applications.  The mRNA transcribed was then further processed using the MEGAclear Kit 
(Ambion, Texas, USA) (following manufacturers instruction with some adaptations – see 
Appendix I) in order to generate clean mRNA for use in injections.  Quality and quantity 
of the mRNA was checked using gel electrophoresis and NanoDrop 1000 
spectrophotometer (Thermo Fisher Scientific, Wilmington, USA). 
 
2.2.3.10. Preparation of injection mix 
Prior to use, mRNA solutions were centrifuged at >13000g for 5 minutes at 4
o
C.  Injection 
mixes contained a final concentration of 700ng/μl of mRNA and 300ng/μl of plasmid 
DNA.  Injection buffer (10x) and molecular grade water were added to make up the 
injection mix to 30μl.  The injection mix was divided equally between three 0.2ml micro 
centrifuge tubes and stored at -80
o
C until required.  When needed, a tube containing 
injection mix was placed on ice and allowed to defrost.  Once thawed, it was centrifuged at 
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>13000g for ten minutes at 4
o
C to allow any debris to settle at the bottom of the tube.  It 
was then placed back on ice ready to be loaded into the needle. 
 
2.2.4. Making a single-ended piggyBac flightless RIDL construct from a single-
ended piggyBac vector and flightless RIDL insert 
2.2.4.1. Restriction digests of vector (OX3982) and insert (OX4077) 
A digest of plasmid OX3982 (Oxitec Ltd.) was carried out with Pac1 (NEB) to linearise 
the plasmid (Fig. 2.2A).  A double digest of plasmid OX4077 (Oxitec Ltd.) was carried out 
with Pac1 (NEB) and Nde1 (NEB) in order to linearise the plasmid and to fragment the un-
required band (Fig. 2.2B).  This was to ensure that the required band could be excised 
cleanly from the agarose gel.  The digested fragments were then purified prior to a further 
restriction digest. 
 
2.2.4.2. Purification of DNA following restriction digests 
DNA was purified following restriction digests using the Qiagen MinElute Reaction Clean 
Up Kit.  The manufacturer‟s instructions were followed with the exception that spin 
columns from the Qiagen PCR Clean Up Kit were used when fragments of greater than 
4Kb in size were present.  This kit allows clean up of DNA from aqueous solutions.  In the 
presence of high salt solution, up to 5μg of DNA is absorbed to silica-membrane in the 
spin column whereas contaminants pass through.  These impurities are discarded and DNA 
is eluted in 30μl molecular grade water (a change to the manufacturer‟s protocol which 
suggests 10μl). 
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2.2.4.3. Restriction digests of OX3982 and OX4077 
A digest of OX3982 and OX4077 was carried out with Srf1 (NEB) according to 
manufacturer‟s directions (Fig. 2.2A).  This cut OX3982 creating a band of 9Kb and one of 
5.5Kb.  The latter contained the required sequence.  Srf1 was also used to cut OX4077 to 
create two bands of 4.6Kb and one of 8.35Kb (Fig. 2.2B).  Again, the latter contained the 
required sequence.  The entire of the digests with both plasmids were run on a 0.7% TAE-
agarose gel.  The required DNA fragments were then excised and placed in a 1.5ml micro-
centrifuge tube and stored at -20
o
C prior to gel purification. 
 
2.2.4.4. Extraction of DNA fragments from agarose gel 
Once a DNA band had been visualised on a TAE-agarose gel and identified as the required 
fragment, it was excised using a scalpel blade, excess agarose removed and the DNA 
purified using a Qiagen Qiaex II Gel Purification Kit for purification of DNA fragments 
from 40bp to 50Kb.  Manufacturer‟s guidelines were followed.  Addition of a high salt 
buffer solubilises the agarose at 50
o
C and causes dissociation of the DNA binding proteins 
from the DNA fragments.  The DNA fragments adsorb in the presence of high salt to the 
Qiaex II particles in the spin column whilst impurities including the solubilised agarose 
remain in the supernatant.  After further wash steps with an ethanol-containing buffer, 
DNA fragments are eluted in a low salt medium.  A sample of the extracted, purified, 
eluted DNA was run on a 0.8% agarose gel to ensure presence of the expected-length 
fragments of DNA. 
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2.2.4.5. Ligation of DNA fragments 
The blunt ends of vector and insert were ligated using the NEB Quick Ligation Kit 
following the manufacturer‟s protocol.  Various ratios of vector: insert were used to 
optimise ligation conditions.  1μl of Quick T4 DNA Ligase was added to the solution of 
insert, vector and 2 X Quick Ligation buffer at a total volume of 20μl.  After leaving the 
ligation reaction for 5min at room temperature, the reactions were placed on ice prior to 
transformation of plasmid into chemically-competent cells. 
 
2.2.4.6. Colony PCR 
Colony PCR was carried out for 96 colonies transformed previously, using the general 
technique described above.  The primers used to amplify a known sequence within the 
plasmid were #100 (GGGCGCGGCGATCGCGTTTAAACGGATCCGCGCT) and 
#TD137 (GGCGGGTACCGGAGCTTGATAACATTATACCTAAACCC) which, when 
used together would give a DNA fragment with an expected length of 1049bp.  The 
following cycling conditions were used: 1 cycle of 94
o
C for 2min; 30 cycles of 94
o
C for 
30sec, 55
o
C for 30sec, 72
o
C for 1min; then an extension step of 72
o
C for 7min.  5μl of 
PCR products were run on a 1% TAE-agarose gel.  Four of the colonies generated 
fragments of the expected size and 15μl of the relevant cultures were used to inoculate 3ml 
of LB (Amp) broth which was then placed in a shaking incubator for 16 hours (overnight). 
 
2.2.4.7. Diagnostic restriction digests 
Minipreps from the four inoculated cultures were digested using the restriction enzymes 
Kpn1 and Nde1 (NEB).  This double digest was expected to cut the new plasmid into 
fragments of the following lengths; 8.5Kb, 2.9Kb and 2.5Kb.  The digested samples were 
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visualised on a 1% TAE-agarose gel.  Three of the four minipreps from individual colonies 
were shown to contain the correct plasmid and could be sent for sequencing (GATC 
Biotech, London) using the primers Diag4-pB3 
(ATGAGACGAGAGTAAGGGGTCCGTC) and Diag4-pB5 
(CCAGAGCGATACAGAAGAAGC). 
 
2.2.4.8. Endo-free maxiprep of new plasmid #4244 
Sequencing of all three minipreps indicated that the plasmid had been correctly constructed 
and an endo-free maxiprep was made in order that the plasmid could be used for 
microinjection of An. gambiae embryos.  The plasmid was assigned the number OX4244 
(pB-Attp-Hr5IE1-DR-tet014AngaA4pi-ubittAv2-FRTlox).  Glycerol stocks were also 
made and stored at -80
o
C.   
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Figure 2.2 (opposing page):  Schematic of construction of a single ended piggyBac flightless RIDL plasmid from a single ended piggyBac 
vector and flightless RIDL insert. 
A)  Single ended piggyBac vector containing a RIDL gene not appropriate for injection into An. gambiae (OX3982).  This plasmid was digested 
with Pac1 to linearise the plasmid.  After DNA purification a further digest with Srf1 was carried out.  The required 5.5Kb fragment was excised 
from the agarose gel and purified. 
B)  Plasmid containing a flightless RIDL insert under control of the An. gambiae Actin4 promoter (OX4077).  This plasmid was double digested 
with Pac1 and Nde1 to linearise the plasmid and fragment the un-required band. Plasmid DNA was purified and a further digest with Srf1 was 
undertaken to remove the 8.35Kb insert from the original plasmid.  Required DNA fragments were excised from the gel and purified. 
C)  Successful ligation of the 2 purified blunt-ended fragments created the new OX4244 single ended piggyBac vector containing a flightless 
RIDL gene whose expression is driven by the An. gambiae promoter. 
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2.3. Results 
2.3.1. Microinjection of An. gambiae with OX3688 
Preblastoderm embryos of An. gambiae (Keele) were co-injected with OX3688 (Oxitec 
Ltd., Figure 2.3) at 300ng/μl and piggyBac messenger RNA at 700ng/μl in 1 x injection 
buffer to generate a mosquito line carrying the RIDL flightless gene, under control of the 
Ae. aegypti Actin4 gene, between two independent piggyBac cassettes.   
Prior to injection, in vitro transcription of piggyBac mRNA was performed using plasmid 
OX3081 (Figure 2.4).  The plasmid was linearised prior to in vitro transcription using the 
restriction enzyme Xba1.  The mRNA generated was then visualised on a TAE agarose gel 
to check its quality as seen in Figure 2.5. 
Over a 6 month period a total of 6 rounds of injections were undertaken.  A total of 6468 
Keele embryos were injected, of which 293 hatched (4.5%), 210 pupated (71.7%) and 203 
survived (96.7%) to adulthood (G0).  Groups of 1-3 G0 males were backcrossed to virgin 
Keele females.  Table 2.2 shows the breakdown of survival rates for each round of 
injections with this construct co-injected with piggyBac mRNA.  Groups of 5-10 G0 
females were backcrossed to virgin Keele males.  All progeny resulting from the 
backcrossed G0s were screened for fluorescence and G1 transformants identified by 
DsRed2 expression all over the body of the larvae (Hr5IE1), or by eye-specific expression 
(3xP3) of either ECFP or DsRed2.  This construct (OX3688) is unusual in that integration 
could occur in several different ways thus fluorescence patterns could differ between 
integration events.  
G1 transformants were identified from progeny generated as a result of backcrossing G0 
adults from injection round 3.  Relatively small numbers of G0 adults generated from this 
injection round meant that after the first gonotrophic cycle, adults from this round were 
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pooled to promote feeding and oviposition.  This meant that, as the transformed 
mosquitoes were identified as arising from the second gonotrophic cycle, they could not be 
traced back to a narrower group of G0s.  No further transformants were identified from 
subsequent blood feeds therefore it can be assumed that the integration event occurred in a 
mosquito that had since died.  The presence of only 12 fluorescent G1 larvae all with the 
same fluorescence profile suggests that there was just one single integration event (Figure 
2.6).  The transformed larvae only showed expression of ECFP under control of the eye-
specific 3xP3 promoter.  Visualising the larvae under the DsRed2 filter did not show 
fluorescence profiles due to expression of DsRed2 under control of either 3xP3 or Hr5IE1 
promoters.  This indicates that integration of construct OX3688 was only partial, that is to 
say, only one piggyBac end was integrated into the mosquito genome and thus the RIDL 
gene and the second piggyBac cassette was not included in the integration event. 
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Injection 
Round 
Number of 
injected 
embryos 
Larvae 
(% of number 
injected) 
Adults entered 
into 
backcrosses 
(% of larvae) 
Number of 
transgenic G1 
resulting from 
backcrosses 
1 629 
35 
(5.6) 
29 
(82.9) 
0 
2 1983 
50 
(2.5) 
35 
(70.0) 
0 
3 970 
27 
(2.8) 
18 
(66.7) 
12 
4 1573 
31 
(2.0) 
19 
(61.3) 
0 
5 807 
16 
(2.0) 
8 
(50.0) 
0 
6 274 
134 
(48.9) 
94 
(70.2) 
0 
 
Table 2.2:  Total number of injections, survival rates and G0 adult numbers generated by 
each round of injections into An. gambiae (Keele) using OX3688.  Numbers of G1 
transformants are also identified. 
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Plasmid  
backbone 
OX3688 
18500 bp 
DsRed2 
newVP16 
AmCyan1 
bla (amp[R]) 
Hr5 
GAGA x2 
tetOx14 
Scraps intron 
Adh intron 
sex-specific intron 
 
nls 
ATG start 
ubiquitin 
piggyBac 3' 
TETR 
possible male exon 
piggyBac 5' 
piggyBac 3' 
PiggyBac 5' SV40 polyA 
hsp70 minpro 
AeAct4 Promoter 
3xP3 
3xP3 
IE1 promoter 
K10 3'UTR approx 
exon2 
exon1 
DsRed2 
nls 
XbaI (82) 
XbaI (1061) 
XbaI (7008) 
StuI (7308) 
StuI (10664) 
StuI (16934) 
AttP 
pUC ori 
piggyBac 
 cassette 
piggyBac 
 cassette 
RIDL 
gene 
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Figure 2.3 (opposing page):  Plasmid OX3688 containing two complete piggyBac cassettes and flightless RIDL gene (18.5Kb) 
This plasmid was provided by Oxitec Ltd. and contains a RIDL gene with a tetracycline switch, flanked by two entire piggyBac cassettes 
(Dafa'alla et al., 2006).  In the absence of tetracycline, the integrated RIDL gene causes a build up of the protein VP16 (from the Herpes simplex 
virus) in flight muscles of the female mosquito causing death of female mosquitoes only.  In this construct, the tetracycline-dependent 
transcription activator (tTAV) is driven by the Ae. aegypti Actin4 promoter.  The attP site is a short sequence of 60bp that ensures site-specific 
integration of any Phase 2 plasmid that carries an attB site. 
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Figure 2.4 (opposing page):  Plasmid OX3081 (4.8Kb).   
This plasmid is used for in vitro transcription of piggyBac transposase mRNA that is co-injected with the transformation vector OX3688 
(piggyBac transposase coding sequence under the control of the T7 promoter and the 3` UTR from the DmVasa gene).  After linearization with 
Xba1, a T7 polymerase reaction is performed, which transcribes the plasmid DNA downstream of the T7 bacteriophage promoter, followed by 
mRNA preparation for microinjection.   
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Figure 2.5 (opposing page):  Visualisation of in vitro transcribed piggyBac mRNA on a native TAE gel to assess quality and quantity for 
microinjection 
A 1% agarose RNA gel run for 50 minutes in TAE buffer at 70V.  Lanes 1 and 8 show the 1Kb GeneRuler DNA ladder (Fermentas).  Lane 2 is a 
sample of linearised plasmid, OX3081, cut with Xba1 prior to the T7 transcription reaction taking place. This shows clearly that the DNA is both 
linear and of the correct size (4.8Kb).  Lanes 3 and 6 are samples of mRNA after the transcription reaction has taken place, from two different 
batches of the reaction.  The gel shows that the quantity of mRNA transcribed is consistent and clear bands with little smearing indicate that the 
mRNA is of good quality and that samples are not contaminated with RNases.  Lanes 4 and 7 are samples of corresponding mRNA after clean-
up with the MEGAclear Kit (Ambion).  There is a smaller amount of mRNA in these samples in comparison to the amount of RNA prior to 
clean-up, but there is a clear definition to the RNA bands and the amount is consistent between the two batches, thus indicating that the mRNA 
is injection quality and can therefore be aliquoted into RNase-free microcentrifuge tubes and stored at -80ºC ready for use in subsequent 
microinjections. 
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Figure 2.6 (opposing page):  An. gambiae larva expressing the AmCyan marker under the control of the 3xP3 promoter.   
This expression profile indicates that a partial integration of OX3688 has occurred whereby only a single piggyBac cassette has integrated into 
the genome.  1A and 2A are bright field images of the same larva at different magnifications (x20 and x80 respectively).  1B and 2B are images 
at the same magnifications as their corresponding pictures but as seen under the Cy GFP 31044v2 filter set (Leica MZFLIII).  1B and 2B are 
typical 3xP3 profiles, with the arrows indicating eye (E) AmCyan expression. 
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2.3.2. Microinjection of An. gambiae with OX4244 
Preblastoderm embryos of An. gambiae (Keele) were co-injected with OX4244 (Oxitec 
Ltd., Figure 2.7) at 300ng/μl and piggyBac messenger RNA at 700ng/μl in 1 x injection 
buffer to generate a mosquito line carrying the RIDL flightless gene under control of the 
An. gambiae Actin4 promoter, contained within a single piggyBac cassette.   
 
Prior to injection, in vitro transcription of piggyBac mRNA was performed using plasmid 
OX3081 (Figure 2.4).  This mRNA was then visualised on a TAE agarose gel to check its 
quality as seen in Figure 2.5. 
 
Over a 6 month period a total of 6 rounds of injections were undertaken.  A total of 4858 
Keele embryos were injected, of which 314 hatched (6.5%), 26 larvae (13.5%) showed 
transient expression and 131 survived (40.5%) to adulthood (G0).  Groups of 1-3 G0 males 
were backcrossed to virgin Keele females.  Table 2.3 shows the breakdown of survival 
rates for each round of injections with this construct co-injected with piggyBac mRNA.  
Groups of 5-10 G0 females were backcrossed to virgin Keele males.  All G0 larvae were 
screened for transient expression of DsRed2.  All progeny resulting from the backcrossed 
G0s were screened for presence of DsRed2 fluorescence driven by the Hr5IE1 enhancer-
promoter. 
 
Although transient expression was seen in 8.3% of G0 larvae, no G1 progeny resulting from 
back crosses were seen to exhibit a fluorescence profile. 
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Injection 
Round 
Number of 
injected 
embryos 
Larvae 
(% of number 
injected) 
Number of 
transients 
(% of larvae) 
Adults entered 
into 
backcrosses 
(% of larvae) 
1 767 
72 
(9.4) 
0 
14 
(19.4) 
2 479 
39 
(8.1) 
0 
15 
(38.5) 
3 1391 
109 
(7.8) 
0 
63 
(57.8) 
4 524 
27 
(5.2) 
5 
(16.7) 
16 
(59.3) 
5 1485 
58 
(3.9) 
18 
(30.9) 
20 
(34.5) 
6 212 
9 
(4.7) 
3 
(33.3) 
3 
(33.3) 
 
Table 2.3:  Total number of injections, survival rates and G0 adult numbers generated by 
each round of injections into An. gambiae (Keele) using OX4244.  Numbers of G0 
transients are also identified. 
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RIDL 
flightless 
gene 
within 
single 
piggyBac 
cassette 
OX4244 
13908 bp 
bla (amp[R]) 
DsRed2 
newVP16 
Hr5 
GAGA x2 
tetOx14 
A4 intron 
Scraps intron 
Adh intron 
piggyBac 5' 
piggyBac 3' 
ATG start 
AttP 
nls 
ATG start 
ubiquitin 
TETR 
SV40 polyA 
TetRApaR 
tetNotF 
AngaActin4 Promoter 
hsp70 minpro 
IE1 promoter 
pUC ori 
K10 3'UTR approx 
exon 1 
exon 2 (truncated) 
nls 
Plasmid  
backbone 
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Figure 2.7 (opposing page):  Plasmid OX4244 containing the flightless RIDL gene within a single piggyBac cassette (13.9Kb) 
This plasmid contains a RIDL gene with a tetracycline switch, contained within a single piggyBac cassette.  In the absence of tetracycline, the 
integrated RIDL gene causes a build up of the protein VP16 (from the Herpes simplex virus) in flight muscles of the female mosquito causing 
death of female mosquitoes only.  In this construct, tTAV is driven by the An. gambiae Actin4 promoter.  The attP site is a short sequence of 
60bp that ensures site-specific integration of any Phase 2 plasmid that carries an attB site.   
 
 
 130 
2.3.3. Microinjection of An. gambiae with OX4356 
Preblastoderm embryos of An. gambiae (Keele) were co-injected with OX4356 (Oxitec 
Ltd., Figure 2.8) at 300ng/μl and mariner messenger RNA at 700ng/μl in 1 x injection 
buffer to generate a mosquito line carrying a promoter-marker sequence separated by a 
whole piggyBac cassette, contained within a single mariner cassette.   
 
Prior to injection, in vitro transcription of mariner mRNA was performed using plasmid 
OX3947 (Figure 2.9).  The plasmid was linearised prior to in vitro transcription using the 
restriction enzyme BamH1. 
 
Over a 5 day period a single round of injections was undertaken.  A total of 3344 Keele 
embryos were injected, of which 162 hatched (4.8%), 39 larvae (24.1%) showed transient 
expression and 43 survived (26.5%) to adulthood (G0).  Groups of 1-3 G0 males were 
backcrossed to virgin Keele females.  Table 2.4 shows the breakdown of survival rates for 
injections with this construct co-injected with mariner mRNA.  Groups of 5-10 G0 females 
were backcrossed to virgin Keele males.  All G0 larvae were screened for transient 
expression of DsRed2.  All G1 progeny were screened for DsRed2 fluorescence driven by 
the Hr5IE1 enhancer-promoter. 
 
Although transient expression was seen in 24.1% of G0 larvae, no G1 progeny were seen to 
exhibit a fluorescence profile. 
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Number of 
injected 
embryos 
Larvae 
(% of number 
injected) 
Number of 
transients 
(% of larvae) 
Adults entered 
into 
backcrosses 
(% of larvae) 
3344 
162 
(4.8) 
39 
(24.1) 
43 
(26.5) 
 
 
 
Table 2.4:  Total number of injections, survival rates and G0 adult numbers generated by 
the round of injections into An. gambiae (Keele) using OX4356.  Numbers of G0 larvae 
exhibiting transient expression are also identified. 
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OX4356 
13492 bp 
bla (amp[R]) 
AmCyan 
pB transposase CDS 
attB 
AgNanos Intron 
mariner-right 
mariner-left 
piggyBac 5' 
piggyBac 3' 
3xP3 
3xP3 
AgNanos Promoter 
pUC ori 
AeNanos 3'UTR 
1st part of 5'UTR 
2nd part of AgNanos 5'UTR 
DsRed2 
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Figure 2.8 (opposing page):  piggyBac mobilisation assessment plasmid OX4356 (13.5Kb) 
This plasmid was constructed with the intent of using it to assess mobility of the piggyBac transposon.  A mariner transposon is used to insert 
the plasmid into the genome of the mosquito.  Transformants are identified as showing eye-specific expression of the AmCyan fluorophore only.  
The piggyBac transposase gene is also included in the plasmid sequence, driven by the An. gambiae nanos promoter.  Remobilisation of the 
piggyBac element within the construct, due to active transposase expression at early-stage embryonic development, would result in a second 
fluorescence profile (eye-specific DsRed2) being generated in progeny of the mosquitoes it was mobilised in, as the3xP3 promoter and DsRed2 
marker sequences would then be joined.  Construction of OX4356 by Oliver St John, Oxitec Ltd. 
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OX3497 
7719 bp 
mariner transposase 
transcription start 
T7 promoter 
T7 Terminator 
Ae-nanos 3'UTR 
BamHI (1) 
bla (amp[R]) 
pUC origin 
 135 
 
 
 
 
 
 
Figure 2.9 (opposing page):  Plasmid OX3947 (7.7Kb).   
This plasmid is used for in vitro transcription of mariner transposase mRNA that is co-injected with the transformation vector OX4356.  After 
linearization with BamHI, a T7 polymerase reaction is performed, which transcribes the plasmid DNA downstream of the T7 bacteriophage 
promoter, followed by mRNA preparation for microinjection.   
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2.3.4. Effect of Tetracycline on hatch rates, larval survival and pupation rates of 
An. gambiae (Keele) 
Mosquitoes injected with a RIDL construct containing a tetracycline switch are raised in 
water containing tetracycline to prevent activation of the RIDL gene.  In order to assess the 
effect of being reared in tetracycline, hatch rates, pupation rates and mortality rates were 
calculated from populations of An. gambiae reared in two concentrations of tetracycline, 
10μg/ml and 30μg/ml. 
 
The average hatch rate is higher in the control group than in either experimental group 
(Table 2.5 and Figure 2.10A).  Data was tested for normality and analysed using ANOVA 
(with Tukey‟s post-test) showing that this difference was not significant (p = 0.40; d.f. = 
2). 
 
Pupation began on day 8 (post-hatching) for the control and experimental groups, and for 
all groups pupation peaked on day 10 as shown by Figure 2.11.  A two way ANOVA 
confirms that the day does have an impact on pupae numbers which was as expected and is 
the case for all groups; p < 0.0001 (d.f. = 5).  However, there is no significant difference in 
the pupation rate each day (proportionally to the number of larvae at the start of the 
experiment), p = 0.58 (d.f. = 1) between experimental groups and the control.  The average 
pupation rate is higher in the control group than the two experimental groups (Figure 
2.10B).  Data was tested for normality and analysed using ANOVA (with Tukey‟s post-
test).  This analysis indicated that this difference was not significant (p = 0.42; d.f. = 2). 
 
The mortality rate for both experimental groups is higher than in the control group (Figure 
2.10C).  After testing for normality, data was analysed using ANOVA (with Tukey‟s post 
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test).  The difference in mortality between groups was found to be significant (p = 0.0057; 
d.f. = 2).  Tukey‟s post test indicates that the significant difference in mortality rates lies 
between the control group and the group reared at 10μg/ml tetracycline (p < 0.05).  There 
is no significant difference when comparing any other pairs of groups. 
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Tetracycline 
concentration 
Av. hatch rate 
 
Av. pupation rate 
 
Av. mortality rate 
 
0 mg/ml 
(control) 
0.77 0.79 0.20 
10 mg/ml 
 
0.73 0.71 0.36 
30 mg/ml 
 
0.72 0.77 0.27 
 
 
Table 2.5:  Average hatch rate, pupation rate and mortality rate of An. gambiae reared in 
water containing different concentrations of tetracycline. 
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Figure 2.10 (opposing page):  Effect of tetracycline on larval development and 
growth. 
L1 larvae were allowed to hatch and larvae were then maintained at a density of 0.2 
larvae/ml in water or water supplemented with tetracycline.  Bars represent means and 
standard deviations are indicated.  A) Effect of tetracycline on hatch rates in An. gambiae 
(Keele).  There is no significant difference between control and experimental groups; B) 
Effect of tetracycline on pupation rates in An. gambiae (Keele).  There is no significant 
difference between control and experimental groups; C) Effect of tetracycline on mosquito 
mortality rates.  There is no significant difference between the control group and those 
mosquitoes reared at 30μg/ml tetracycline, but there is a significant difference between the 
control group and those mosquitoes reared at 10μg/ml (p < 0.05).  Significant levels are 
indicated above bars in the colour of the bar the significance level corresponds with (*; p < 
0.05; **, p < 0.001; ***, p < 0.0001; ns, no significant difference) 
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Figure 2.11:  Effect of tetracycline on daily pupation rates of An. gambiae (Keele). 
Control groups were set up whereby larvae were reared in distilled water only.  Two 
experimental groups contained larvae reared in water containing either 10μg/ml or 30μg/ml 
of tetracycline respectively.  Pupation rates relative to the initial numbers of L1 larvae 
(those that had successfully hatched) were calculated per day from absolute pupae 
numbers.  Statistical analysis (ANOVA) confirms that there is no significant difference 
between experimental groups and the control (p = 0.58).   
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2.4. Discussion 
2.4.1. Larval development in tetracycline 
Tetracycline is known to cross cell membranes easily, without use of cross-membrane 
channels (Lycett et al., 2004).  It can therefore access every cell within the developing 
larvae which makes it very useful as a „switch‟ for the RIDL system.  When rearing 
transgenic mosquitoes containing a tet-off switch, they must, in order for the system to 
have the desired effect, be subjected to a large enough concentration of tetracycline 
throughout the larval rearing process.  However, there is also a possibility that a 
tetracycline concentration at too high a level may itself have a detrimental effect on 
mosquito development.  As An. gambiae are notoriously difficult to transform and 
subsequently maintain as transgenics, concern was raised that rearing larvae in tetracycline 
may have a deleterious effect due to direct toxicity of tetracycline to larval cells.  Ae. 
aegypti mosquitoes injected with RIDL constructs are reared in water containing 
tetracycline at a concentration of 30μg/ml (Fu et al., 2010).  As An. gambiae are well 
known for being less robust in terms of rearing than Ae. aegypti, it was sensible to assess 
survival/pupation rates of An. gambiae at different tetracycline concentrations in order to 
maximise survival of injection survivors and further generations.  It was expected that 
rearing larvae in water containing tetracycline would have some detrimental effect on 
pupation rates and overall mortality, with a greater effect at the higher concentration of 
tetracycline.  However, as is clear from Figures 2.10 and 2.11, there is no difference in 
pupation rates between control groups and those reared on tetracycline at either 10 or 30 
μg/ml.  Hatch rates also remain unaffected by presence of tetracycline (Figure 2.10A) but 
there is a significant difference in mortality rates (survival to adulthood) between 
experimental and control groups.  Unexpectedly, there is a greater detrimental effect at 
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10μg/ml of tetracycline than at 30μg/ml (Figure 2.10C).  This suggests that it is not the 
mere presence of tetracycline which has a toxic effect on the larvae.  A direct toxic effect 
may only be clear at higher concentrations of tetracycline than the ones used here.  
Mosquitoes contain, within their mid-guts at both larval and adult stages, a range of 
microorganisms which are thought to aid the digestion process (Rani et al., 2009; Gusmao 
et al., 2010).  Ae. aegypti are known to host a dense population of rod-shaped Gram-
negative bacteria within the midgut.  As a consequence of this, it is suggested that these 
bacteria share a nutritional interdependence with the host (Gusmao et al., 2010).  Studies 
looking at the effect that natural gut flora have on insects often use tetracycline to clear 
mosquito guts of bacteria (Gaio Ade et al., 2011).  Rani et al. (2009) demonstrate the rich 
diversity of gut micro-flora in lab strain and field-caught An. stephensi mosquitoes.  A 
more diverse flora was observed in field-caught mosquitoes, which is consistent with the 
hypothesis that their diet is more varied and certainly much less sterile than mosquitoes 
bred and reared in a laboratory setting.  This again suggests that gut microorganisms are a 
necessary resource for aiding the digestive process (Rani et al., 2009). It is also possible 
that gut flora are partially responsible for vectorial capacities of vector insects, by 
maintaining parasites such as Plasmodium spp. at a level which is less detrimental to both 
the host and the parasite itself, allowing transmission of the parasite (Rani et al., 2009).  
Certainly it has been documented that a reduction in mid-gut microflora increases infection 
rates of P. falciparum in experimentally infected An. gambiae (Beier et al., 1994).  Gaio et 
al. (2011) demonstrate that reducing gut bacteria by feeding antibiotics (including 
tetracycline) to adult Ae. aegypti mosquitoes affects the digestion of blood proteins.  Lysis 
of red blood cells was slower in mosquitoes with reduced gut bacteria, thus they had fewer 
protein products available to them after a blood meal which impacted on fecundity (Gaio 
Ade et al., 2011).  This evidence suggests that consistent exposure to antibiotics such as 
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tetracycline could have a detrimental effect on mosquitoes which may not be a result of 
direct toxicity.  Results from this study suggest that a lower level of antibiotic is more 
harmful than a higher level.  This was unexpected.  Reasons for this are unclear but it is 
possible that the higher level of tetracycline caused a decrease in all bacteria present in the 
mosquito as well as those in the water.  This could mean that larvae, although having fewer 
beneficial gut bacteria, were also subjected to fewer harmful bacteria and therefore any 
deleterious effects were counterbalanced.  However, larvae subjected to a lower level 
antibiotic concentration may have had their gut flora partially diminished thus having an 
effect on digestion and ability to utilise food resources whilst larval water also had only a 
partial reduction in flora thus allowing any harmful bacteria present to have a greater 
effect.  The insectary where the experiment was undertaken is used routinely for rearing 
RIDL strains of Ae. aegypti with a view to mass rearing.  Therefore a higher level of 
antibiotic in larval-rearing water would have a greater effect on reducing these bacteria 
than a lower level of antibiotic.  It would thus be expected that those larvae reared at lower 
concentrations of tetracycline would come into contact with a greater number of harmful 
bacteria which may account for the greater mortality rates seen in this cohort.  The data 
produced from this set of experiments provided the basis for the decision to rear G0 
mosquitoes and subsequent generations, from injections with the RIDL construct, at a 
tetracycline concentration of 30μg/ml. 
If RIDL technology is to be used in terms of mass rearing more studies are required to 
examine the consequences of rearing mosquitoes in water containing antibiotics.  Use of 
antibiotics in the laboratory may also impact these mosquitoes when they are released, as a 
reduction in gut flora may impact on fitness of mosquitoes in the field, especially when 
they come into contact with a much less sterile diet. 
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2.4.2. Microinjection of Anopheles gambiae 
Microinjection of An. gambiae embryos is a challenging technique whereby successful 
transformation is not efficient.  An. gambiae is not an easy organism to work with, and 
there are many steps in the transformation procedure which could be assigned as factors 
influencing the efficiency of this technique.  Initial injections were into embryos that had 
been desiccated for a set amount of time once attached to the cover slip.  It was found that 
there was a great range of variability in desiccation even when timing was so accurate.  
This was especially the case between egg papers and between injection days, and was thus 
attributed to a differing level of humidity in the local environment.  Injections from Round 
1 of those done using OX4244 were into embryos which underwent not timed desiccation, 
but rather desiccation by eye.  This resulted in a much smaller range in the variability of 
the desiccation of the embryos between days and egg papers and consequently went some 
way to standardising this step of the procedure therefore improving the microinjection 
protocol.  An. gambiae embryos are not resistant to desiccation in the same way as Ae. 
aegypti embryos, and consequently need to be restored to full turgor during the injection 
process.  Not injecting enough mix increases the risk of mortality prior to hatching due to 
over-desiccation, but conversely, injection of too much mix can cause the embryo to burst 
which again, will increase mortality rates at the embryonic stages.  The dichotomy 
presented here probably contributed to the very low hatch rates attained in the initial 
rounds of injection with OX3688 (Table 2.1).  The hatch rate in the final round of 
injections into An. gambiae with OX3688 was almost 20 times higher than in several of the 
previous injection rounds.  It is likely that, with practice, more embryos were injected with 
sufficient mix to ensure they had reached a suitable internal pressure without being 
overfilled.  However it is not likely that this, alone or even coupled with a very pure 
DNA/mRNA mix, would result in such a dramatic increase in survival of G0s.  It is worth 
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noting however, that immediately prior to round 6 of injections with OX3688, following 
advice from Dr D. Nimmo, the programme used to pull needles for microinjection was 
altered, thus making the needles both longer and much finer.  Finer needles were more 
prone to blunting and blocking, and therefore had to be changed more frequently, but were 
thought to be less damaging to the embryos themselves.  Fewer injections overall were 
undertaken in this round as the newer needles were more flexible than previous ones used.  
It is therefore logical to suggest that finer needles and injection of fewer embryos with 
more care taken over each injection, may account for the sharp increase in survival to 
larval stages. 
Initial rounds of injection were into the periplasmic space at the posterior end of the 
embryo which became more pronounced after desiccation.  The inner membrane 
surrounding the syncitial mass was not pierced.  Physiologically, injection into the 
periplasmic space causes less disruption to the embryo and consequently survival rates 
were expected to be higher.  It was also suggested that transgenics previously produced by 
members of the research group had been created via injection into this space between 
membranes.  As a result of this, all rounds of injection of construct OX3688 were into the 
periplasmic space (Table 2.1).  This did give rise to transformed individuals but the 
technique was not at all efficient.  It was suggested that the site of injection may play a big 
role in altering transformation efficiency.  Injection of a small amount of DNA/mRNA mix 
into the syncitial mass itself with a very fine needle was thought to increase the rate of 
transient expression seen in surviving G0 larvae. This was an indicator that sufficient DNA 
had entered the embryo which in turn would increase transformation efficiencies.  The 
initial 3 rounds of injection with OX4244 were performed in exactly the same manner as 
with OX3688, with the site of injection being the periplasmic space.  It was thought that 
the smaller size of OX4244 would improve transformation efficiencies without the need to 
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alter the site of injection.  It has been documented that transformation efficiencies of 
mariner-like transposons decrease as the size of the transposon increases (Geurts et al., 
2003).  Certainly OX4244 and OX4356 are approximately 5Kb shorter than OX3688.  
When transforming Drosophila melanogaster with piggyBac, it was shown that an increase 
in transposon size by one third caused a decrease in transformation efficiency of two-thirds 
(Handler and Harrell, 1999).   However, after 3 rounds of injection with the smaller 
OX4244 construct into the same site it was decided that it was worth injecting directly into 
the syncitial mass.  Rounds 4-6 of injection with OX4244 were performed with a very fine 
needle into the syncitial mass of each embryo.  A small amount of injection mix was 
placed into the cell mass at the very posterior end, the needle retracted slightly and the 
embryo filled back to full internal pressure by injecting more mix into the periplasmic 
space.  Piercing of the inner membrane and subsequent injection of foreign DNA/mRNA 
into the embryo had a detrimental effect of survival (Table 2.2) as expected.  However, the 
rate of transient expression in G0 surviving L1 larvae increased indicating that plasmid 
DNA was staying within posterior cells.  With practice, survival rate when injecting into 
the syncitial mass also increased as indicated by hatch rates for round 6 when injecting 
OX4244 (Table 2.2) and round 1 when injecting OX4356 (Table 2.3).  Injections with this 
construct were also into the syncitial mass. 
It is not possible to determine whether the transgenic larvae which resulted from a partial 
integration of OX3688 came from a G0 exhibiting transient expression as at the time these 
injections took place, screening for transient expression in G0 larvae was not undertaken as 
a matter of course.  Anecdotal evidence from other groups routinely transforming 
mosquitoes suggests that increased transient expression rates are a good indicator for 
increased transformation rates regardless of the size of construct.  However, even when 
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transient expression rates were increased by altering the site of injection, transformation 
with OX4244 and OX4356 was not achieved. 
It is possible that transformation efficiency into An. gambiae with such large and 
complicated plasmids is so low that the numbers of embryos injected were just not 
sufficient to produce enough G0 adults which had plasmid DNA integrated into germline 
cells, and which were fertile and could consequently successfully mate with wild type 
mosquitoes to produce viable and possible transgenic offspring.  Transformation 
efficiencies using a piggyBac vector vary between mosquito species and are worked out as 
the proportion of integration events per fertile injection survivor.  Often a 50% fertility rate 
is assumed amongst injection survivors.  In Ae. aegypti, efficiency ranges between 4% and 
11% (Kokoza et al., 2001; Lobo et al., 2002; Nimmo et al., 2006) and in An. stephensi it 
ranges between 4% and 12% (Ito et al., 2002; Moreira et al., 2002).  For both Ae. 
albopictus and An. gambiae (both species known to be more technically demanding), 
transformation efficiency is around 2-3% (Grossman et al., 2001; Labbe et al., 2010) 
which is considerably less than has been achieved with other species.  In only one 
documented case has a  much higher transformation efficiency been achieved with An. 
gambiae of 3-18% (Lombardo et al., 2005).  The authors suggest that the increased 
efficiency is due to improvement and modification to the original paper by Lobo et al. 
(2006) which outlines the procedure for germ-line transformation of mosquitoes.  The 
authors also suggest that time of injection as well as temperature, both in relation to the 
embryo may play a part. But it is not possible to extrapolate an exact reason for the 
increased transformation efficiency seen with An. gambiae in the work performed by 
Lombardo et al. (2009) compared with previous studies and the injections carried out here.  
At each life stage after microinjection, no matter how carefully eggs and larvae are cared 
for, loss is inevitable.  Increasing numbers at each step of the whole protocol increases the 
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likelihood of getting transformants.  Working alone limits the number of injections 
possible in a finite amount of time which is not ideal in terms of effectiveness. It also 
means that G0 injection survivors hatch out over an extended period of time and thus 
pupate over an extended period of time.  As a result it is necessary to have wild type strains 
(for back-crossing) pupating over the same time frame in order to have adult mosquitoes 
mating and feeding at the optimum time points.  Maintaining injections to generate enough 
numbers to maximise the potential for transgenesis whilst caring for G0 injection survivors 
and sustaining wild type populations at optimal levels for back-crossing proved to be quite 
difficult.  However, having small populations of back-crossed G0 adults at different stages 
due to injections being spread over several days meant that these populations were fed on 
different days rather than all together as they were when injections were undertaken with 
the help of others.  This therefore meant that G1 offspring were laid and hatched over a 
longer period of time and not simultaneously thus screening of G1 larvae was less intense 
which meant fewer long periods of time spent screening for fluorescence, but instead it had 
to be managed alongside screening G0 larvae for transient expression, sexing G0 pupae 
ready for back-crossing, as well as setting up back-crossing and dealing with maintenance 
of wild type mosquitoes for back-crossing.  It could be possible that working alone could 
reduce the chance of seeing transformants.  The injections using OX3688 were undertaken 
with a second person lining up embryos and the overall rate of survival of G0s from larval 
stage to adult stage is 69.3%.  This decreases to 41.7% when injections with the similar 
OX4244 construct were undertaken alone.  However, injections with OX4356 were also 
performed with the help of a second person lining up embryos and the rate of survival to 
adult stage is even lower, at 26.5%.  It was expected that, due to their being reared in water 
containing tetracycline to ensure that the RIDL gene remained „switched off‟, survival of 
G0 survivors to adulthood would, in fact, be reduced when the RIDL constructs were 
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injected in comparison to non RIDL constructs.  However, experiments to determine the 
effect of tetracycline on wild-type larvae showed that rearing larvae in water containing 
tetracycline at a concentration of 30mg/ml had no effect on any parameters measured 
including mortality rates.  Therefore it can be expected that rearing in tetracycline at this 
concentration would have no effect on rate of survival.  Consequently, seeing a lower 
survival rate when injecting the non-RIDL construct OX4356 is not surprising.  This 
therefore, points to other factors causing an effect on survival rates and possibly, as a result 
of this, an effect on transformation efficiency. 
 
2.4.3. Microinjection of RIDL constructs 
There is evidence to suggest that piggyBac will remobilise easily once inserted in the 
genome of a host insect (Horn et al., 2003; Handler, 2004; Lorenzen et al., 2007).  
Although this is not necessarily the case for all insect species.  For example, there is 
experimental evidence which strongly suggests that piggyBac will not remobilise within 
the genome of Ae. aegypti (Sethuraman et al., 2007).  Little is known about its potential for 
remobilisation within An. gambiae.  Post-integration instability could compromise its 
ability as a transformation vector as it would be less than ideal for an effector gene to be 
able to move around the genome.  Movement around the genome could compromise the 
effectiveness of this gene due to position effects, or could compromise the fitness of the 
host (Handler, 2004).  Dafa‟alla et al. (2006) describe a method for transposon-free 
insertion of an effector gene in the Medfly, Ceratitis capitata.  This involves injection with 
a construct whereby the effector gene and marker is flanked by two complete piggyBac 
ITR sequences each containing fluorescent marker genes.  Upon integration of the whole 
cassette, three markers can be visualised in the transformed insects using fluorescence 
microscopy.  Once the line is established, injection of embryos with a transposase source 
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causes remobilisation of either of the independent piggyBac ends, and upon repetition of 
this can result in removal of both piggyBac sequences leaving a transposon-free effector 
gene and its marker (Dafa'alla et al., 2006).  The same principle was applied in the case of 
injection with OX3688 whereby the RIDL gene is flanked by two independent piggyBac 
cassettes.  Integration of both piggyBac cassettes as well as the effector gene was expected 
to occur as this transposon does not always use the closest pair of terminal sequences (Li et 
al., 2001).  However, a transposition event may be more likely when transposons are 
shorter (Berg and Spradling, 1991).  Indeed, as indicated by the fluorescence profile of the 
transgenic larvae produced by injection with OX3688 (Fig. 2.6) which displayed only 
expression of AmCyan under control of the 3xP3 promoter, only one shorter piggyBac 
cassette was integrated into the genome of An. gambiae throughout the whole set of 
injections.  Changes to the injection protocol to ensure maximal survival of embryos, as 
well as other factors, as discussed above, may increase the likelihood of obtaining 
transgenic mosquitoes using double ended constructs, and indeed large constructs in 
general 
  
2.4.4. Microinjection of piggyBac remobilisation construct 
As previously discussed, it is known that piggyBac is capable of remobilising once in the 
genome of several host species (Horn et al., 2003; Handler, 2004; Lorenzen et al., 2007).  
If large scale release programs of transgenic insects are to take place, stability of 
transgenes must be assessed, in terms of mass rearing and subsequent release so that 
realistic models can be produced.  Understanding the stability of insertions is necessary to 
ensure effectiveness of control programs can be maintained (Handler, 2004).  Relatively 
little is known about the stability of transposon-mediated transgene-insertions with no 
studies having been undertaken to address the issue of transgene stability within large-scale 
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applications and over extended generations for any insect species including Drosophila 
(Schetelig et al., 2011).  The piggyBac transposon is thought to remain immobilised once 
in the germ-line cells of Ae. aegypti mosquitoes, even in the presence of a viable 
transposase source (Sethuraman et al., 2007).  The transposon Mariner did show some 
propensity for germ-line remobilisation but this was incredibly rare, which, unlike with 
piggyBac, mirrored that of previous work looking at post-integration stability of Mariner 
in Drosophilds (Wilson et al., 2003).  Hermes was also shown to transpose somatically in 
Ae. aegypti cells but no germ-line remobilisation events were detected (O'Brochta et al., 
2003).  In the malaria vector An. stephensi, the transposon Minos was shown to be stable 
with no germ-line remobilisation events detected (Scali et al., 2007).  Currently, little is 
known about the stability of transposon-mediated insertions in the major malaria vector 
An. gambiae.  Microinjection of OX4356 with piggyBac was undertaken as the initial step 
of addressing this issue.  The construct was designed to be inserted into the genome using 
the Mariner (Mos1) TE.  Insertion of the plasmid would then be verified using 
fluorescence microscopy whereby expression of AmCyan under control of the eye-specific 
promoter 3xP3 would indicate the integration of the entire sequence (Fig. 2.8).  This would 
include a gene for the production of an endogenous piggyBac transposase source under the 
control of the An. gambiae nanos promoter, responsible for embryonic pattern formation.  
The nanos mRNAs accumulate in oocytes and in the posterior of early developing embryos 
(Calvo et al., 2007).  The tight control and placement of the mRNAs makes nanos an ideal 
promoter for a transposase source as it would then be located in the posterior of the early 
embryo.  This endogenous piggyBac transposase source would be present in all mosquitoes 
within the transgenic line and should allow the entire piggyBac element also integrated 
within the plasmid to remobilise.  Elick et al. (1996) report, using genetically tagged 
elements, that the piggyBac transposon is capable of precise excision and insertion from 
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donor plasmid to target sites in a Lepidopteran cell line.  These precise events are catalysed 
by the transposase enzyme coded for by the transposon itself (Elick et al., 1996).  
Grossman et al. (2000) followed these studies by showing that piggyBac is capable of 
precise excision and insertion, only in the presence of an exogenous transposase, in An. 
gambiae Mos55 cell lines.  Indeed, piggyBac is consistent in showing precise excision, 
leaving the target TTAA site intact upon excision (Fraser et al., 1995).  It inserts at a 
specific sequence in the host genome (TTAA) and in fact has a sequence which bears little 
in the way of similarity to other superfamilies of transposons (Sarkar et al., 2003).  This 
precision means that piggyBac is ideal as a transformation vector.  In the case of a 
transgenic strain containing the OX4356 construct, precise excision of piggyBac would 
leave the TTAA site intact and would cause the 3xP3 promoter sequence and DsRed2 
marker sequence to become aligned thus altering the fluorescence profile of any mosquito 
in which piggyBac remobilised.  If remobilisation were to occur in somatic tissue, the 
mosquito would have patches of DsRed expression in these tissues.  In mosquitoes 
whereby germline remobilisation had occurred, the expression profile of DsRed would 
match exactly that of the original transgenic AmCyan marker.  This would allow 
visualisation of piggyBac movement post-integration and could be done over many 
generations.  Any movement seen visually could then be verified by molecular methods.  A 
limiting factor with this approach to assessing the potential of piggyBac to remobilise once 
integrated into the genome of An. gambiae lies in the initial creation of the transgenic line.  
As clear from the results of this experiment, OX4356 did not readily integrate upon 
microinjection of around 3300 embryos.  This could be due to factors specific to the 
microinjection technique rather than the construct itself, or could be due to the large size of 
the construct.  There is also the possibility that transposase itself is toxic to the developing 
embryo.  As the promoter controlling expression of transposase is nanos, an early-onset 
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gene, the transposase would be translated early in embryonic development and if toxic to 
An. gambiae, could cause a higher likelihood of mortality in any transformed embryos.  
Therefore An. gambiae could have been transformed in this experiment but death of the 
embryo prior to hatching or very soon after hatching, and consequently before screening, 
would mean that any transgenics were not seen.  If this is the case, then it would be 
difficult to create a transposase-driver line of An. gambiae, and would make assessing 
stability of piggyBac difficult via this route. 
It has been demonstrated that transformation of the malaria vector An. gambiae is possible, 
not only with transformation markers by themselves (Grossman et al., 2001), but also with 
antimalarial peptides (Meredith et al., 2011).  However, the creation of viable transgenic 
strains of any insect, especially An. gambiae, is challenging for many reasons.  Although 
transgenic strains of Anopheles exist which have exhibited anti-malarial properties (Ito et 
al., 2002; Yoshida et al., 2007; Meredith et al., 2011), there is much to be learned about 
the long-term stability of transposable elements, and consequently the transgenes, if these 
transgenic mosquitoes are to be reared in a mass scale with a view to release.  If future 
studies prove the piggyBac element to be mobile within the germline post-integration into 
the An. gambiae genome, it may be necessary to use molecular technology which would 
render the TE immobile.  This could be by complete removal of the TE by utilising the 
transposons‟ own propensity for remobilisation (Dafa'alla et al., 2006) or by disruption of 
the ITR sequences which are recognised and bound by the transposase thus facilitating 
excision and movement of the TE.  This could be achieved by the inclusion of loxP and 
FRT recognition sites in the plasmid integrated into the genome of the mosquito.  
Subsequent exposure to the required recombinases would thus cause removal of 
undesirable portions of the integrated DNA sequences leaving only the effector gene, 
whether it be a conditional lethal gene or one encoding an antimicrobial peptide (Handler, 
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2004).  The use of site-specific genetic technologies to create stable transgenic insect 
strains is discussed by Schetelig et al. (2011).  The authors conclude that maintenance of 
stable integrations of any transgene and reduction in the likelihood of horizontal gene 
transfer is of utmost importance when considering any release program (Schetelig et al., 
2011).  The microinjection technique, certainly with An. gambiae, is challenging with 
much more information required to ensure its reliability and efficiency.  However, 
regardless of the effector gene, much more needs to be learned about stability within the 
germ line and long-term effects of the effector on the mosquito itself regarding 
reproductive fitness. 
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Chapter Three 
3. Effects of multiple feeding on the antimalarial 
properties of Vida3 peptide within transgenic An. 
gambiae 
3.1. Introduction 
It has been speculated that the use of transgenic insects involved in a large-scale release 
program could be the future of control initiatives to combat various diseases of both 
medical and veterinary importance, and to target agricultural pests.  Traditional control 
methods, certainly for the control of vector insect species such as mosquitoes, involve the 
use of insecticides.  Resistance to these compounds has become widespread and has proved 
to be one of the most rapid cases of evolutionary adaptation documented (Hemingway et 
al., 2004).  Pyrethroids are commonly used for indoor residual spraying and for 
impregnating bednets as they have a low toxicity to humans.  It is thought that pyrethroid 
resistance in An. albimanus developed in just 3 years (Read et al., 2009).  The ability of 
mosquito populations to become resistant so quickly, also reflected in M-form An. gambiae 
populations of West Africa where pyrethroid resistance is now significant, affecting 
control measures which were once effective (N'Guessan et al., 2009) means that other 
methods of mosquito control must be considered. 
There are two broad methods of controlling vector-borne disease using genetically 
modified insects – population replacement and population suppression.  Both methods 
involve the alteration of DNA within the host species.  Population suppression using the 
Sterile Insect Technique (SIT) has been carried out with great success targeting several 
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insect species.  The agricultural pest causing myiasis, Cochliomyia hominivorax (New 
World screwworm fly) was eliminated from parts of Southern and Central America 
(Krafsur et al., 1987).  Success has also been seen when targeting the crop pest, Ceratitis 
capitata (Mediterranean fruit fly) (Robinson, 2002) and the sleeping sickness vector,  
Glossina austeni (tsetse fly) (Vreysen et al., 2000).  Similar attempts were made to 
suppress the population of An. albimanus in El Salvador (Lofgren et al., 1974).  This effort 
was successful when targeting a small 15km
2
 area but less so when a larger area was 
targeted on the Pacific coast.  A previous attempt at population suppression of An. 
albimanus on the Pacific coast was unsuccessful due to immigration (Benedict and 
Robinson, 2003).  Conventional SIT does come at a cost in terms of male reproductive 
fitness, which is reduced by exposure to radiation, and female contamination as both sexes 
have to be reared to adulthood then sex-sorted (Thomas et al., 2000).  In fact radiation and 
its effect on fitness of released males is a major concern with this technology (Andreasen 
and Curtis, 2005).  Release of Insects with a Dominant Lethal (RIDL) is a newer 
molecular-based technology which is, in effect, an upgrade of SIT involving integration of 
a dominant lethal gene into the genome of the insect using microinjection techniques.  This 
gene is under control of a tetracycline „switch‟ thus causing its effect to be conditional.  
This conditional lethal effect is life-stage and sex-specific (Thomas et al., 2000).  Using 
RIDL technology negates the use of radiation to compromise viable egg production, and 
reduces costly mechanical sex-sorting methods by use of genetic sex-sorting mechanisms.  
In fact, a transgenic sexing strain of An. stephensi has already been developed which would 
be highly beneficial in terms of mass rearing and release of males only (Catteruccia et al., 
2005).  The exploitation of sex-specific splicing in C. capitata (medfly) has lead to the 
production of strains of this insect which have non-viable females, when tetracycline is 
removed from the system (Fu et al., 2007).  This technology has been extended to 
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mosquitoes, leading to the development of Ae. aegypti strains which exhibit a flightless 
phenotype only in females.  This has the same effect as an entirely lethal gene, as the 
inability to mate and blood feed successfully leads indirectly to population suppression of 
the species (Fu et al., 2010).  The long-term aim concerning production of such a strain is 
mass rearing with a view to large-scale release in field trial situations to assess male fitness 
outside of the laboratory setting.  As with SIT, male fitness is key in using RIDL as part of 
an integrated control program.  Although sexing strains exist there are currently no 
documented strains of Anopheles in existence which possess integrated RIDL genes under 
control of a tetracycline switch, thus suitable for mass rearing.  However, a strain of An. 
gambiae which demonstrates early embryonic lethality and sex-ratio biasing via 
exploitation of homing endonuclease genes has been created (Windbichler et al., 2008).  
Although RIDL technology offers some solutions to the problems caused by SIT, it is by 
no means fool-proof and there are many issues which still remain to be addressed, 
especially in terms of released-male fitness (Nolan et al., 2011). 
The population replacement control approach also involves the integration of novel DNA 
into target species.  Genes encoding natural or synthetic antimicrobial peptides (AMPs) are 
inserted into the genome of the target species with the aim of reducing its vectorial 
capacity for the parasite in question.  Ae. aegypti, An. stephensi and An. gambiae are 
amongst the mosquito species successfully transformed with genes coding for molecules 
that impair pathogen development (Ito et al., 2002; Moreira et al., 2002; Kim et al., 2004; 
Abraham et al., 2005; Jasinskiene et al., 2007; Yoshida et al., 2007; Isaacs et al., 2011; 
Meredith et al., 2011).  These peptides target specific stages within the parasite lifecycle 
by using gene promoters to drive expression of the peptide at a specific time point and 
within a particular tissue, thus increasing efficacy of the effector molecule.  The mid-gut 
specific carboxypeptidase promoter has been used to drive expression of many effector 
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molecules in several different mosquito species with the aim of targeting parasites shortly 
after the blood meal has been taken (Coutinho-Abreu et al., 2009).  Transgenic strains of 
An. stephensi expressing PLA2 (bee venom phospholipase) and SM1 peptides in the 
midgut have been shown to have a reduced vectorial capacity for transmission of the 
rodent malaria, P. berghei.  Although mosquitoes expressing PLA2 were less able to pass 
on malaria infections than wild type counterparts, they were also significantly less fit 
(Moreira et al., 2002; Moreira et al., 2004).  Reduced fitness was not a problem with those 
mosquitoes expressing the SM1 tetramer however they were shown only to have a reduced 
vectorial capacity with regards to P. berghei (Ito et al., 2002).  An. stephensi mosquitoes 
expressing CELIII (haemolytic C-type lectin from sea cumber) have been documented as 
the first anophelines to show a reduction in vectorial capacity across different Plasmodium 
species, possibly as the molecule targets red blood cells as well as the parasite itself.  The 
authors suggest anecdotally that no fitness cost to the mosquito is incurred but this is yet to 
be tested (Yoshida et al., 2007).   
The vitellogenin promoter has also been used to express effector molecules in mosquitoes 
to target stages present in the fat-body.  Reports by Shin et al. (2003) suggest that 
transgenic Ae. aegypti expressing either Cecropin A or Defensin A under control of this 
promoter are more likely to survive injection with the pathogenic bacteria Enterobacter 
cloacae (Shin et al., 2003).  This promoter was then used in An. stephensi to drive 
expression of a DsRed reporter gene thus providing the initial indicator that it can function 
very well as a promoter, causing accumulation of reporter gene products in the fat-body of 
the insect (Chen et al., 2007b).  It has also been demonstrated that a salivary gland-specific 
promoter (anopheline antiplatelet protein, AAPP) is able to drive expression of the DsRed 
reporter gene (Yoshida and Watanabe, 2006).  This was shown, once again, in An. 
stephensi mosquitoes, as a candidate promoter to drive a transgene which could target the 
 160 
Plasmodium parasite at the sporozoite stage in the salivary glands.  Expressing such a 
peptide alongside a peptide specifically produced in the midgut in a double-barrelled attack 
on the parasite may be even more effective.  In the attempt to block malaria transmission in 
anophelines, the major malaria vector has not been forgotten.  The Ae. aegypti 
carboxypeptidase promoter has been used to drive expression of the naturally occurring 
AMP, Cecropin A, in the midgut of An. gambiae.  Challenge of these mosquitoes with P. 
berghei saw a 60% decrease in oocysts in transgenic mosquitoes compared to their wild 
type counterparts (Kim et al., 2004). 
More recently, transgenic An. gambiae have been created which express a synthetic 
peptide known as Vida3 in the midgut, using the An. gambiae carboxypeptidase promoter 
sequence (Meredith et al., 2011).  The data show a consistent reduction in parasite 
intensity of the mouse malaria P. yoelii nigeriensis by around 85%, and also indicate a 
knockdown effect on the human malaria P. falciparum, though this result was less 
consistent (Meredith et al., 2011).  Vida3, a 14 amino acid synthetic peptide, was selected 
for use as an effector molecule as it was designed to be effective against all sporogonic 
stages of the murine malaria parasites, P. berghei and P. yoelii (Meredith et al., 2011).  In 
comparison to other similar short hybrid peptides which had different expected secondary 
structures, Vida3 exhibited the highest level activity against P. berghei and P. yoelii 
sporogonic stages in culture, and showed the highest knockdown of P. berghei when 
injected and orally administered to infected An. gambiae mosquitoes (Arrighi et al., 2002).  
The difference in effectiveness of these peptides may be due to their secondary structure, 
and the exact mode of action against parasites may be different to that assigned to many 
other larger AMPs (>20 amino acids).  The smaller size of Vida3 is responsible for a loss 
of ability to span parasite membranes to form pores, and consequently an alternative mode 
of action is proposed as a mechanism by which a membrane is targeted (Arrighi et al., 
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2002).  The sequence coding for the Vida3 peptide was integrated into the genome of An. 
gambiae by means of the two-phase site-specific phiC31 integration system.  It is the first 
reported integration of an effector gene using the unidirectional Streptomyces phiC31 site-
specific system in the malaria vector, An. gambiae (Meredith et al., 2011).  The first step 
of this two-phase process involves transposon-mediated insertion of an attP recognition 
sequence into the host genome, alongside a promoter-marker sequence combination, 
allowing identification of transformed individuals.  This attP site is crucial in the second 
stage of the two-phase process, whereby the phase one lines are injected with plasmids 
containing an attB recognition sequence which, catalysed by phage phiC31 integrase, 
interact with the attP site and recombine to give attL and attR sequences, no longer 
recognised by integrase.  The plasmid injected, as well as the attB site and the effector 
gene with tissue-specific promoter, also contains a second promoter-marker sequence in 
order that individuals transformed with the phase two construct can be uniquely identified.  
Any phase two transgenic insect displays two fluorescence profiles.  This system was 
described as a tool for precise transformation in Drosophila (Groth et al., 2004), and was 
subsequently described in Ae. aegypti as providing a means for increased efficiency of 
transformation (Nimmo et al., 2006).  However, Meredith et al. (2011) did not see 
increased efficiency when using this system for integration of novel DNA, but speculate 
that there may be an impact on efficiency caused by size of plasmid.  Nevertheless, the 
phiC31 integration system demonstrates an ability to transform An. gambiae with an 
effector molecule which exhibits an anti-malarial phenotype when expressed in the mid gut 
of mosquitoes.  Not only that, but phase one lines generated and characterised could be 
used in the future to generate further phase two lines also showing an anti-malarial 
phenotype whereby Vida3, or other effector, is expressed in a different tissue within the 
mosquito thus targeting different stages of Plasmodium. 
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Interestingly, Arrighi et al. (2002) report that Vida3 is active against oocysts, which 
develop under the basal lamina in a suspected immune-privileged site, protected from 
AMPs by a capsule made up of basal lamina components.  This suggests that Vida3, when 
injected into the haemolymph, is small enough to be able to come into contact with the 
developing oocyst (Arrighi et al., 2002).  As the EVida3 An. gambiae strain expresses the 
peptide under control of the carboxypeptidase promoter, expression should be limited to 
the midgut of the mosquito, as demonstrated by RT-PCR of Vida3 expression in midgut 
and carcass from EVida3 strain (Meredith et al., 2011) as the signal peptide which directs 
the transport of the protein is also included.  It is not, therefore expected that this peptide, 
in this strain, would show activity against any other parasite stage other than ookinetes in 
the midgut.  However, due to its small size, and clear ability to access oocysts under the 
basal lamina, it was speculated that it may be able to cross the midgut epithelium and have 
a detrimental effect on developing oocysts.  It was also hypothesised that a second blood 
meal may boost the immune response of an infected mosquito as it provides more 
resources to fight an infection, but also, in the case of the EVida3 strain, provides a second 
boost of Vida3 peptide.  This of course, would only have an effect if the midgut stages of 
the parasite were still in the midgut at the time of the second blood meal, or indeed, if the 
peptide could cross the midgut epithelium to target oocysts in the same manner as when 
injected into the haemolymph (Arrighi et al., 2002).  It has previously been documented 
that anopheline mosquitoes will take multiple blood meals within one gonotrophic cycle 
(Briegel and Horler, 1993; Nirmala et al., 2005), and certainly within the time taken for an 
infection of Plasmodium to become infective, at the sporozoite stage (Lopes et al., 2007).  
Furthermore, there is evidence to suggest that infection with Plasmodium increases the 
volume of blood taken by a sporozoite-infected mosquito, as well as increased probing and 
the likelihood that more hosts will be fed upon (Koella et al., 1998).  Certainly blood 
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feeding habits of mosquitoes are important topics to research in order to create accurate 
mathematical models.  This is especially true when considering the effect of novel anti-
malarial peptides against Plasmodium when mosquitoes expressing these peptides obtain 
further resources from multiple blood feeds.  Consequently a study was designed whereby 
the transgenic EVida3 strain of An. gambiae expressing the Vida3 peptide was offered a 
second naïve blood meal in order to ascertain the effect this had on the intensity of P. yoelii 
nigeriensis infection within the mosquitoes by counting live oocysts within the midgut.  
The transgenic line EVida3 would be compared directly to the phase one transgenic line E 
as a control to ensure the only difference between the two lines was the production of 
Vida3 peptide.  This meant that the experiment would look at the effect of the second 
blood feed on parasite intensity with respect to production of Vida3 peptide in the 
mosquito midgut.  Meredith et al. (2011) had already demonstrated the efficacy of the 
Vida3 peptide in challenge experiments with P. yoelii nigeriensis against EVida3 
transgenic line.  Providing a second blood feed was not expected to have a significant 
effect on prevalence of infection with P. yoelii nigeriensis due to the timing of the second 
feed, and because it has already been demonstrated that although a considerable 
knockdown effect of the parasite occurs due to presence of the Vida3 peptide, it does not 
prevent all ookinetes invading the mosquito midgut epithelial cells (Meredith et al., 2011).  
This is an interesting topic in terms of insects transformed with genes coding for novel 
immune peptides as there is documented evidence to suggest a reproductive-fitness cost 
associated with mounting an immune response in wild type An. gambiae (Ahmed et al., 
2002; Hurd et al., 2005; Ahmed and Hurd, 2006). 
In order to better relate the effect of any enhanced immune response to production of 
Vida3, an experiment to more accurately determine how much Vida3 peptide is produced 
by the transgenic mosquito was designed.  A dose-response curve approach was taken with 
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the idea of feeding Vida3 peptide to the phase one host strain (line E), used to generate the 
EVida3 phase two strain, at varying concentrations.  The mean knockdown effect of oocyst 
burden could then be established for each peptide concentration against a control whereby 
no peptide was fed alongside the infected blood meal.  EVida3 mosquitoes fed on the same 
infected blood could then be dissected, knockdown effect determined and the dose-
dependent curve from the E line data used to determine an approximate level at which 
Vida3 is produced in the transgenic line. 
 
Ethics Statement 
All animals were handled in strict accordance with good animal practice as defined by the 
UK Animal (Scientific Procedures) Act 1986 and approved by the UK Home Office, 
licence number PPL 40/2997. Work was also approved by the University of Keele Animal 
care and Ethical Review Committee. 
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3.2. Materials and Methods 
3.2.1. Multiple feed experiment comparing An. gambiae transgenic lines E and 
EVida3 when challenged with Plasmodium yoelii nigeriensis 
3.2.1.1. Maintenance of P. yoelii nigeriensis 
Infection with P. yoelii nigeriensis in male T0 mice was established using cryopreserved 
infected mouse blood.  Subsequent passage of blood to a fresh mouse ensured better 
synchrony of infection.  Mice were reared under controlled conditions at a temperature of 
18
o
C with a 14:10 light:dark cycle.  Thin smears of tail blood were Giemsa-stained in order 
to establish parasitaemia of each mouse used.  Exflagellation rates, and thus infectivity, 
within each mouse were estimated by counting the mean number of exflagellating 
gametocytes in 10μl of tail-blood over 12 fields of view.  All experiments involving mice 
were carried out by trained personnel with appropriate Home Office licences. 
 
3.2.1.2. Setting up lines prior to infected feed 
Two weeks prior to the feeding date, 8 trays of 200 newly hatched L1 stage larvae for both 
the E and EVida3 lines were set up.  These were maintained following the standard 
protocol.  For each line, pupae were collected every day and placed into a small cage 
containing 10% glucose solution with 0.05% PABA (para-aminobenzoic acid) and left to 
emerge.  The following morning adults were removed from the cage and placed in a 
separate cage containing 10% glucose with 0.05% PABA so all adults were of a known 
age. 
Around 150 adult females from each line of around 3-4 days old were transferred to a large 
pot to ensure ease of blood-feeding.  Females were transferred to these pots 2 days prior to 
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the feed to allow them to settle.  Mosquitoes were starved of sugar overnight to maximise 
blood-feeding.  Water was removed from cages on the morning of the infected feed. 
 
3.2.1.3. Giving an infected blood-feed 
A T0 mouse infected with P. yoelii nigeriensis, shown to be exflagellating, was 
anaesthetised and placed over both pots of mosquitoes so both lines could feed 
simultaneously from the same mouse.  Records were made of parasitaemia, exflagellation 
rates and which line got the head/tail of the mouse.  The feeding was supervised at all 
times and the mouse was kept warm throughout the feeding procedure.  The mosquitoes 
were given ample time to feed without causing distress to the mouse.  Once the majority of 
mosquitoes had been fed, each pot was given 10% glucose with 0.05% PABA. 
 
3.2.1.4. Removal of non-blood-fed mosquitoes 
The morning after the blood feed was offered, both lines of mosquitoes were knocked 
down by chilling.  This ensured that engorged mosquitoes could be separated from those 
which had not fed.  Consequently it was certain that, at this point in the experiment, all 
remaining mosquitoes had taken no less than one blood meal.  Engorged mosquitoes for 
each line were split into two equally sized cohorts and placed into small cages containing 
10% glucose with 0.05% PABA.   
 
3.2.1.5. Multiple blood meals 
One cage of each line was allowed to lay 2 days post blood-meal.  At the same time as the 
oviposition vessel was placed in these cages, the sugar was removed.  The following day (3 
days after initial feed) the mosquitoes in these two cages were offered a blood meal using 
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the Hemotek feeding system following the usual protocol.  Gravid females who had not 
laid eggs were not removed.  The mosquitoes were given sufficient time to feed without 
being disturbed.  The following morning non-engorged mosquitoes were removed, after 
chilling, to ensure that all mosquitoes in those cages had received no less than two blood-
meals. 
 
3.2.1.6. Post-blood meal maintenance of lines E and EVida3 
Non-engorged mosquitoes were removed, after chilling, from the cages which were offered 
the second blood meal to ensure that all mosquitoes in those cages had received no less 
than two blood-meals.  Mosquitoes in all cohorts were subsequently not given an 
opportunity to oviposit.  All cages were maintained on 10% glucose with 0.05% PABA ad 
libitum for the remainder of the experiment, and this was checked twice daily to ensure its 
availability. 
 
3.2.1.7. Mid-gut dissections 
At 6 and 7 days post infected feed, 50 surviving mosquitoes from each cohort were 
dissected and mid-guts examined for presence of P. yoelii nigeriensis oocysts in order that 
prevalence and intensity of infection be determined.  The four populations were 
randomised by a colleague not involved in the experiment so that dissections be carried out 
„blind‟.  Prior to dissection, mosquitoes were immobilised by chilling for approximately 20 
minutes.  Dissections were carried out by 2-4 colleagues, each dissecting a similar number 
of mosquitoes to minimise operator-error.  Each mosquito was transferred to PBS on a 
labelled slide and the mid-gut dissected out of the abdomen using forceps.  The mid-gut 
was transferred to PBS on a separate labelled slide, covered with a cover slip and viewed 
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on a light microscope at a magnification of x100.  The number of oocysts infecting the 
mid-gut was recorded as was the number of melanised ookinetes.  Ovaries were also 
dissected out and egg number counted and recorded alongside oocyst number/melanised 
ookinete number for each mosquito in every population.  Carcasses were stored in 70% 
alcohol so wing length could also be measured to gain a mean wing length per population 
to rule out significant size difference between cohorts. 
 
3.2.2. Vida3 dose-dependent curve to assess levels of expressed Vida3 peptide in 
An. gambiae EVida3 transgenic line 
3.2.2.1. Maintenance of P. yoelii nigeriensis 
As described in section 3.2.1.1. 
 
3.2.2.2. Setting up lines prior to infected feed 
Two weeks prior to the feeding date, 12 trays of 200 newly hatched L1 stage larvae for the 
E line, and 3 trays of EVida3 line were set up.  These were maintained following the 
standard protocol.  For each line, pupae were collected every day and placed into a small 
cage containing 10% glucose solution with 0.05% PABA and left to emerge.  The 
following morning adults were removed from the cage and placed in a separate cage 
containing 10% glucose with 0.05% PABA so all adults were of a known age. 
Two days prior to the infected feed 80 adult females between 4 and 7 days old were 
transferred to each of 5 small Perspex cages for the E line.  At the same time 80 adult 
females, also aged between 4 and 7 days old, from the EVida3 line were transferred to a 
single Perspex cage.  All cages contained 10% glucose solution with 0.05% PABA which 
was removed at least 4 hours before giving the infected feed. 
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3.2.2.3. Vida3 dimer peptide solution 
2mg of Vida3 dimer peptide (Molecular Weight of 3.875kDa) was dissolved in Molecular 
Grade Water (Sigma) to yield a stock solution with a concentration of 2mM which was 
stored at -20
o
C until required.  This stock solution was used to create four different 
concentrations of peptide in 50μl of water.  This was then diluted in 450μl of P. yoelii 
nigeriensis-infected mouse blood which was fed to four cohorts of the E line.  The fifth 
cohort of the E line was fed on 50μl of molecular grade water alone, mixed with 450μl 
infected mouse blood.  The EVida3 line was also fed on 450μl infected blood mixed with 
50μl water containing no peptide.  All 50μl aliquots of peptide and water controls were 
kept on ice until blood was collected and was ready to be mixed with peptide and placed in 
the Hemotek feeding system. 
 
3.2.2.4. Feeding An. gambiae transgenic lines on P. yoelii nigeriensis-infected 
mouse blood 
In order that each cohort of mosquitoes could be statistically compared in terms of 
prevalence and intensity of infection, populations had to be fed on homogeneous blood.  
Feeding 6 cages of mosquitoes requires 3 infected mice so, once anaesthetised, each mouse 
underwent a cardiac puncture and blood was pooled in a 15ml falcon tube kept on ice at 
4
o
C until ready to be transferred to a membrane feeder.  450μl infected mouse blood was 
mixed, by pipetting, with 50μl peptide solution (or water controls) and transferred to a 
1.5ml reservoir.  The blood was contained within the reservoir by a single layer of 
Parafilm.  The Hemotek feeding system maintained the blood at 37
o
C whilst each of the six 
cages of mosquitoes were simultaneously fed on the blood-peptide (or control) mix.  The 5 
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E line populations were fed on a water control (0μM Vida3), and final peptide 
concentrations of 25μM, 50μM, 100μM and 200μM respectively.  The population of 
EVida3 were fed on a water control (0μM Vida3).  
3.2.2.5. Post-blood meal maintenance of lines E and EVida3 
As described in section 3.2.1.6. 
 
3.2.2.6. Mid-gut dissections 
As described in section 3.2.1.7. 
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3.3. Results 
3.3.1. Effects of multiple feeding on infection levels in An. gambiae transgenic 
lines E and EVida3 when challenged with Plasmodium yoelii nigeriensis 
Parasite challenge experiments were designed to test the efficacy of the Vida3 peptide 
expressed in the mosquito midgut upon ingestion of an infected blood meal, and to 
establish any further action on the parasite if a second, naïve blood meal was taken.  Four 
separate and independent challenge experiments with Plasmodium yoelii nigeriensis were 
undertaken over a period of 3 months (Table 3.1).  In all experiments, the initial infected 
blood feed was given to both transgenic and control mosquitoes with both groups feeding 
on the same mouse to ensure a comparable initial infection between cohorts.  The effect of 
taking one or two blood meals was measured by counting oocyst and melanised oocysts on 
the midgut of infected mosquitoes to determine intensity and prevalence of infection 
(Table 3.2).  Melanised parasites were included in the counts as they were frequently 
observed, and as they had traversed the midgut epithelium, were seen as invading parasites.  
Any non-blood fed mosquitoes were removed from the study, therefore leaving only those 
which had taken a blood meal.  In addition to this, only those mosquitoes that had eggs 
present in the ovaries upon dissection were included in the study.   
 
3.3.1.1. Female wing lengths 
No difference in wing lengths between the homozygous strains of E and EVida3 was 
observed (p = 0.4524).  This indicates that a similar size blood meal was taken by each 
group, as wing length is a good measure of body size (Fig 3.1).   
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Figure 3.1:  Wing lengths of female mosquitoes dissected as part of P. yoelii 
nigeriensis  infection challenge  
Wing lengths are well documented as a good representation of body size. Mosquitoes with 
similar size bodies are expected to take a blood meal of a similar size.  Data were found 
not to follow a normal distribution in one of the four experimental groups.  Therefore non-
parametric analysis was performed.  Vertical lines denote the maximum and minimum 
values, horizontal lines mark the median and the interquartile range of the data is boxed.  A 
Kruskall-Wallis test was used to confirm that there were no significant differences in wing 
lengths between the groups (p = 0.4524).  Statistical difference is shown above boxplots in 
the colour of the boxplot to which the significance level corresponds (ns, not significant). 
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3.3.1.2. Prevalence of Plasmodium yoelii nigeriensis infection 
In all experiments prevalence was lower in line Evida3 fed once compared to line E line 
fed once (Table 3.2).  When looking at groups receiving two blood meals, experiments 2 
and 3 show a reduction in prevalence in line EVida3 compared to line E.  However, 
experiment 1 indicates that prevalence is unaffected by the line, and experiment 4 shows 
the opposite result to that seen in experiments 2 and 3 where the highest prevalence is 
observed in line EVida3 (Table 3.2).  The pooled data indicates the general trend for higher 
prevalence in E when compared to EVida3 when mosquitoes receive either one (88% 
compared to 68%) or two (85% compared to 79%) feeds (Table 3.2).  Fig. 3.2A shows 
differences in prevalence between lines E and EVida3 in all 4 independent experiments, 
and pooled data.  The data shown is representative of all members of line E and line 
EVida3 regardless of feeding status.  This difference is significant for both experiment 2 (p 
= 0.0014) and for the pooled data (p = 0.0010).  When taking into account only line E, 
prevalence decreases when a second blood meal is given, in all but experiment 2.  The 
pooled data again reflects the general trend showing a decrease in prevalence from 88% to 
85% when these mosquitoes take a second, naïve, blood meal post-infection.  Interestingly 
and conversely, with the exception of experiment 3, there is an increase in prevalence 
when EVida3 mosquitoes obtain a second blood meal at 3 days post-infection (Fig. 3.2C).  
The pooled data shows an overall increase in prevalence from 68% to 79% when EVida3 
are given a second blood meal (Table 3.2).  Although general trends exist when comparing 
prevalence in line E fed once to line E fed twice, and when comparing prevalence in line 
EVida3 fed once to the same line fed twice, none of these differences are statistically 
significant for either strain (Fig. 3.2). 
 
 
 174 
 
Experiment 
Parasitaemia 
(exflagellation) 
(mouse) 
Strain (times 
fed) 
n 
Median 
parasite 
intensity 
(mosquito) 
Interquartile 
range 
(mosquito) 
1 
13% 
(0.6) 
E (once) 24 4.5 0.25-13.5 
E (twice) 19 2 0-7 
EVida3 (once) 36 1 0-4 
EVida3 
(twice) 
31 3 0-8 
2 
12% 
(1.5) 
E (once) 37 32 12.5-120.5 
E (twice) 34 43.5 8-122.5 
EVida3 (once) 46 6 0-22.25 
EVida3 
(twice) 
33 11 1.5-40 
3 
10% 
(1.5) 
E (once) 5 5 4.5-67.5 
E (twice) 6 13.5 1.5-46.5 
EVida3 (once) 12 10 4-13.5 
EVida3 
(twice) 
10 2.0 0-44 
4 
9% 
(1.0) 
E (once) 41 67 18.5-217.5 
E (twice) 40 76.5 10-206.5 
EVida3 (once) 42 29.5 3.75-44.5 
EVida3 
(twice) 
38 23 7.75-60.25 
1-4  
E (once) 107 27 5-110 
E (twice) 99 28 3-114 
EVida3 (once) 136 6 0-23 
EVida3 
(twice) 
112 9 1-35.75 
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Table 3.1 (opposing page):  Details of P. yoelii nigeriensis infection experiments with 
E and EVida3 transgenic lines 
Parasitaemia and exflagellation rates within infected mice are given, along with numbers 
of mosquitoes dissected.  Median parasite intensity and interquartile ranges are also shown.  
Data was tested for normality using D‟Agostino and Pearson omnibus normality test which 
found all data not be non-normally distributed (p < 0.01 in all cases).  Parameters are given 
for experiments 1-4 as well as for pooled data. 
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Experiment 
Strain (times 
fed) 
 
n 
Prevalence of 
infectiona 
Mean 
infection 
intensity ± 
SDb 
pc 
(significance) 
1 
E (once) 24 0.75 11.25 ± 16.38 
0.0722 
(ns) 
E (twice) 19 0.68 5.53 ± 8.003 
EVida3 (once) 36 0.53 2.67 ± 3.505 
EVida3 (twice) 31 0.68 5.00 ± 6.501 
2 
E (once) 37 0.92 65.08 ± 76.57 
<0.0001 
(***) 
E (twice) 34 0.97 71.35 ± 72.73 
EVida3 (once) 46 0.72 15.85 ± 25.01 
EVida3 (twice) 33 0.79 36.58 ± 64.91 
3 
E (once) 5 1.00 29.80 ± 45.69 
 
E (twice) 6 0.83 25.17 ± 33.86 
EVida3 (once) 12 0.83 10.75 ± 8.75 
EVida3 (twice) 10 0.70 23.30 ± 36.19 
4 
E (once) 41 0.93 
124.00 ± 
130.7 
0.0012 
(**) 
E (twice) 40 0.85 
121.80 ± 
146.6 
EVida3 (once) 42 0.81 37.36 ± 51.29 
EVida3 (twice) 38 0.89 43.66 ± 55.79 
1-4 
E (once) 107 0.88 73.93 ± 102.7 
<0.0001 
(***) 
E (twice) 99 0.85 76.29 ± 111.3 
EVida3 (once) 136 0.68 18.55 ± 34.67 
EVida3 (twice) 112 0.79 29.05 ± 51.22 
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Table 3.2 (opposing page):  Oocyst prevalencea and mean intensityb of P. yoelii 
nigeriensis infection in An. gambiae E and EVida3 lines fed either once or twice 
aPrevalence reflects the percentage of mosquitoes within which parasites had invaded 
midgut epithelial cells; bMean intensity of infection represents the mean number of 
invading parasites within the midgut of the infected mosquito; cA Kruskal-Wallis test was 
used to evaluate the statistical significance of the mean intensity of infection data.  This 
was followed by a Dunns multiple comparison test to establish which pairs of infection 
intensities showed statistically significant differences.  Statistical analysis of experiment 3 
is not given as n is too low.  This experiment is, however, included in the pooled data. 
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Figure 3.2 (opposing page):  Prevalence of infection with P. yoelii nigeriensis in 
transgenic lines E and EVida3 
(A) Histograms show prevalence for lines E and EVida3 in experiments 1–4 and the 
pooled data.  There is a trend to reduced prevalence in EVida3 although significant 
differences are only seen in Experiment 2 (p = 0.0014) and in the pooled data (p = 0.0010).  
(B) Histograms show prevalence for line E, fed either once or twice in experiments 1-4 and 
pooled data.  There is a general trend towards reduced prevalence in line E fed twice but 
none of these differences are significant.  (C)  Histograms show prevalence for line EVida3 
fed either once or twice, in experiments 1-4 and pooled data.  There is a general trend 
towards increased prevalence in EVida3 fed twice but none of these differences are 
significant.  Data was analysed by chi squared goodness of fit, with a Fishers Exact test. 
Statistical differences are indicated above bars according to significance level (**, p < 
0.001; ***, p < 0.0001) 
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3.3.1.3. Links between mouse and mosquito infections 
Overall a general inverse correlation between parasitaemia in the murine host and 
mosquito parasite intensity is apparent.  Mean intensity of parasite infection increases from 
an average of 6.1 in experiment 1, where the parasitaemia in the murine host was 13%, to 
81.7 in experiment 4 where parasitaemia was 9%.   The best infection rate (when taking 
into account all groups dissected) is found in the experiment which started with the lowest 
mammalian host parasitaemia (9%) and the lowest exflagellation rate (1.0). 
 
3.3.1.4. Intensity of Plasmodium yoelii nigeriensis infection 
Intensity of infection is variable over all four experiments; therefore separate boxplots are 
shown for each experiment as well as the pooled data (Fig. 3.3).  Statistical analysis was 
not performed on data generated by experiment 3 as numbers were too low, but this 
experiment was included in the pooled data.  A comparison of E with EVida3 when lines 
were fed only once shows a 75% decrease in oocyst burden on mosquito midguts when the 
Vida3 peptide is expressed (p < 0.0001).  This is reflected by comparing those groups 
receiving a second blood meal 3 days post-infection.  In this case the knockdown of P. 
yoelii nigeriensis is less marked but a decrease in mean intensity of infection of 63% is 
seen (p = 0.0006).  When comparing the effects of the second blood meal on mean 
intensity of infection in line E, experiments 1, 3 and 4 show a decrease in parasite burden 
of 51%, 15% and 2% respectively in E line fed twice compared with the control group fed 
only once.  Experiment 2 however indicates a 9% increase in mean intensity of infection 
when E line received a second blood meal.  When the data from all four experiments is 
pooled, a small increase in parasite burden of 4% is seen in those groups of E line fed 
twice in comparison to those fed once, a non-significant result (p = 0.9331).  A similar 
overall pattern is seen when comparing the effects of a second blood meal in EVida3 
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transgenic line.  However, experiments 1 to 4 all show an increase in mean intensity of 
infection, of 47%, 57%, 54% and 14% respectively, when EVida3 receives a second blood 
meal.  Pooling of data results in a mean intensity of infection which is 1.5 times higher in 
those EVida3 cohorts fed twice than in the control group of EVida3 fed once, though the 
result is not significant (p = 0.0720).  Percentage differences in parasite burden between 
compared cohorts as well as p values from statistical analyses, from pooled data, are seen 
in Table 3.3. 
 
3.3.1.5. Numbers of melanised parasites within mosquito midguts 
Parasite intensity took into account numbers of oocysts and number of melanised parasites 
present on mosquito midguts as they are both representative of invading parasites.  
Numbers of melanised parasites were also recorded independently of oocyst number for 
each mosquito. Taking into account the pooled data, there is no significant difference in 
number of melanised parasites between line E fed once compared to E fed twice (p = 
0.7468) or between EVida3 fed once and EVida3 fed twice (p = 0.2300).  However, there 
is a significant difference between line E fed once and EVida3 fed once (p < 0.0001) and 
between line E fed twice and EVida3 fed twice (p = 0.0011).  Differences between cohorts 
are illustrated in Fig. 3.4. 
 
3.3.1.7 Numbers of oocysts within parasite midguts 
The number of live oocycts were recorded for each mosquito midgut, as well as melanised 
ookinetes.  Numbers of live oocysts were generally low with the majority of mosquitoes in 
each experimental group having no oocycts present at all.  In each cohort of mosquites 
there was at least one individual which had a markedly high intensity of infection with live 
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parasites.  In three of these cohorts (E fed once, E fed twice and EVida3 fed twice) these 
individuals contained over 300 oocysts.  Taking into account the pooled data, there is no 
significant difference when comparing any pair of experimental groups (p = 0.4470).  
Graphical representation of the data can be seen in Fig. 3.5.  
 
3.3.1.7 Numbers of eggs present in ovaries 
Egg numbers were also recorded upon dissection of mosquitoes.  Statistical analyses of 
data using Mann-Whitney test to compare pairs of cohorts showed that there is no 
significant difference in egg number per female between lines E and EVida3 fed twice (p = 
0.7392).  There is a significant difference, however, in egg number per female between 
lines E and EVida3 fed once (p = 0.0182).  Within transgenic lines, there is a highly 
significant difference in egg production between those cohorts fed once and those fed 
twice (E, p < 0.0001; EVida3, p < 0.0001).  Differences between cohorts are illustrated in 
Fig. 3.6. 
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Cohorts comparedd 
Percentage differencee in 
mean intensity of infection 
p value 
(significance) 
E (C) (fed once) 
vs. 
EVida3 (fed once) 
 
75% ↓ 
 
p < 0.0001 
(***) 
E (C) (fed twice) 
vs. 
EVida3 (fed twice) 
 
62% ↓ 
 
p = 0.0005 
(***) 
E (C) (fed once) 
vs. 
E (fed twice) 
 
3% ↑ 
 
p = 0.8578 
ns 
EVida3 (C) (fed once) 
vs. 
EVida3 (fed twice) 
 
36% ↑ 
 
p = 0.1029 
ns 
 
 
Table 3.3:  Percentage differencese in mean infection intensity and p values for 
compared cohortsd of transgenic lines using the pooled data set 
dWhere cohorts are compared, the control group is denoted as (C); eAn increase compared 
to the control is denoted with ↑ and a decrease with ↓.  A Mann-Whitney test was used to 
evaluate pairs of data for statistical analysis and a 95% confidence limit was used to 
indicate significance. 
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Figure 3.3 (opposing page):  Parasite intensity of P. yoelii nigeriensis in E and EVida3 
transgenic lines after receiving either one or two blood meals  
Boxplots show parasite intensity for lines E and EVida3 from four independent 
experiments (A-D) and the pooled data (E).  Oocysts and melanised ookinetes were scored 
as invading parasites.  Vertical lines denote the maximum and minimum values, horizontal 
lines mark the median and the interquartile range of the data is boxed.   
Non-parametric statistical analysis (Kruskal-Wallis test) was carried out to ascertain 
significant differences in parasite intensity between lines.  Dunns multiple comparison post 
test was performed to analyse differences between pairs of cohorts.  Experiment 3 was not 
tested independently for statistical differences as numbers were too low in all cohorts, but 
this data is included in pooled data.  Statistical difference is shown above boxplots in the 
colour of the boxplot to which the significance level corresponds (***, p < 0.0001; **, p < 
0.001; p < 0.05; ns, not significant). 
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Figure 3.4 (opposing page):  Number of melanised parasites per mosquito midgut in transgenic lines and EVida3 after receiving either 
one or two blood meals 
The boxplot shows the number of melanised parasites for lines E and EVida3 from pooled data.  Vertical lines denote the maximum and 
minimum values, horizontal lines mark the median and the interquartile range of the data is boxed.  Data were found not to follow a normal 
distribution and therefore a Mann-Whitney test was used to analyse pairs of data.  There was no significant difference between line E fed once 
and line E fed twice, or between line EVida3 fed once and EVida3 fed twice (p = 0.7468 and p = 0.2300 respectively).  However there is a 
significant difference in number of melanised parasites between line E fed once and EVida3 fed once (p < 0.0001) and also between E fed twice 
and EVida3 fed twice (p = 0.0011).  Statistical difference is shown above boxplots in the colour of the boxplot to which the significance level 
corresponds (***, p < 0.0001; *, p < 0.05; ns, not significant). 
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Figure 3.5 (opposing page):  Number of oocysts per mosquito midgut in transgenic lines and EVida3 after receiving either one or two 
blood meals 
The boxplot shows the number of oocysts for lines E and EVida3 from pooled data.  Vertical lines denote the maximum and minimum values, 
horizontal lines mark the median and the interquartile range of the data is boxed.  Data were found not to follow a normal distribution and 
therefore a Kruskal-Wallis test was used to analyse data.  There was no significant difference between experimental groups analysed (p = 
0.4470)  Statistical difference is shown above boxplots in the colour of the boxplot to which the significance level corresponds (ns, not 
significant). 
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Figure 3.6 (opposing page):  Egg numbers per mosquito in transgenic lines E and EVida3 after receiving either one or two blood meals 
The boxplot shows number of eggs per female for lines E and EVida3 from pooled data.  Vertical lines denote the maximum and minimum 
values, horizontal lines mark the median and the interquartile range of the data is boxed.  Data were found not to follow a normal distribution 
and therefore Mann-Whitney tests were used to analyse pairs of data.  There was no significant difference between lines E and EVida3 when fed 
twice (p = 0.7392).  There is, however, a significant difference between lines E and EVida3 when fed only once (p = 0.0182).   Within transgenic 
lines there is a very highly significant difference in egg production between those groups fed once and those fed twice (E, p < 0.001; EVida3, p < 
0.0001).  Statistical difference is shown above boxplots in the colour of the boxplot to which the significance level corresponds (***, p < 0.0001; 
*, p < 0.05; ns, not significant). 
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3.3.2. Vida3 dose-dependent curve to assess levels of expressed Vida3 peptide in 
An. gambiae EVida3 transgenic line 
Mosquitoes fed on homogeneous P. yoelii nigeriensis infected blood via a membrane 
feeder.  The only difference between cohorts was the concentration of Vida3 peptide added 
to the blood.  The control group of E was fed water instead of peptide, as was the 
experimental cohort of line EVida3.  At 7 days post infection, mosquitoes were dissected 
in order that parasite intensity on the midguts could be determined.  This was repeated over 
several occasions with the intention of attaining results from at least 3 separate 
independent repeated experiments.  On all occasions, although both parasitaemia and 
exflagellation rates of male gametocytes obtained from the murine host was indicative of a 
good infection, dissection of mosquitoes showed no infection to be present in any of the 
cohorts. 
 
 
 193 
3.4. Discussion 
3.4.1. Effects of multiple feeding on infection levels in An. gambiae transgenic 
lines E and EVida3 when challenged with Plasmodium yoelii nigeriensis 
3.4.1.1. Effect of a second blood meal and the Vida3 peptide on parasite 
prevalence 
Prevalence of infection with P. yoelii nigeriensis, which is the percentage of dissected 
mosquitoes showing evidence of a parasite burden on their midguts, is seen to be higher in 
transgenic line E than in EVida3 (p = 0.0010), regardless of whether one or two blood 
meals are taken.  It is unlikely that this reduction in prevalence is due to EVida3 taking a 
smaller blood meal, and consequently ingesting fewer gametocytes as the wing length data 
shows there to be no significant difference between transgenic lines.  Wing length is a 
good indicator of body size (Hurd et al., 1995), and a positive, direct correlation between 
body size and blood meal size is known (Briegel, 1990).  This fact, combined with the 
removal of any mosquitoes not fully engorged from the study, means that it is reasonable 
to assume that within each challenge experiment, both transgenic lines take a similar size 
blood meal, thus ingesting a similar number of gametocytes.  Consequently blood meal 
size is not likely to a factor affecting parasite prevalence.  The Vida3 peptide within the 
midgut of EVida3 is expected to have an immediate effect, upon ingestion of the blood 
meal, on the ookinete stage of the parasite as indicated by initial feeding studies (Arrighi et 
al., 2002).  Thus it could be extrapolated from this, that a reduction in the prevalence of 
infection was expected within EVida3 when compared to E.  This is because a greater 
proportion of EVida3 mosquitoes are able to clear the infection prior to the ookinete 
invading the midgut epithelial cells.  It may be expected therefore, that a subsequent blood 
meal may cause reduction in prevalence for both strains, in comparison to those receiving 
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only one blood meal as the mosquitoes have greater access to resources and mounting an 
immune response is costly to the mosquito (Ahmed et al., 2002).  Inclusion of a wild type 
strain, for example, KIL, when undertaking these experiments may have been useful in 
order to determine the effect of a second blood meal on infection with Plasmodium, whilst 
removing any confounding factors presented by transgenesis.  A reduction in prevalence is 
seen in line E where a second blood meal is taken.  It is not, however, a significant 
difference (p = 0.6733).  This suggests that taking a second blood meal does not influence 
prevalence of infection, certainly not when the blood meal is taken 3 days post infection.  
This may be due to the timing itself of the blood meal or may be influenced as well by the 
immune status of the blood meal which, for this experiment, is naïve.  It would be expected 
that EVida3 would also show a reduction in prevalence for the same reasons as E when 
given a second blood meal.  In fact it would be reasonable to suggest that an even more 
marked reduction in prevalence may be possible in EVida3 if the second wave of 
translation of Vida3 peptide were detrimental to the parasite.  For example, if the peptide 
were able to have an effect on the oocysts themselves due to its small size conferring an 
ability to cross the midgut epithelium.  The peptide itself is expressed only on the midgut 
lumen side due to presence of a signal peptide which is cleaved from the protein after 
transportation so an ability to cross the midgut lumen would be necessary for Vida3 to 
have an effect on oocysts.  However in the case of EVida3 there is, in fact, an increase in 
prevalence of infection in the cohorts fed a second time.  Though again, this is not a 
significant difference (p = 0.0958).  This makes it very unlikely that the Vida3 peptide is 
able to access the parasite once it has entered the midgut epithelial cells. 
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3.4.1.2. Inclusion of melanised parasites in intensity data 
Intensity of infection was measured as the number of oocysts present on the midgut of 
infected mosquitoes as well as the number of melanised ookinetes present within the 
epithelium.  The genetic background of the transgenic lines is An gambiae (KIL) which is a 
wild type laboratory strain originally unable to melanise P. yoelii nigeriensis ookinetes 
(Hurd et al., 2005).  However previous infection studies have since suggested that 
contamination of this wild type strain with another wild type strain kept in the same 
insectary has occurred prior to it being used as the background strain for transgenic lines.  
In these infection studies, a melanisation response was frequently observed (Meredith et 
al., 2011).  It is likely that the contaminating strain was An. gambiae (G3) as it has a 
documented melanisation trait (Hurd et al., 2005).  However, this issue was not 
investigated further.  The ideal when undertaking infection studies is a comparison of 
numbers of viable oocysts only which means that the melanising trait within a host strain is 
considered to be a confounding factor.   For the purposes of this experiment, the main 
target of which was to assess the effect of multiple feeding on infection levels, melanised 
ookinetes have been included in parasite counts on midguts of mosquitoes due to them 
being deemed successful as invading parasites. It is worth bearing in mind that some 
melanised ookinetes may never have been able to give rise to viable oocysts, even though 
they have invaded midgut epithelium cells, due to damage by the Vida3 peptide (or other 
immune peptide), prior to invasion of these cells, but there is no way of assessing this. 
 
3.4.1.3. Action of the Vida3 peptide in vivo 
A reduction in mean intensity of infection of 75% and 63%, for those mosquitoes taking 
one or two blood meals respectively, was found when comparing EVida3 to E (p < 0.0001 
and p = 0.0006).  Along with the prevalence data this indicates that the Vida3 peptide is 
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responsible for knockdown of P. yoelii nigeriensis at the midgut ookinete stage within the 
mosquito host and further corroborates studies undertaken by Meredith et al. (2011) where 
the mean reduction in parasite burden was 79% - a value similar to the one attained here 
for the mosquito groups receiving one blood meal.  The Vida3 peptide clearly causes a 
highly significant reduction in numbers of invading parasites.  It is possible to speculate 
that this is due to its structure – large numbers of ß-pleated sheets and coils, but no α-
helices – since other peptides in initial studies showed a less marked effect on the parasite 
(Arrighi et al., 2002).  Structural differences altering hydrophobicity and charge 
distribution between peptides may result in differing modes of action and ability to act 
against a particular parasite.  This may have been the reason for the increased knockdown 
ability of Vida3 in comparison to other synthetic peptides in the original AMP study 
undertaken by Arrighi et al. (2002).  The authors speculate that action on the parasite 
membrane, due to the small size of Vida3, is less likely to be caused by formation of pores 
but is instead by means of other proposed mechanisms stated in previous studies (Arrighi 
et al., 2002).  In EVida3, the effector peptide is expressed under control of the 
carboxypeptidase promoter and is therefore present in the midgut, shortly after the blood 
meal is taken, from where it can exert its effect on the parasite.  There is a 16 hour time 
frame post-infected feed, within which Vida3 can remain active against the parasites 
(Ahmed and Hurd, 2006).  After this, the parasite invades the midgut epithelial cells and is 
no longer accessible to Vida3.  Proteases within the mosquito midgut are not active at high 
levels until 24 hours post blood meal, and consequently will not cause significant 
degradation of Vida3 until well after ookinetes have exited the midgut, therefore its ability 
to target the parasite is not compromised in this way (Arrighi et al., 2002).      
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3.4.1.4. Effect of the second blood meal on infection intensity in lines E and 
EVida3 with respect to increased resources 
 The main aim of this experiment was to test the effect of a second blood meal on infection 
intensity in both line E and line Evida3.  When considering pooled data for line E, there is 
an increase in parasite intensity of only 4% when the mosquitoes took a second (naive) 
blood meal at 3 days post-infection.  This result is not significant (p = 0.9331) and 
therefore the conclusion can be drawn that taking a second blood meal has no effect on P. 
yoelii nigeriensis infection intensity in line E.  When considering line EVida3, there was 
also an increase in parasite intensity of 35% when the line is fed twice - a much greater 
increase than seen with line E.  Although this result is once again not significant (p = 
0.0720), it is quite close to the 0.05 significance level which suggests that a larger sample 
size may be required to test the hypothesis further for more conclusive results.  An increase 
in mean parasite intensity for both transgenic lines is slightly surprising as a second blood 
meal theoretically provides more resources for an increased immune response against the 
parasite.  The second blood meal at 3 days post-infection, even though it causes a second 
wave of anti-malarial peptide to be released into the midgut, clearly has no further 
detrimental effect on the parasite than that caused by the peptide present with the initial 
infected blood meal.  If the slight increase in mean parasite intensity in both transgenic 
lines is a true trend, then this could suggest that a factor affecting both lines in the same 
manner is responsible for this increase rather than it being an effect of the Vida3 transgene 
itself.  It would therefore be feasible that a second blood meal at this stage of development 
within the mosquito could provide a higher relative increase in resources for the parasite 
than for its host.  A further explanation could be that the non-significant increase in 
intensity is just a random artefact of this experiment, and the availability of a second blood 
meal is incidental to parasite intensity.  The more marked increase in mean parasite 
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intensity in EVida3, which is close to being significant, could then be deemed as being due 
to the presence of the transgene within this line.  The mosquito uses more resources from 
the second blood meal than its line E counterparts in the production of the Vida3 peptide, 
which at this stage of the parasites‟ life cycle is ineffective.  Therefore resources are less 
available to be put towards an immune response against the midgut stages of P. yoelii 
nigeriensis which manifests as an increase in parasite burden on dissection at 7 days post-
infection.  It is interesting to note that a challenge study using P. yoelii yoelii infected An. 
stephensi mosquitoes indicated an increase in infection intensity when mosquitoes were 
given a second (naïve) blood meal 3 days post infection when compared to mosquitoes 
only receiving the original infected feed (Lopes et al., 2007).  The authors suggest that the 
second blood meal provides a higher availability of nutrients leading to faster maturation 
of oocysts.  The authors also give a different hypothesis in that the need for digestion of the 
second blood meal and/or requirement for further egg production could lead to a decreased 
immune response as the mosquito directs resources towards the other processes (Lopes et 
al., 2007).  This then leads to increased oocyst formation as it is more important to the 
mosquito to ensure further reproductive success than to prevent oocysts forming on the 
midgut.  In the experiment undertaken here, the increased numbers of eggs produced by 
those mosquitoes in their second gonotrophic cycle (Fig. 3.5) would appear to partly 
corroborate this hypothesis as they seem to be putting more resources into the second egg 
batch than the first.  A study by Rono et al. (2010) also indicates a close link between egg 
production and mosquito immune response to infection with Plasmodium.  This is 
discussed in more detail in section 3.4.1.8. 
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3.4.1.5. Effect of the second blood meal on the melanisation pathway 
The An. gambiae (KIL) host strain used here appears to have a propensity for melanising 
midgut parasites.  As these encapsulated parasites are seen to be invading parasites, they 
were included in the intensity data.  Production of melanin to encapsulate parasites uses up 
host resources, as does production of the Vida3 peptide.  A second blood meal, at day 3 
post-infection may provide mosquitoes with a second boost of resources which would 
enable them to boost their immune response such that they become efficient at melanising 
these invading stages so they are less likely to develop viable oocysts.  This would result in 
the parasite intensity data being made up of mainly melanised parasites and fewer oocysts 
in those mosquitoes fed twice in comparison to those fed once in both transgenic lines.  
This experiment actually indicates that there is no significant difference between the 
number of melanised parasites seen when comparing the cohorts fed once to those fed 
twice with either line E (p = 0.7468) or line EVida3 (p = 0.2300) (Fig. 3.4).  This suggests 
that the resources provided by the second blood meal have no effect on the melanisation 
pathway.   
3.4.1.6. Differences in parasite intensity between lines E and EVida3  
The reduction in mean parasite intensity observed in this experiment for EVida3 in 
comparison to E is clearly due to an effect of the Vida3 peptide on the parasite stages 
present within the midgut bolus.  Due to this, the number of melanised parasites in the 
midgut epithelial cells should be reduced in EVida3 fed once when compared to the 
number of melanised parasites in line E fed once as there are fewer ookinete stages to 
invoke the encapsulation pathway.  Although the second blood meal does not appear to 
influence melanin production in either line, production of the Vida3 peptide in line 
EVida3, when receiving the second blood meal, may divert resources away from melanin 
production to favour Vida3 production, thus causing a further decrease in the number of 
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melanised parasites observed in this line when compared to its line E counterparts also fed 
twice.  This may go some way to explaining the significant reduction in melanised 
parasites seen in this experiment when comparing line E fed twice with line EVida3 fed 
twice (p = 0.0011) (Fig 3.4).  It could be said that if the production of Vida3 peptide takes 
away resources from other immune defence mechanisms, such as the melanisation 
response, then any invading ookinetes are thus more likely to develop into viable oocysts.  
As a consequence, the life cycle of the parasite is able to continue, rendering these 
mosquitoes more effective vectors, as it only takes one viable oocyst to release sporozoites 
capable of invading salivary glands for that mosquito to become an efficient vector.  Only 
by ensuring that any active novel antimalarial peptide expressed in the midgut of the 
mosquito provides 100% knockdown of the ookinete so it cannot invade epithelial cells 
will a totally compromised vector be created.  Another solution would be to ensure a zero-
sporozoite phenotype whereby the peptide is active against the sporozoite stage in the 
haemolymph or salivary gland of the mosquito prior to it becoming infective.  Arrighi et 
al. (2002) report that the Vida3 peptide is indeed capable of knocking down stages of 
mouse malaria other than the ookinete.  Thus an „attack‟ of the parasite can be multistage 
and at more than one compartment to ensure an effective reduction of vectorial capacity.  
From this experiment it is impossible to know which, if any, oocysts are viable.  To 
determine this, larger cohorts of mosquitoes would be required in order that some 
individually be dissected at later stages to establish presence/absence of sporozoite-stage 
parasites in the salivary glands.  Alternatively, mosquito infectivity to mice could be 
gauged.  Oocyst numbers in general were low in all sets of experiments, possibly due to the 
propensity of the background KIL strain to melanise invading ookinetes, so it is difficult to 
compare infection levels based on oocyst data alone.  It could also be the case that line 
EVida3, although less melanisation occurs, perhaps due to a diversion of resources to 
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production of Vida3, still produces many fewer viable oocysts due to damage caused to 
ookinetes in the blood meal bolus.  This can only really be gauged by assessing the number 
of sporozoites.  So although the parasite is able to invade the epithelial cells, the damage is 
such that oocysts seen under the basal lamina will not produce sporozoites capable of 
infecting salivary glands of further mammalian hosts.  Analysis of oocyst data alone 
indicates that, although there is a trend towards fewer oocycts being present in line EVida3 
when compared to line E, these differences are not statistically different and thus 
conclusions cannot be drawn about decreased infectivity in the EVida3 strain.  It does 
appear when analysing total numbers of invading parasites that there is certainly a 
knockdown effect from the Vida3 peptide, however, it is worth bearing in mind that only a 
single viable oocyst is required for a mosquito to become infective.  It is possible that there 
is a parasite self-limiting factor which determines infection intensity in general on the host 
mosquito midgut.  This would ensure that infections do not become so heavy as to 
endanger the life of the host, which would of course mean that the parasite could not be 
passed on to the mammalian host in order to continue its life cycle.  If this is the case, it is 
possible that a second blood meal, at this time frame, would not increase numbers of 
oocyts present on the midgut, but would instead increase the sizes of the already present 
live oocyts.  Further experiments would be necessary to look at oocyst size on midguts of 
mosquitoes fed twice in comparison to those only receiving a single blood meal. 
At this stage it seems impossible to create real links between effects of a second blood 
meal and the effect on Plasmodium infection.  This is partly because of several 
confounding factors which are as a result of the creation of the transgenic line in a 
melanising strain.  The mosquito immune system is complicated, and the introduction of 
genes encoding novel AMPs only serves to make the system more complicated, increasing 
the number of unknown interactions.  More work is necessary to ensure that links between 
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immune response, feeding and other parameters such as egg laying (fecundity) are mapped 
so it is possible to create accurate models for release. 
 
3.4.1.7. Differences in fecundity between gonotrophic cycles in lines E and 
EVida3 
Invasion of the midgut by the ookinete is associated with a massive immune response 
initiated in the midgut but also active systemically, which is thought to lead to apoptosis in 
ovaries at the same time, thus causing a possible reduction in reproductive fitness of the 
mosquito (Hurd et al., 2005; Ahmed and Hurd, 2006).  It is plausible, therefore, that a 
second blood feed taken by the mosquito within one gonotrophic cycle would increase the 
number of eggs that mosquito produced due to a further nutrient boost delivered by the 
blood meal.  Briegel et al. (1993) have shown that a multiple blood feeding strategy in 
anophelines does indeed increase fecundity in non infected mosquitoes compared to those 
which receive only one blood meal.  Extrapolating from this evidence leads to the 
possibility that were infected mosquitoes to engage in this multiple feeding strategy within 
a gonotrophic cycle, they too would also increase fecundity when compared to infected 
mosquitoes taking only a single blood meal per cycle.  If resources were stretched due to 
the increased immune response directed at midgut-invading ookinetes, it is possible that 
subsequent blood meals could help provide these resources at the right time thus allowing 
for a reduction of apoptosis in the ovaries and increasing fecundity, that is if apoptosis here 
is linked to a reduction in nutrients.  In the case of lines such as EVida3, the subsequent 
blood meals, if within the 16 hours post-infected feed when ookinetes are still present in 
the midgut, would provide a further wave of peptide production and may reduce the 
infection further.  The timing of the second blood feed in this experiment meant that this 
was not a factor as the second feed was within the time frame (7 days) within which it 
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takes P. yoelii nigeriensis to traverse the epithelial cells of the midgut and develop to the 
oocyst stage, but it was not given to the mosquitoes within the initial gonotrophic cycle.  It 
is harder, therefore to compare fecundity as an effect of the second blood meal as that 
would be a comparison between gonotrophic cycles.  However, it is still possible to 
compare the effect of the second blood meal on fecundity between the transgenic lines and 
therefore ascertain an effect of the transgene on fecundity when mosquitoes are infected 
with Plasmodium.  Incidentally, it has been documented that the first gonotrophic cycle of 
An. gambiae is not likely to be the most productive in terms of egg numbers per female.  
An. gambiae from Amani, Tanganyika (East Africa) reared at temperatures close to that 
maintained in our insectaries, were seen to have a peak egg production at 7 days post-
eclosion which stayed at this level for several days before dropping off.  This corresponded 
with the 3
rd
 gonotrophic cycle (Armstrong and Bransby-Williams, 1961).  Furthermore, 
An. gambiae from Suakoko (Liberia) showed a peak in mean egg production on the 4
th
 
gonotrophic cycle (Scholte et al., 2006).  These data indicate that fecundity is likely to 
increase with the second gonotrophic cycle of An. gambiae when compared to the first.  
For both transgenic lines investigated here, there is a significant difference in fecundity 
between the cohorts fed once and those fed twice (p < 0.0001 in both cases), with those fed 
twice showing the highest rates of fecundity (Fig. 3.5).  This is in line with previous 
studies on wild type mosquitoes and indicates that infection with Plasmodium ookinetes 
within the midgut does not totally compromise egg production in either line.  In some 
laboratories, mosquitoes receive only one feed which selects for those which produce most 
eggs during the first gonotrophic cycle.  This would mean that comparisons with other 
studies could not be drawn.  However, in our laboratory, mosquitoes are fed more than 
once in their life time, and as such, such selection pressures are not imposed.  Ahmed & 
Hurd (2006) suggest that egg production (when infected with Plasmodium) during the first 
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gonotrophic cycle is compromised due to the immune response, instigated by invasion of 
the midgut epithelial cells, diverting resources away from oogenesis.  It is likely that this 
phenomenon was observed in both lines in this experiment during the first gonotrophic 
cycle resulting in a lower egg production.  The second blood feed was non-infective and 
consequently only provided resources and would not have initiated any further substantial 
up-regulation of the immune response in the mosquito host caused by introduction of 
further parasites.  A review by Cirimotich et al. (2011) suggests that the antibacterial 
immune response of An. gambiae is at least partially responsible for immunity to 
Plasmodium.  As such, it is possible that even a naïve blood feed as given to these cohorts 
of mosquitoes was enough to generate an immune response due to an increase in foreign 
bacteria present in the midgut.  If this is indeed the case, then there would continue to be a 
possible diversion of nutrients from oogenesis and egg maturation toward an immune 
response and as such, a second feed would have no effect on egg development.  It is 
perhaps worth noting that where a second blood feed was given, it was with horse blood 
treated so as to be free from growing bacteria.  This would perhaps, provide fewer immune 
„agonists‟ than would a blood feed from a mammalian host.  It is worth noting at this stage, 
that the mosquitoes from all cohorts were maintained outside of blood feeding on sugar not 
containing antibiotics.  This means that their natural gut bacteria would still be intact.  It 
has been suggested that the natural bacterial load in the anopheline gut is associated with 
lower Plasmodium infections (Dong et al., 2009).  In this case, disturbing the natural load 
was not deemed useful, even if it would have increased the likelihood of infection with 
Plasmoidium.  This was because a clear view, more representative of that which occurs 
naturally, was required, especially when analysing the effect of further blood meals.  More 
knowledge of the interactions between natural gut bacteria, immune response in the 
mosquito and infection with parasitic diseases is necessary to ensure a full picture when 
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considering generating insects refactory to human disease (Cirimotich et al., 2011).  If the 
second feed did provide extra resources which were available to be used for egg 
development, rather than the immune response, the mosquito would be able to generate 
more eggs from this gonotrophic cycle at a level more inline with non-infected mosquitoes 
giving a more pronounced difference in egg production between cycles than is expected 
from non-infected wild type mosquitoes.  To verify this, a similar study would have to be 
undertaken with non-infected mosquitoes as a control.  A study by Hogg and Hurd (1995) 
however, indicates that infection with Plasmodium oocysts, which is the stage of the 
parasite present during the second gonotrophioc cycle, also results in a reduction in 
fecundity.  
3.4.1.8. Differences in fecundity between lines E and EVida3 
A comparison of the egg production between transgenic lines is quite interesting.  There is 
a small, yet significant difference in egg production between line E and Evida3 (p = 
0.0182) when both lines received only the initial infected blood meal with E producing 
more eggs than EVida3.  Given the reduction in intensity of infection and parasite 
prevalence in the EVida3 line fed once, it seemed more likely that the immune response 
initiated by parasite entry into the midgut of these mosquitoes would be reduced compared 
to their line E counterparts.  The expectation was that EVida3 would show higher 
fecundity than E when given only the initial challenge feed.  Clearly this is not the case, 
and as the only difference between these two transgenic lines is the production of the 
Vida3 peptide itself (and its associated fluorescent marker) it seems likely that it is this 
which is behind the decreased fecundity of EVida3.  It is feasible that Vida3 production is 
costly to the mosquito and resources ploughed into production of this peptide, as well as 
up-regulation of the immune response as the parasite enters the midgut, leave fewer 
available resources for egg production within the first gonotrophic cycle when P. yoelii 
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nigeriensis is present.   There is no significant difference in egg production between line E 
and line EVida3 (p = 0.7392), both of which had received a second blood meal, and both of 
which produced more eggs than their cohorts which had only received the initial infected 
blood meal (Fig. 3.5).  This suggests that production of a second wave of Vida3 peptide 
has no effect on egg production after the first gonotrophic cycle, certainly when 
mosquitoes do not receive a second challenge from a parasite.  It is well documented that 
there are fitness costs associated with transgene insertion, and fecundity is often used as a 
parameter with which to measure fitness (Marrelli et al., 2006; Amenya et al., 2010).  It 
has also been shown that some mosquitoes expressing genes which incur refractoriness to 
malaria parasites are „fitter‟ than wild type mosquitoes when challenged with malaria 
parasites (Marrelli et al., 2007).  It is therefore necessary to determine fitness costs 
associated with the Vida3 peptide in the EVida3 transgenic line, not just in terms of 
fecundity, but in terms of several measurable parameters connected with evolutionary 
fitness of organisms including longevity as well as analysis of transgene frequency across 
several generations. 
The interactions between the mosquito immune system and the parasite are complicated, 
and are made more so by having a novel antimicrobial peptide expressed which adds a 
further depth to the complex interactions seen in infected mosquitoes.  Not only is there a 
possible complication added by the AMP, but the sheer presence of a transgene may exert 
fitness costs on the mosquito as well.  Rono et al. (2011) demonstrate an interaction 
between immunity and reproduction and highlight the requirement for further exploration 
of the trade-off between the two processes.  Their studies suggest that Lipophorin and 
Vitellogenin (both nutrient-transport proteins) are required, not only for oogenesis within 
the mosquito, but also for Plasmodium survival in the mosquito host.  However, there is 
evidence to suggest an interaction with the antiparasitic factor TEP1.  Knockdown of 
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Lipophorin and Vitellogenin by RNAi causes a reduction in the maturation of oocytes, as 
well as an increase in effieciency of TEP1 binding to the surface of Plasmodium ookinetes 
in the mosquito midgut. The authors therefore propose that Lipophorin is required for 
oogenesis and normal expression of Vitellogenin after an infectious blood meal.  They also 
suggest that Vitellogenin also contributes to oogenesis as well as having a negative impact 
on TEP1 binding to ookinetes therefore indicating that the negative impact of lipophorin 
on ookinete survival is indirect (Rono et al., 2011).  The study also implicates NF-κB 
factors REL1 and REL2 as factors limiting Vitellogenin expression after an infectious 
blood meal (Rono et al., 2011).  
Clearly more studies are required before the complexities of the interactions between 
parasite and host are understood well enough to provide accurate models, should such 
transgenic lines be taken to the field. 
 
3.4.2. Vida3 dose-dependent curve to assess levels of expressed Vida3 peptide in 
An. gambiae EVida3 transgenic line 
Meredith et al. (2011) demonstrate that the transgenic line EVida3 shows midgut-specific 
expression of the synthetic Vida3 peptide which is able to significantly knockdown the 
mouse malaria P. yoelii nigeriensis in challenge studies.  This evidence is corroborated 
further by the multiple feeding experiments detailed here.  To date there is no data 
available on the quantity of Vida3 produced by this transgenic line upon ingestion of a 
blood meal. Thus an experiment was designed which would generate a dose-dependent 
curve by means of which a quantitative assessment of the amount of Vida3 produced could 
be achieved.  Thus several different cohorts of the transgenic phase one line E (from which 
line EVida3 was generated) were fed mouse blood infected with P. yoelii nigeriensis.  
Each cohort had a different concentration of the Vida3 peptide mixed with the mouse 
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blood, ranging from 0μM to 200μM.  A cohort of EVida3 was fed simultaneously on the 
same mouse blood mixed with a water control (Vida3 peptide at 0μM).  The knockdown 
effect on the parasite by line E could then be charted with respect to the amount of Vida3 
peptide fed.  The dose-response curve generated could then be used to work out the amount 
of Vida3 produced by line EVida3 by determining the knockdown effect.  This was to be 
repeated at least 3 times to ensure that results were comparable even with different 
murine/mosquito infection levels.  The major consideration therefore, with this experiment 
compared to the previous challenge experiment was how to generate a statistically 
comparable infection in all 6 cohorts of mosquitoes.  For this experiment to work, all 
mosquitoes had to be fed on the same blood in order that the curve generated was able to 
be used in the manner intended.  As there were 6 different cohorts of mosquitoes to feed, it 
was impossible to use the blood from only one mouse as 0.5ml of blood was required per 
cage and a single mouse will only give between 1 and 1.5ml.  Direct feeding from mice 
was not possible because Vida3 peptide had to be added to the blood (or water for proper 
controls) so feeding via a membrane was necessary.  Due to this, and because several mice 
were required, it was decided to use three mice and pool blood from them.  Aliquots of this 
pooled, and therefore homogeneous, blood were then taken and peptide, or water, added 
and the whole aliquot fed to the relevant cohort of mosquitoes.  This ensured all 
mosquitoes were subjected to the same infection intensity which meant that groups would 
be comparable as knockdown effect of each group, in relation to the water control, was the 
measured parameter.  The experiment was started on several separate occasions, and in 
each case the mosquitoes fed well from the membrane feeder.  This was obvious not only 
from observations, but upon dissection where over 99% were found to be gravid.  However 
at 7 days post-infection with P. yoelii nigeriensis, no oocysts were found on the midguts of 
the mosquitoes from any of the cohorts, and no evidence of melanisation was present. 
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Previous work by Arrighi et al. (2002) had shown that challenge of anophelines with 
murine malaria was possible when feeding AMPs with infected blood via a membrane 
feeder, so the challenge was then to determine a protocol which ensured that the 
mosquitoes in this dose-response curve were infected with P. yoelii nigeriensis thus 
allowing for reproducible data.  In the previous experiment looking at the effect of multiple 
feeding, it was clear that mice with a parasitaemia of around 10% gave good infections.  
Anecdotal evidence had suggested that, when giving an infected feed via a membrane, a 
higher parasitaemia in the mice from which blood was obtained would be more likely to 
initiate better infection rates in the mosquitoes.  As a consequence of this, initially the mice 
selected for this experiment had parasitaemias of around 20 to 25%. Smears of blood from 
each mouse showed exflagellation events though rates were not always measured.  Smears 
of pooled blood were not looked at for exflagellation events as it was thought that it would 
take too long to observe this prior to using the blood and afterwards, with any remaining 
blood, would not give an accurate portrayal of the rate in the membrane feeders.  After 
initial experiments did not result in mosquitoes with midgut infections, it was suggested 
that it would be perhaps more beneficial to use mice exhibiting a lower parasitaemia of 
around 5-8% as used for P. berghei infection studies (Arrighi et al., 2002).  This change to 
the protocol was not implemented as any infections previously achieved with anophelines 
in this laboratory with P. yoelii nigeriensis fed via membrane feeder have been attained 
with higher parasitaemias.  As P. berghei and P. yoelii are different to handle in the 
laboratory, it was decided that other parameters would be altered as a matter of priority 
over parasitaemias.  Deliberately for infection experiments, blood was not collected from 
mice directly infected from the cryovial as the infection can sometimes be erratic.  This 
settles after passaging which gives a more stable parasitaemia which is useful when 
pooling blood from mice.  It also means that the infection is more predictable thus making 
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it possible to gauge when it will be possible to start the experiment in terms of parasitaemia 
being at the right level at a suitable time.  This has a consequence for mosquito husbandry 
which can influence the reproducibility of the experiment.  Having a stable, predictable 
infection in mice means that age of mosquitoes can be tailored to maximise feeding 
potential, and will be comparable between replicates.  Although the protocol used for 
infected membrane feeds for the 2002 Vida3 peptide study (Arrighi et al.) used blood from 
a mouse directly infected with P. berghei directly from the cryovial, this was not viable in 
terms of this experiment where reproducibility was paramount.  Feeding mosquitoes of the 
same age each time and therefore having a predictable infection was key to this.  Thus, 
after personal communication with Romanico Arrighi, it was decided that a change to the 
dose-dependent curve experimental protocol would be implemented whereby infected mice 
would not be considered for use once 4 passages had been attained.  Infections on the 
midgut of mosquitoes were not observed after this change in protocol was implemented. 
Infections were possible with the same mosquito-mouse-parasite system when feeding 
mosquitoes of the same lines directly on an infected mouse for the multiple feed 
experiments.  This evidence, combined with sporadic infections having been achieved in 
the past when feeding via a membrane feeder suggested that the reason for the lack of 
infections observed in the dissected mosquitoes was not associated with the mouse 
infection.  It therefore seemed more likely that the problem lay between collection, storage, 
pooling and transfer of blood.  The initial step in collection of the blood is the cardiac 
puncture.  This was performed by a skilled technician, taking around 1 minute per mouse.  
It was strongly believed that this step could not be optimised further.  In the original 
protocol, once collected from the mouse, blood was transferred to a falcon tube kept in a 
37
o
C water bath to maintain a constant temperature prior to delivery to the mosquitoes.  
Once blood was collected and transferred to a Falcon tube, addition of peptide (or water 
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control) and transfer to the membrane feeder was done as quickly and efficiently as 
possible.  This was to reduce the likelihood of the parasites becoming less viable which is 
more probable the longer they are out of the natural host.    No infections were seen in the 
mosquitoes when following this protocol so after personal communication with R. Arrighi, 
it was decided to make an alteration to the part of the protocol involving temporary storage 
of collected blood prior to addition of peptide and transfer to the membrane feeder.  Instead 
of storing collected blood at 37
o
C, blood was stored at 4
o
C in a Falcon tube kept on ice.  
The microcentrifuge tubes containing the peptide solutions, and the water controls, were 
also stored on ice to maintain the lower temperature until the blood-peptide mix was 
transferred to the membrane feeder.  The membrane feeder would then heat the mix back 
up to 37
o
C in order that the mosquitoes would feed.  Despite the initial lower temperature, 
observations showed that mosquitoes were as quick to feed as they had been when the 
blood-peptide mix was maintained at 37
o
C.  The small quantity of blood (50μl) transferred 
to the membrane feeder probably allowed the increase in temperature to take place very 
rapidly.  Pooling and storage of infected mouse blood at 4
o
C prior to transfer to the 
membrane feeder followed the protocol used with similar infection studies undertaken 
previously with Vida3 and P. berghei (Arrighi et al., 2002).  It was thought that the lower 
storage temperature would slow down or halt any infection-related reactions which take 
place within the blood, and these would then be resumed once in the membrane feeder as 
temperature was brought back up to 37
o
C.  It was thought more likely that this temperature 
decrease would therefore mimic more closely a direct feed from the mouse as it reduced 
the likelihood of aberrant reactions taking place in the blood outside of the host prior to 
feeding the mosquitoes which may have had an adverse effect on the parasite thus 
compromising the infection.  This adapted protocol was used for three dose-dependent 
curve experiments, and in all of these, no parasites were detected on dissected mosquito 
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midguts.  Running concurrently with these experiments, other groups were performing 
similar infection studies using P. yoelii nigeriensis to challenge An. stephensi mosquitoes.  
Upon dissection of these mosquitoes, they were also found not to be infected (V. Carter, 
Pers. Comm.). 
 
3.4.3. Other methods for quantifying in vivo production of the Vida3 peptide 
Meredith et al. (2011) conclusively demonstrated, by use of RT-PCR, that Vida3 is present 
exclusively in the midgut of the EVida3 transgenic line.  Western blotting to further 
corroborate this data was not possible.  Other laboratories have also struggled to obtain 
Western blots for midgut-expressed proteins (A. James & M. Jacobs-Lorena, Pers. Comm.)  
Moreira et al. (2002) did achieve it with the bee venom phospholipase PLA2, however this 
protein is bound to the midgut epithelial cells and not free in the lumen.  There are of 
course a large number of total proteins present in the midgut when a blood meal is taken 
which may impede Western blot results.  Presence of Vida3 peptide in the midgut of blood 
fed mosquitoes could have been shown by immuno-staining, using anti HA antibodies with 
a FITC/IgG conjugate.  However, raising the Vida3-specific antibody would be expensive 
and time-consuming.  Not only that, but the fluorescent conjugate would likely be larger 
than the Vida3 peptide itself.  Nevertheless, Western blotting or immuno-staining would 
not have achieved a quantification of the Vida3 peptide present in the midgut which was 
the aim for the dose-dependent curve experiment.  Using a Bradford‟s protein assay would 
allow for quantification of peptides and is both fast and accurate.  However it is non-
specific thus requiring the purification of Vida3 from the large amounts of proteins present 
in the blood meal bolus.  This was not achievable in the time frame given.  Quantifying the 
amount of Vida3 expressed by the EVida3 transgenic line has still not been possible.  
Knowing such information would be useful in terms of looking at resource requirements 
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for mosquitoes expressing novel peptide especially if such transgenic insects are to be 
trialled in the field. 
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Chapter Four 
4. Fitness assessments of transgenic Anopheles 
gambiae expressing the Vida3 peptide 
4.1. Introduction 
It has already been demonstrated by several different laboratories that the creation of 
mosquitoes which are impaired in their capacity to transmit disease is possible (Ito et al., 
2002; Moreira et al., 2002; Fu et al., 2010; Isaacs et al., 2011; Meredith et al., 2011).  
Impaired vectorial capacity is achieved, either by insertion of an effector gene which 
hinders the pathogen‟s ability to survive within the insect host, or by insertion of a 
dominant lethal gene causing death of the mosquito prior to the pathogen completing its 
life cycle and reaching its infective stage.  For transgenic technology to be a viable part of 
an integrated control strategy to reduce incidence of diseases such as Dengue, Yellow 
Fever (Aedes spp.) and Malaria (Anopheles spp.), then it relies on the genetically modified 
mosquito being able to successfully compete with wild type field mosquitoes for required 
resources.  Genetically modified mosquitoes therefore have to exhibit minimal fitness costs 
associated with the transgene.  Such imposed fitness costs would ultimately impair the 
released mosquitoes‟ ability to reproduce.  Effective inheritance of the transgene by 
subsequent generations and its integration into field populations thus causing population 
replacement or suppression would lead to achieving the ultimate goal of disease control.  
Creation of genetically modified mosquitoes by use of transposon-mediated transgenesis 
can impair fitness of the resulting transformed mosquito lines due to position effects, or as 
a direct negative effect caused by the gene products expressed in the transgenic line 
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(Marrelli et al., 2006).  When plasmids are microinjected into mosquito embryos it is 
necessary to be able to detect transformed individuals.  It is usual to include a fluorescent 
marker gene as well as the effector gene in injected plasmids which means that the 
transgenic phenotype can be visualised in larval stages (Labbe et al., 2010; Meredith et al., 
2011).  Not only does this mean that the host genome must incorporate a much larger 
amount of DNA but it also means that the transgenic lines express the marker gene product 
as well as the intended effector gene product.  Fluorescent marker genes are often 
expressed in a tissue-specific manner, for example linked to the eye-specific 3xP3 
promoter.  Even with simple promoter-marker combinations, there are reports of adverse 
fitness effects, in the laboratory, on the transgenic lines which have this DNA incorporated 
into their genome (Catteruccia et al., 2003), however these reports are not widely reported 
in all generated lines (Moreira et al., 2004).  The mosquito lines transformed for the 
purpose of RIDL not only express fluorescent markers, but also a repressible transcription 
transactivator protein (tTA) which allows for the control of the whole system as explained 
in section 2.1 (Fu et al., 2010).  This protein can be ubiquitously expressed and as a 
consequence the mere presence and accumulation of this foreign protein may have a toxic 
effect on the cells.  Indeed, this protein can itself be used as the effector in dominant lethal 
systems (Fu et al., 2007; Phuc et al., 2007).  The RIDL system is designed to selectively 
kill mosquitoes of specific sex and life-stages by expression of toxic proteins, for example 
VP16 in the indirect flight muscles of females (Fu et al., 2010).  In the RIDL system, leaky 
expression of the VP16 protein (or indeed tTA protein) may result in males also suffering 
from effects of accumulation of these toxic products, which may manifest as a non-lethal 
phenotype, but with an overall detrimental effect on the reproductive fitness of the 
transgenic line.  Indeed, evidence from Fu et al. (2010) shows that the alternative splicing 
pathway is not able to prevent tTA expression in some males.  This may have implications 
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on the use of RIDL in the field as this requires transgenic males to mate with wild type 
females.  If the male is unable to successfully compete with wild type males for mates then 
this technology becomes useless.  Expression of antimicrobial peptides (AMPs), or 
peptides and/or proteins shown to be active against Plasmodium can be linked to tissue-
specific promoters as these peptides are designed to target a particular life stage of the 
parasite for which the mosquito is the vector (Ito et al., 2002; Moreira et al., 2002; 
Meredith et al., 2011).  Contrary to the RIDL system, these peptides are not designed to be 
in any way detrimental to the mosquito itself however this does not automatically rule out 
any negative fitness effect.  Such transgenic lines would be used in the field as part of a 
population replacement strategy.  Although this would involve a males-only release, there 
is emphasis on both sexes being able to compete effectively for mates and being fit in 
terms of reproductive capability.  This system is a little different to RIDL where much 
more emphasis is on reproductive fitness of males since females die due to the dominant 
lethal gene effect.  Interestingly, Moreira et al. (2004) report a difference between two 
AMPs (both with their expression under the control of the carboxypeptidase promoter) in 
their effect on fitness of transgenic An. stephensi. This indicates that the choice of effector 
protein itself can have a considerable and possibly unpredictable effect on the fitness of 
transgenic lines.   In a review of fitness costs imposed by transgenesis, Marelli et al. (2006) 
suggest that the reason for the decreased fitness in the PLA2 line (Moreira et al., 2002) 
when compared to wild type is due to damage caused to midgut epithelial cells.  This does 
not occur with the SM1 line (Ito et al., 2002) which shows no difference in fitness when 
compared to wild type An. stephensi.  This evidence reiterates that the difference in action 
of AMPs may have an effect on fitness.  
Fitness costs can be imposed on transgenic lines, not only due to the presence of foreign 
proteins within host tissues, but also as a direct effect of the integration of DNA constructs 
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into the host genome.  These position effects can cause insertional mutagenesis by 
disrupting native gene function in the transgenic line.  A project (Drosophila Gene 
Disruption Project – GDP) has been developed which collects mutant strains of Drosophila 
created using the integration of transposons to disrupt gene function.  Single transposon 
insertions associated with different genes allow for analysis of gene function (Bellen et al., 
2011).  The P element was originally used in Drosophila to disrupt genes by targeting open 
reading frames (Spradling et al., 1995).  It is now known that the P element exhibits a 
strong tendency to integrate within promoter regions whereas it seems that piggyBac has 
evolved to, on the whole, avoid disruption due to transposition in potentially deleterious 
regions of host DNA (Bellen et al., 2011).  Both transposons, along with Minos tend not to 
transpose within Polycomb-regulated regions of DNA, but whereas P and piggyBac display 
preferences for certain areas outside the Polycomb-regulated regions, Minos is effectively 
random in its insertion sites (Bellen et al., 2011).  Most integrations of transposons do not 
cause any interruption to native genes as insertion occurs outside coding regions, so 
minimising fitness costs.  However, disruption of a functional gene, for example one 
encoding an essential gene product, would incur severe fitness costs (Marrelli et al., 2006).  
Insertional mutagenesis is not highly reported in mosquitoes, with data from published 
studies focusing on Drosophila.  This indicates that, in the case of most genes, the effect is 
largely recessive and therefore will only be seen in homozygotes as the wild type allele 
present in hemizygotes would be enough to rescue the deleterious genotype (Anholt et al., 
1996; Lyman et al., 1996).  In their review, Marrelli et al. (2006) conclude that insertional 
mutagenesis is unlikely to provide a transgenic line whereby homozygotes for the insertion 
have a fitness advantage over hemizygotes or wild type counterparts.  However, in the 
creation of many lines, one can choose the line which exhibits a phenotype closest, in 
terms of fitness, to the wild type.  Even so, when it comes to field releases, fitness costs 
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may have to be counteracted by release of the transgenic line in huge numbers, or by the 
addition of a gene drive mechanism which effectively gives the transgenic line a selective 
advantage (Marrelli et al., 2006). 
It is known that inbreeding can have a detrimental effect on fitness of any organism due to 
accumulation of deleterious alleles, though this is also dependent on parameters such as 
population size, growth rate and history (Theodorou and Couvet, 2006).  Transgenic lines 
come from very few individuals, and often only a single mosquito, crossed to one or few 
wild type mosquitoes (depending on whether they are male or female), thus causing a 
genetic bottleneck and the fixation deleterious alleles which can impact on fitness of the 
line (Catteruccia et al., 2003).  A study comparing the effects of genetic modification and 
inbreeding on larval competition and adult energy reserves in Ae. aegypti indicates that the 
genetically modified strain fared the least well with limited larval food (Koenraadt et al., 
2010).  The inbred strain also did worse under stress conditions, based on a composite 
index of survival, development rate and size, than the wild type strain thus demonstrating 
that inbreeding is likely to have a negative effect on fitness in mosquitoes (Koenraadt et 
al., 2010).   
Since transgenesis of mosquitoes has been established as a plausible method of control, 
several studies on fitness have been undertaken to help determine how transgenesis affects 
mosquito biology (Catteruccia et al., 2003; Irvin et al., 2004; Amenya et al., 2010; 
Koenraadt et al., 2010; Bargielowski et al., 2011).  Irvin et al. (2004) and Catteruccia et al. 
(2003) assessed the fitness cost associated with insertion of plasmids containing 
fluorescent markers in homozygous Ae. aegypti and An. stephensi respectively.  
Catteruccia et al. (2003) assessed competition between transgenic and wild type strains of 
An. stephensi, assuming Hardy-Weinberg principles so that allele frequencies could be 
measured at each generation.  Four independent transgenic lines possessing different 
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combinations of genes and markers and different insertion sites were assessed.  A sharp 
decrease in transgene allele frequency over a few generations was observed in each line 
and the transgene became extinct in between 4 and 16 generations (Catteruccia et al., 
2003).  Two lines created using the same construct showed a pattern of transgene 
persistence which was not significantly different from each other.  This was particularly 
interesting as one insertion lay within the coding region of a gene similar to the D. 
melanogaster chaoptin precursor gene whereas the other insertion was outside of any open 
reading frames.  The authors speculate that the gene product is non-essential in An. 
stephensi but disruption of the gene was likely to be selectively disadvantageous 
(Catteruccia et al., 2003).  The third line used within the study contained the same 
fluorescent marker as the lines mentioned above but within a different construct.  Two 
repeats of the experiment using this line both showed an initial sharp drop in transgene 
frequency but eventual loss of the transgene allele was possibly due to random genetic drift 
(Catteruccia et al., 2003).  This analysis indicated that there was an excess of hemizygotes 
when experiments were undertaken with the fourth transgenic line containing a different 
marker gene to the previous three lines analysed.  Again, eventual loss of the transgene 
allele was seen (Catteruccia et al., 2003).  Measuring fitness parameters such as longevity, 
feeding rate, larval development time and fecundity was not part of this study, however the 
authors do say that homozygous lines propagated for more than 40 generations showed no 
differences to the wild type when these parameters were assessed (Catteruccia et al., 2003).  
Irvin et al. (2004) measured such parameters in their fitness study, looking at the effect of 
transgenesis on Ae. aegypti using three different transgenic lines.  One line contained a 
simple EGFP marker cassette (termed EGFP), and the other two contained the marker 
along with a transposase gene encoding transposase for either the Hermes or Mos1 
transposable elements, termed autoHermes and pBacMOS respectively (Irvin et al., 2004).  
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All transformed strains showed a significant reduction in fecundity and longevity when 
compared to the wild type strain.  Interestingly autoHermes and pBacMOS strains showed 
the longest post-oviposition development times but the shortest pre-oviposition 
development time and fared the least well in terms of adult longevity.  The EGFP strain 
was the least fecund of all strains (Irvin et al., 2004).  This indicates that transgenesis does 
not have a uniform effect across all fitness parameters, therefore a collective fitness 
assessment is a more accurate measure of fitness of transgenic lines.  Across all parameters 
measured, Irvin et al. (2004) showed that transgenic strains fared significantly less well 
than wild type strain.  However, they were keen to point out that all three strains were 
developed for use within the laboratory setting, and further work on those developed for 
possible release in the field would have to be assessed in terms of fitness separately and, 
depending on findings in the laboratory, in conditions more closely resembling those in the 
field (Irvin et al., 2004). 
Since these initial studies assessing fitness in strains of mosquitoes transformed purely for 
the laboratory, more studies have been undertaken which assess similar parameters in 
strains transformed for purposes of controlling disease (Moreira et al., 2004; Li et al., 
2008; Amenya et al., 2010; Koenraadt et al., 2010; Bargielowski et al., 2011).  Moreira et 
al. (2004) set up cage experiments with equal numbers of (hemizygous) transgenic and 
wild type An. stephensi in order to determine transgene allele frequencies over 6 
generations.  The two separate transgenic lines they used express either SM1 or PLA2 into 
the midgut under the control of the carboxypeptidase promoter.  Both of these peptides 
have been shown to inhibit Plasmodium development in these transgenic lines (Ito et al., 
2002 and Moreira et al., 2002 respectively).  It was expected, for both lines, that within the 
F1 generation, the fluorescent phenotype would be at a frequency of 0.5 and all subsequent 
allele frequencies would follow the Hardy-Weinberg principle at each generation.  No 
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consistent deviation from expected values was seen with the SM1 line.  However deviation 
from expected frequency values was seen from the F2 generation and all succeeding 
generations in the PLA2 line, with a sharp decrease in transgene allele frequency (Moreira 
et al., 2004).  Lifespan, fecundity and fertility were all measured and compared to a wild 
type control for each hemizygous transgenic line.  No significant differences were 
observed with the SM1 line, but the PLA2 line showed a significant reduction in fecundity 
compared to the wild type, even when the decrease in blood meal consumption was taken 
into account (Moreira et al., 2004).  The authors suggested that differences in fitness 
observed may have been due to the difference in action of the two peptides, as SM1 is 
present in the midgut lumen whereas PLA2 attaches to epithelial cells and is known to 
cause damage (Moreira et al., 2004).  Transgenic An. stephensi lines expressing the SM1 
peptide into the haemolymph, under control of the vitellogenin promoter, have also been 
the subject of fitness studies.  Two of the lines carry a single insertion (VD35 and VD26) 
and one carries a double insertion of the transgene (VD9).  Interestingly each line was 
tested in the homozygous state and all three lines exhibited some fitness costs, seemingly 
associated with carrying the transgene, and particularly in relation to fecundity, larval 
developmental time and reproductive longevity (Li et al., 2008).  Several other fitness 
parameters were also measured, such as adult survivorship, egg hatchability, larvae-to-
pupae viability, and mating success.  No significant differences between wild type and any 
of the transgenic lines was observed when measuring these parameters (Li et al., 2008).  In 
further studies, similar cage experiments to those undertaken by Moreira et al. (2004) were 
used to assess allele frequencies across 6 generations.  For each transgenic line, transgene 
allele frequency was significantly lower by generation 6 than would be expected if the 
population were subject to Hardy-Weinberg principles (Li et al., 2008). 
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Site-specific transgene integration has been reported as a stable and efficient way of 
introducing transgenes into a known site within the genome (Nimmo et al., 2006) and can 
go some way to negating fitness effects caused by position effects and/or inbreeding 
depression and fixation of deleterious alleles associated with this (Amenya et al., 2010).  
Seven fitness parameters were measured in four (hemizygous) transgenic lines of An. 
stephensi carrying a phiC31 attP docking site and fluorescent marker and results recorded 
for both males and females where possible.  There were six instances where the transgenic 
lines significantly outperformed the wild type strain, but as was the case where the effects 
of transgenesis had significant negative effects on measured parameters, the results were 
not consistent across traits or lines (Amenya et al., 2010).  This lack of uniformity between 
fitness parameters means that it cannot be concluded that the transgene has an unequivocal 
impact on fitness and suggests that these lines are suitable for use as phase one docking 
strains for site-specific integration of effector genes (Amenya et al., 2010).  A transgene is 
thought to be stable within a population if it does not have the potential to move around the 
genome between generations.  Further research is required to assess stability of the 
transgene within populations and to assess competitiveness of transgenic males compared 
to the wild type as these parameters seem to play a large role in fitness (Li et al., 2008).  
Koenraadt et al. (2010) compared fitness of wild type, inbred and transgenic strains of 
Aedes aegypti.  This was designed to test the principle that genetic modification has an 
effect on fitness due to the presence of the transgene itself, rather than inbreeding 
depression.  The transgenic strain used in the study expressed a simple marker gene 
(EGFP) and was used in its homozygous state.  Larval competition between strains and 
adult energy reserves were assessed, as well as several other parameters to create an 
overall index of performance (Koenraadt et al., 2010).  The transgenic line was found to 
fare least well in comparison to wild type for all measured parameters with most 
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differences exhibiting statistical significance.  The transgenics also displayed lower 
survivorship and the longest development times of the three strains with the effect on 
development most pronounced at high-diet conditions but the effect on survival clearest 
when under more stress, i.e. low-diet therefore high competition (Koenraadt et al., 2010).  
The authors suggest that there could be an interaction between parameters, therefore high 
competition for food resources increases larval mortality meaning fewer and more 
infrequent interactions between remaining larvae which in turn leads to larger and 
consequently more fecund adults and no eventual fitness cost (Koenraadt et al., 2010).  
The index of performance found the wild type strain to have an overall competitive 
advantage at the larval stage and it exhibited overall increased fitness when compared to 
the inbred strain, which in turn was more fit than the transgenic strain.  This suggests that 
the initial hypothesis was correct – genetic modification has an effect on fitness, and this 
effect is additional to that due to inbreeding alone (Koenraadt et al., 2010).  The 
competition element tested in this study is important as it mimics more closely the situation 
in the field.  Bargielowski et al. (2011) report on the fitness of a RIDL strain of Ae. aegypti 
considered ready for field release.  This strain (OX513A) contains a late-acting dominant 
lethal gene and a DsRed2 fluorescent marker gene and originated from the Rockefeller 
strain.  It was subsequently outcrossed to a Mexican strain for 5 generations so that 97-
99% of the genome corresponds to this strain.  To minimise inbreeding effects, 44 
independent homozygous females were mated with homozygous males and pooled to 
create the homozygous OX513A line as used for this study (Bargielowski et al., 2011).    
Several parameters indicative of fitness were measured, each at different larval densities.  
A significant difference between wild type control and transgenic line was seen for all 
parameters measured but the effect density had on either the control or the transgenic line 
was not uniform across all measured parameters (Bargielowski et al., 2011).  Adult 
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longevity and wing length were the most greatly influenced by density, with the effect 
more pronounced in transgenic adults and males exhibiting the most severe density effect.  
The author comments that the shorter larval development time seen in the transgenic line is 
useful in terms of mass rearing, but speculates that this may be a cause of the smaller adult 
size observed in this line which may impact on fitness due to an effect on reproductive 
success (Bargielowski et al., 2011).  This is a major consideration in a line proposed for 
field release and indeed competition studies looking at male competitiveness compared to 
the wild type strain would go some way to addressing the issue.  It is worth noting that the 
wild type strain used as the control for this study was not the Mexican strain, but the 
Rockefeller strain.  The differences seen between the control and OX513A lines may 
therefore be, at least in part, due to genetic differences between the lines.  However, it is 
reasonable to suggest that transgene products may be held to account for the apparent 
overall reduction in fitness observed in the transgenic line when compared to the wild type, 
with the build up of foreign gene products in mosquito cells having a toxic effect 
(Bargielowski et al., 2011).   
From various fitness studies undertaken, it is evident that loss of transgenic alleles within a 
laboratory population may be due to fixation of deleterious alleles during establishment of 
homozygous lines, or be directly associated with or insertion point within the genome or 
indeed with expression of the transgene itself.  This points to site-specific integration as a 
way of combating this issue as it provides a method of assessing multiple phase one 
docking strains in terms of fitness and picking the one which more closely matches the 
relevant wild type strain.  Even so, further assessment of fitness, once the effector gene 
was inserted, would have to be undertaken prior to release in the field to determine any 
effect caused by the effector gene itself.  What is striking from looking at data generated 
from numerous fitness studies, is that the effect of genetic modification (and associated 
 225 
inbreeding) on the fitness of mosquito lines is not consistent.  This makes it even more 
important and relevant to ascertain fitness costs of any line which may have the potential to 
be used in the field as part of a control strategy. 
The study undertaken here is designed to look at several fitness parameters in the 
transgenic An. gambiae line EVida3 (Meredith et al., 2011).  This is an important step in 
increasing our understanding of this line and its potential performance.  Due to the known 
fitness costs of inbreeding, the study was undertaken using hemizygotes generated by 
outcrossing the homozygous line with the KIL laboratory strain.  Hemizygotes carrying the 
Vida3 gene were generated via reciprocal crosses with the KIL line and the homozygous 
EVida3 line.  This was so that a comparison could be made between those inheriting the 
Vida3 gene via the maternal route and those inheriting it via the paternal route.  These 
hemizygous lines were named EV3M and EV3P, respectively, for the purposes of the 
fitness studies.  KIL is the background strain for the transgenic line and was used as the 
wild type control for the fitness experiments. 
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4.2. Materials and Methods 
4.2.1. Making EVida3 transgenic line homozygous using a combination of 
husbandry, screening and molecular methods 
4.2.1.1. Enrichment of the EVida3 transgenic line 
Once it was established that the EVida3 transgenic line was not homozygous, extra trays 
were put up for the line and were screened using the fluorescence microscope for the 
DsRed marker gene under control of the 3xP3 promoter.  Larvae at the L3/L4 stages were 
screened and any negatives removed to ensure that any remaining larvae possessed at least 
one copy of the marker and consequently the Vida3 transgene.  A new cage was set up for 
the screened pupae and once adults had emerged and were old enough to have mated they 
were offered a blood meal.  This procedure was repeated for 5 generations so the 
population was enriched to ensure relatively high numbers of homozygotes. 
 
4.2.1.2. Setting up small populations to generate homozygous lines 
Small populations of 3 male and 3 female mosquitoes (1 day old) were set up in pots and 
given enough time to mate (around 3-5 days).  Adult mosquitoes came from the main 
enriched population and were selected as larvae based on their perceived fluorescence 
intensity.  All populations had access to sugar and water ad libitum. When satisfied that 
populations had mated, a blood meal was offered.  Each population was then given the 
opportunity to lay in suitable oviposition vessels.  Once the populations had laid, these 
larvae were reared as independent populations.  After laying, parent mosquitoes were then 
knocked down and all 6 used to prepare genomic DNA for further downstream analysis.  
Any females that had not laid eggs were excluded. 
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4.2.1.3. Genomic preparations of each small potential homozygous line 
Genomic DNA was prepared from each group of 6 adults which had laid eggs following 
removal of the heads using the Puregene Cell and Tissue Kit (Gentra Systems) following 
the protocol given, but with quantities of solutions adapted for use with multiple 
mosquitoes (See appendices for details).  The genomic DNA was used for downstream 
applications to determine presence/absence of the Vida3 transgene. 
 
4.2.1.4. PCR to determine phase one integration site 
Two separate PCR reactions were undertaken for genomic DNA representative of each 
individual possible homozygous population.  One universal forward primer (TD_UN-
E_FWD 5` – CCATCCCCAAAAAAATGAACTGAAA – 3`) was paired with either a 
wild type-specific reverse primer (TD_WT-E_REV 5` – 
TCCCTCTTATAAGTAAGGGTTGC – 3`) or a transgene-specific reverse primer 
(TD_TG-E_REV 5` – GCAGACTATCTTTCTAGGGTTAAA – 3`).  The universal 
forward primer anneals 140bp upstream of the insertion point and when paired with the 
wild-type-specific primer, which anneals 10bp upstream of the insertion point, produces a 
fragment, in wild-type KIL, of 172bp in length.  When paired with the phase one-specific 
primer, which itself anneals to the left ITR of the piggyBac transposon and spans the 
insertion site, it produces a fragment, in transgenic mosquitoes, of 166bp in length.  The 
PCR reactions were run simultaneously due to the similar lengths of the amplicons 
generated.  For each reaction, 200-400ng of genomic template was amplified with the 
relevant primers (2μM) using the Promega GoTaq system containing 1x buffer and 1.5μM 
MgCl2.  Cycling parameters (MJ Research PTC-200) were 95
o
C for 3 minutes then 30 
cycles (95
o
C, 15 seconds; 55
o
C, 30 seconds; 72
o
C, 30seconds) followed by a final 
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extension step of 72
o
C for 10 minutes.  PCR products were identified using a 1.8% TAE 
agarose gel with HyperLadder IV (Bioline). 
 
4.2.1.5. PCR to determine integrity of attP recognition sequence 
Genomic templates from all possible homozygous lines were tested for presence of attP, 
and thus an unoccupied target site.  This was identified using the primers attR-F-new and 
attL-F-new in reactions containing 200-400ng of genomic template in the presence of 1 x 
buffer (Promega), 1.5μM MgCl2 (Promega) and GoTaq DNA polymerase (Promega).  
Existence of the unoccupied target site resulted in a DNA fragment, 391bp in length.  
Cycling parameters (MJ Research PTC-200) were 94
o
C for 1 minute then 30 cycles (94
o
C, 
30 seconds; 58
o
C, 30 seconds; 72
o
C, 30 seconds) followed by a final extension step of 
72
o
C for 10 minutes.  PCR products were analysed using a 1.8% TAE agarose gel with 
HyperLadder IV (Bioline) 
 
4.2.1.6. PCR to confirm presence of an occupied site by amplification of attL 
and attR 
Genomic DNA indicative, by means of previous PCR analysis, of originating from 
homozygous populations were used as templates for PCR analysis to confirm the presence 
of occupied sites.  The primers attL-F-new-2 and attR-F-new-2 were used to amplify attL 
and the primer pair, attR-forward and attR-reverse, were used to amplify attR.  200-400ng 
of genomic DNA template was amplified with the relevant primer pair using GoTaq DNA 
polymerase (Promega) in the presence of 1 x buffer and 1.5μM MgCl2.  Presence of attL 
and attR sites resulted in expected DNA fragments of 301bp and 224bp in length, 
respectively.  Cycling parameters (MJ Research PTC-200) were 94
o
C for 1 minute then 30 
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cycles (94
o
C, 30 seconds; 58
o
C, 30 seconds; 72
o
C, 30 seconds) followed by a final 
extension step of 72
o
C for 10 minutes.  PCR products were analysed using a 1.8% TAE 
agarose gel with HyperLadder IV (Bioline). 
 
4.2.1.7. Building up the homozygous EVida3 line 
Once the PCR assessment of genomic DNA had been completed, it was then apparent 
which of the original small populations contained only males and females homozygous for 
the Vida3 transgene.  No wild-type PCR products were amplified and no attP (unoccupied 
site) amplification was detected whereas attL and attR were indeed present within this 
population.  Thus, further care was taken to maintain only this population.  Progeny from 
the adults from the original cross were maintained as larvae in suitable containers until 
pupation when they were transferred, in weigh boats, to a small cage and given 
approximately 5 days to emerge and mate.  A blood feed was then offered and 48 hours 
later a suitable oviposition site was placed in the cage.  Once a further generation had been 
laid, the population was again offered a blood meal.  This was repeated a total of four 
times as after this few adult mosquitoes remained alive.  The G1 larvae produced as a result 
of these blood meals were maintained in suitable containers, again until pupation, when 
they were transferred to a further small cage and allowed to emerge and mate.  This 
generation were then offered multiple opportunities for blood-feeding and consequently, 
egg-laying.  This process was repeated until a robust colony of standard size was built up. 
 
 230 
4.2.2. Larval development rate and survivorship 
4.2.2.1. Creating comparable homozygous KIL and hemizygous Evida3 lines 
Trays of KIL and EVida3 lines were set up with equal numbers of larvae and reared in the 
standard manner until pupation occurred.  Pupae were picked and sexed from both wild-
type KIL and homozygous EVida3 lines.  250 female KIL pupae were placed into each of 
two large cages.  Into one of these cages 150 male KIL pupae were also placed, and into 
the other cage, 150 male EVida3 pupae were placed.  A third cage was set up with 250 
female EVida3 pupae and 150 male KIL pupae.  This ensured that all homozygous and 
hemizygous progeny resulting from these crosses would be comparable.  Pupae placed in 
all cages were allowed to emerge and pupal pots were removed from cages.  Adults were 
maintained on water and 10% glucose solution available ad infinitum.  Sugar was removed 
from cages approximately 18-24 hours prior to a blood feed.  A blood meal was offered to 
all cages when adult mosquitoes were approximately 4-7 days old by means of a Hemotek 
feeding system following standard protocol.  Oviposition pots, all of the same size and 
containing the same water volume, were placed into the three cages 2 days post blood-
meal.  Larvae produced as a result of this feed were used for the larval development rate 
and survivorship study.  Comparisons were to be made using KIL against hemizygous 
EVida3 lines from reciprocal crosses named EV3P and EV3M.  This was to ascertain any 
differences between hemizygous progeny with a paternally-inherited transgene and those 
with a transgene inherited maternally. 
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4.2.2.2. Randomised experiment for determining larval development rate and 
survivorship across three different lines 
Exactly 30 L1 stage larvae were counted out into ice-cream tubs (18.5cm length x 10cm 
width x 4.5cm height) and 150ml of distilled water containing liquifry at a concentration of 
3 drops per litre added.  For each line created, 15 repeats were set up.  Tubs were placed on 
trays so one tub of each larval-type was present per tray, and these trays were placed in the 
same section of the insectary in order that each line had equal numbers of repeats per row 
and column so as to minimise placement effects.  All repeats were fed exactly the same 
quantity of fine fish flake at the same time each day.  Water levels were kept constant 
(150ml) by addition of more ddH2O when necessary due to effects of evaporation within 
the insectary. 
 
4.2.2.3. Daily larval counts and sexing of pupae 
Larvae in all tubs were counted daily and counts recorded.  This was done meticulously 
and any dead larvae visible in the tubs were removed.  Once larvae began pupating, pupae 
were picked from tubs, sexed and numbers of males and females recorded for each tub and 
therefore each line.  Pupae from tubs were amalgamated per day within their lines and 
placed in cages whilst keeping sexes separated.  Pupal mortality was recorded by counting 
the number of dead pupae or those which did not give rise to fully emerged adults.  Once 
emerged, adults from each sex were transferred to another cage to minimise the chances of 
them drowning in the pupal pots.  The experiment finished when all mosquitoes had 
emerged as adults. 
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4.2.3. Adult Longevity 
4.2.3.1. Creating comparable homozygous KIL and hemizygous Evida3 lines 
Lines were created following the same protocol as specified in section 4.2.2.1. 
 
4.2.3.2. Standardised rearing of mosquitoes to generate adults of equivalent age 
and size 
Larvae at L1 stage were counted into trays at a density of 0.2 larvae per ml (standard 
density).  This density was upheld for each tray used and for each line used for the 
experiment.  Distilled water containing 3 drops of liquifry per litre was added to the trays 
to create the correct rearing density.  A strict feeding regime was followed in order that all 
larval trays received the same amount of food per larva per tray.  Trays were fed morning 
and afternoon to encourage synchronous pupation.  This standardised procedure ensured 
that all adult mosquitoes used in the longevity study would be comparable. 
 
4.2.3.3. Set-up of adult longevity study 
Pupae were picked from standardised trays, sexed and placed in weigh boats within small 
cages until emergence.  Once emerged, adults were removed from these cages and placed 
in clear plastic pots (10.5cm height x 11cm diameter) with access, ad libitum, to a sugar 
cube and distilled water.  Ten adult males of the same age were placed in each of ten pots 
per line, and the same was set up for emerged female mosquitoes.  Pots were randomly 
distributed in the insectary.  Each day sugar and water levels were maintained, and dead 
mosquitoes removed and counted/recorded for each pot within each line.  The experiment 
reached the end when all mosquitoes in all pots were dead. 
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4.3. Results 
4.3.1. Larval mortality 
Larval death was recorded for each mosquito line each day until every larva had either 
pupated or died.  Fifteen replicates were set up per line, each containing an initial 30 larvae 
so larval death was recorded as number of deaths per replicate and an average taken over 
fifteen replicates.  Three independent experiments were undertaken.  Results were slightly 
variable between the three experiments though statistical analysis showed no statistical 
difference between lines within any experiment.  The control line (KIL) exhibited the most 
variation between experiments with the median larval mortality ranging from 1 larval death 
to 4 per 30 larvae.  Mean larval mortality of KIL, EV3P and EV3M mosquito lines was 
2.69 (9%), 0.96 (3.2%) and 1.67 (5.6%) respectively (Table 4.1) when using pooled data 
for analysis.  Data were tested using the D‟Agostino Pearson omnibus normality test and 
found to be non-normally distributed, thus further analysis to determine differences 
between lines was performed using a Kruskal-Wallis test followed by Dunns multiple 
comparison post test.  There was no significant difference between lines for larval 
mortality (p = 0.368 for pooled data, Table 4.2) as illustrated by Fig. 4.1A-D. 
 
4.3.2. Sex ratio 
As with larval death, 15 replicates per mosquito line were set up, each containing an initial 
30 larvae.  Larval rearing was standardised across all replicates and between each of the 
three independent experiments.  The sex of all larvae surviving to pupation was recorded 
and ratios determined from this data for each experiment as illustrated by Fig. 4.2A-D.  
Ratios from pooled data for KIL, EV3P and EV3M lines are 51.3♂:48.7♀, 49.5♂:50.5♀ 
and 50.2♂:49.8♀ respectively (Table 4.1) as illustrated by Fig. 4.2D.  Data was analysed 
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using a chi-squared contingency test to determine if the mosquito line had an effect on sex 
ratios (Table 4.3).  There was found to be no significant difference in sex ratio between 
lines (p = 0.673 for pooled data, Table 4.2).  A very slight male bias was universal across 
all experiments in the KIL line.  In two of three experiments, EV3M line also exhibited a 
slight male bias.  However, in two of three experiments EV3P displayed a slight bias 
towards females.  In both cases it was experiment 3 which showed the small anomalies in 
bias. 
 
4.3.3. Age at pupation 
For 3 independent experiments, 15 replicates per line, containing 30 larvae in each, were 
set up with larvae reared uniformly across all replicates, lines and experiments.  Mosquito 
age at pupation was recorded for every mosquito reaching this life stage.  Age at pupation 
was recorded separately for male and female mosquitoes.  The mean age at pupation of 
male KIL, EV3P and EV3M lines is 7.66, 7.59 and 8.32 days respectively (Table 4.1).  
Mean age at pupation of female KIL and EV3M lines is 7.76 days, and for females of the 
EV3P line is 7.72 days (Table 4.1). 
Analysis of male and female data using the D‟Agostino Pearson omnibus normality test 
showed that both sets of data were non-normally distributed.  Subsequent analysis was 
therefore undertaken using the Kruskal-Wallis test followed by Dunns multiple comparison 
test to further determine differences between lines.  When considering data pooled from all 
three independent experiments, there was found to be no significant difference between 
lines for age at pupation of females (p = 0.367; Table 4.2) as illustrated by Fig. 4.3D1.  All 
three experiments indicate independently that there is no significant difference in age at 
pupation of females between the KIL and EV3P lines (Figs. 4.3A1, B1 and C1).  However, 
when looking at these 3 experiments and making comparisons between the two remaining 
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combinations of lines (KIL vs. EV3M and EV3P vs. EV3M), it appears that there are 
significant differences between them, of varying levels, even though pooling the data 
results in seeing no significant difference.  This is because the differences are not uniform 
over all three experiments.  This is illustrated in Figs. 2.3A1, B1 and C1. 
When considering the pooled data for male age at pupation, statistical analyses shows a 
significant difference in age when comparing males belonging to the EV3M line with both 
the control (KIL) line and the other hemizygous transgenic (EV3P) line (p < 0.0001 in both 
cases; Table 4.2).  This is illustrated by Fig. 4.3D2.  These differences are a true reflection 
of all three independent experiments which show the exact same significance levels for 
each pair of mosquito lines as shown in Figs. 4.2A2, B2 and C2.  
 
4.3.4. Wing length 
Mosquitoes involved in the wing length study were reared following a strictly uniform 
regime to ensure that any differences observed were due to genetic differences and not due 
to environmental differences.  Wing lengths were measured and recorded for both males 
and females from each of the three lines involved in the fitness studies.  The average wing 
length of male KIL, EV3P and EV3M mosquito lines are 2.95, 2.96 and 2.95mm 
respectively (Table 4.1).  Male wing lengths were shown to follow a normal distribution as 
indicated by the D‟Agostino Pearson omnibus normality test.  Consequently, data was 
analysed by ANOVA followed by Tukey‟s post test to compare pairs of data.  Male wing 
lengths were found to show no significant difference between lines (p = 0.590; Table 4.2) 
as illustrated by Fig. 4.4A.  The average wing length of female KIL, EV3P and EV3M 
mosquitoes are 3.11, 3.16 and 3.16mm respectively (Table 4.1).  As indicated by the 
D‟Agostino Pearson omnibus normality test, female wing lengths were shown to be non-
normally distributed.  Consequently, data was analysed by a Kruskal-Wallis test followed 
 236 
by Dunns post test to compare pairs of data.  Female wing lengths were found to show no 
significant difference between lines (p = 0.112; Table 4.2) as illustrated by Fig. 4.4B.   
 
4.3.5. Longevity 
Longevity was recorded for 100 male and 100 female mosquitoes per line.  These were 
split into 10 replicates each containing 10 newly eclosed adult male or female mosquitoes 
making a total of 200 mosquitoes per line for each of 3 independent experiments.  Every 
day, each replicate was checked for mosquito mortality in order that adult longevity, when 
maintained on sugar/water only, for each line could be mapped.  This continued until all 
mosquitoes were dead.  Mean longevity of male mosquitoes for the KIL, EV3P and EV3M 
lines is 29.5, 33.16 and 26.24 days respectively (Table 4.1).  For female mosquitoes, 
average longevity is 28.57, 34.32 and 30.37 days for the KIL, EV3P and EV3M lines 
respectively (Table 4.1).  Data was analysed using the log-rank (Mantel-Cox) test in order 
to determine significant differences in longevity between lines in both males and females.  
Analysis of pooled data for both female and male mosquitoes indicated a highly significant 
difference in longevity when comparing all the lines (Table 4.2) as illustrated in Figs. 4.5A 
and 4.5E respectively.  Data was then analysed in pairs of lines to determine where the 
major differences in longevity lay.  When considering longevity in females, there was no 
significant difference observed between the control (KIL) line and the EV3M line (p = 
0.462; Table 4.2) and is illustrated by Fig. 4.5C.  However, highly significant differences 
were observed in female longevity between the control (KIL) line and the EV3P line (p < 
0.0001; Table 4.2) and between the two hemizygous lines (p < 0.0001; Table 4.2).  This is 
shown by Figs. 4.5B and 4.5D respectively.  When considering longevity in males, all 
pairs of mosquito lines exhibit significant differences between each other albeit to varying 
degrees.  Comparison of the control (KIL) line with the EV3P line and with the EV3M line 
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indicates significant differences in longevity between these pairs of lines (p = 0.004 and p 
= 0.001 respectively; Table 4.2) which is illustrated by Figs. 4.5F and 4.5G respectively.   
Comparison of the two hemizygous transgenic lines also points to a difference in longevity 
at a higher significance level (p < 0.0001; Table 4.2) which can also be seen in Fig. 4.5H.  
Data from the three independent experiments can be seen in Appendix III. 
Longevity of males in comparison to females were also analysed using pooled data from 3 
experiments (Fig. 4.6).  Longevity of sexes was not significantly different for the control 
(KIL) line (Fig. 4.6A) or for the hemizygous transgenic line EV3P (Fig. 4.6B).  A 
significant difference in longevity was observed between males and females from the 
hemizygous EV3M line (Fig. 4.6C) whereby females were longer lived than males (p = 
0.0023). 
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Fitness Parameter KIL EV3P EV3M 
Mean larval 
mortality
a
 
2.69 ± 0.284 
(9.0%) 
0.96 ± 0.159 
(3.2%) 
1.67 ± 0.185 
(5.6%) 
Mean sex ratios 
(male: female) 
51.3: 48.7 
(n = 1229) 
49.5: 50.5 
(n = 1307) 
50.2: 49.8 
(n = 1275) 
 Male Female Male Female Male Female 
Mean age at 
pupation
b
 (days) 
7.66 ± 
0.032 
7.76 ± 
0.036 
7.59 ± 
0.027 
7.72 ± 
0.028 
8.32 ± 
0.043 
7.76 ± 
0.033 
Mean wing length
b
 
(mm) 
2.95 ± 
0.016 
3.11 ± 
0.018 
2.96 ± 
0.015 
3.16 ± 
0.016 
2.95 ± 
0.021 
3.16 ± 
0.022 
Mean adult 
longevity
c
 (days) 
29.5 ± 
0.830 
28.57 ± 
0.754 
33.16 ± 
0.740 
34.32 ± 
0.793 
26.24 ± 
0.755 
30.37 ± 
0.654 
 
Table 4.1:  Comparison of mean fitness parameters between the control line and 
hemizygous transgenic lines for pooled data from 3 independent experiments. 
Mean values ± SEM is given where applicable. 
a
Larval mortality is given as the mean number of larvae dying before reaching pupation 
where n = 30 per replicate, of which there were 15 per line, within one experiment.  
Percentage mortality is shown in brackets. 
b
Data generated where n = 30 as above. 
c
Data generated where n = 10 per replicate, of which there were 10 per line, within one 
experiment. 
All data was tested to see if it followed a normal distribution and following this, the 
appropriate statistical analyses were performed. 
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Fitness 
Parameter 
Probability 
(significance) 
KIL (control) 
vs 
EV3P 
KIL (control) 
vs 
EV3M 
EV3P 
vs 
EV3M 
Mean larval 
mortality
a
 
p = 0.368 
(ns) 
ns ns ns 
Mean sex 
ratios (male: 
female)
b
 
p = 0.673 
(ns) 
   
 Male Female Male Female Male Female Male Female 
Mean age at 
pupation
a
 
(days) 
p < 
0.0001 
(***) 
p = 
0.367 
(ns) 
ns ns 
p < 
0.0001 
(***) 
ns 
p < 
0.0001 
(***) 
ns 
Mean wing 
length (mm) 
male
c
; 
female
a
 
p = 
0.590 
(ns) 
p = 
0.112 
(ns) 
ns ns ns ns ns ns 
Mean adult 
longevity
d
 
(days) 
p < 
0.0001 
(***) 
p < 
0.0001 
(***) 
p = 
0.004 
(*) 
p < 
0.0001 
(***) 
p = 
0.001 
(*) 
p = 
0.462 
(ns) 
p < 
0.0001 
(***) 
p < 
0.0001 
(***) 
 
 
 
 
 
 
 
 240 
 
 
 
 
Table 4.2 (opposing page): Statistical differences between control (KIL) and 
transgenic lines for five fitness parameters from pooled data from 3 independent 
experiments 
Where appropriate, data for each fitness parameter was tested using the D‟Agostino & 
Pearson omnibus normality test and subsequent statistical analyses were carried out 
accordingly (ns denotes p values which are not significant; ***, ** and * denote p values 
which are statistically significant at the <0.0001, <0.001 and <0.05 levels respectively). 
a
Non-normally distributed data was analysed using a Kruskal-Wallis test followed by a 
Dunns multiple comparison post test.  Where Dunns post test indicated significance 
between lines, a Mann-Whitney test was used to compare pairs of lines to get more exact 
significance levels. 
b
Data was analysed using a chi-squared contingency test. 
c
Data following a normal distribution was analysed using ANOVA followed by Tukeys 
multiple comparison post test. 
d
Kaplan-Meier survival curves were analysed using the log-rank (Mantel-Cox) test. 
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 Male Female Totals 
KIL 630 599 1229 
EV3P 647 660 1307 
EV3M 640 635 1275 
Totals 1917 1894 3821 
 
 
Table 4.3:  Contingency table showing numbers of male and female pupae for control 
and transgenic lines from pooled data from 3 independent experiments 
Data was taken from each of 3 independent experiments.  For each experiment, n = 30 
larvae for each of 15 replicates per line.  Larval mortality meant that less than 450 larvae 
per line for each experiment reached pupation but all which did were included in the data.  
Chi-squared analysis was performed on the pooled data (2 degrees of freedom) to 
determine if the sex bias was different between lines.  χ2 = 0.792; p = 0.673 therefore there 
is no difference in sex bias between the three lines.  
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Figure 4.1 (opposing page): Median larval death per replicate where ‘n’ = 30 for each 
replicate for the KIL control line and two hemizygous transgenic lines 
A) Data from experiment 1; B) Data from experiment 2; C) Data from experiment 3; D) 
Data pooled from 3 independent experiments 
Each replicate initially contained 30 larvae; 15 replicates were included in each of three 
independent experiments.  Larval death was counted when any larva did not achieve 
pupation due to mortality. 
Data were not normally distributed so all bars are representative of the median with the 
interquartile range indicated above and below the median. 
Statistical significance is shown above bars in the colour of the bar to which the 
significance level corresponds (ns, not significant).   
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Figure 4.2. Sex ratios of pupae in the control line KIL and two hemizygous transgenic 
lines 
A) Pupal sex ratios from experiment 1; B) Pupal sex ratios from experiment 2; C) Pupal 
sex ratios from experiment 3; D) Pooled pupal sex ratios from 3 independent experiments. 
Chi squared analysis shows no significant difference in sex ratios between lines for pooled 
data (p = 0.673).  The number of males and females expressed as a percentage of the total 
number of pupae within lines is shown above bars. 
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Figure 4.3 (opposing page):  Comparison of age at pupation between the KIL control 
line and two transgenic lines 
A1) Age at pupation for female pupae from experiment 1; A2) Age at pupation for male 
pupae from experiment 1; B1) Age at pupation for female pupae from experiment 2; B2) 
Age at pupation for male pupae from experiment 2; C1) Age at pupation for female pupae 
from experiment 3; C2) Age at pupation for male pupae from experiment 3; D1) Age at 
pupation for female pupae using pooled data from experiments 1-3; D2) Age at pupation 
for male pupae using pooled data from experiments 1-3 
All data was non-normally distributed with boxplots showing a line at the median.  Where 
applicable, the interquartile range is boxed and the maximum and minimum values are 
indicated. 
Statistical significance is shown above bars in the colour of the bar to which the 
significance level corresponds (***, p < 0.0001; **, p < 0.001; p < 0.05; ns, not 
significant).   
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Figure 4.4 (opposing page):  Comparison of wing lengths between a control line (KIL) 
and two hemizygous transgenic lines reared under strictly uniform conditions 
Male wing lengths followed a normal distribution therefore bars represent the mean with 
SEM also shown.  Female data was non-normally distributed and so boxplots are 
representative of the data.  A line indicates the median, the interquartile range is boxed and 
maximum and minimum values are plotted. 
Statistical significance is shown above bars/boxplots in the colour of the bar/boxplot to 
which the significance level corresponds (ns, not significant).   
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Figure 4.5 (opposing page):  Kaplan-Meier survival curves to compare longevity of 
the control (KIL) line with two hemizygous transgenic lines using pooled data from 
three independent experiments 
Graphs A-D show female survival data and graphs E-H show male survival data.  Graphs 
A and E show survival curves for all three lines included in the experiments.  Graphs B-D 
and F-H compare the survival curves for each combination of pairs of lines for female and 
male mosquitoes respectively.   
All survival data was analysed using the log-rank (Mantel-Cox) test and significance levels 
are displayed on each graph (***, p < 0.0001; *, p < 0.05; ns, not significant). 
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Figure 4.6 (opposing page):  Kaplan-Meier survival curves to compare longevity of 
males and females for each line using pooled data from three independent 
experiments 
A) Survival curve comparing male and female longevity in the control (KIL) line; B) 
Survival curve comparing male and female longevity in the hemizygous transgenic EV3P 
line; C) Survival curve comparing male and female longevity in the hemizygous transgenic 
EV3M line.  
All survival data was analysed using the log-rank (Mantel-Cox) test and significance levels 
are displayed on each graph (**, p < 0.001; ns, not significant).  
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4.4. Discussion 
4.4.1. Use of hemizygous transgenics for fitness studies 
In the fitness studies undertaken here, it was decided that comparisons would be made 
between a control strain of An. gambiae and hemizygote transgenic strains rather than 
homozygous strains.  Previous studies into transgenic fitness have used both homozygous 
transgenic lines (Bargielowski et al., 2011; Koenraadt et al., 2010; Li et al., 2008) and 
hemizygous lines (Amenya et al., 2010; Moreira et al., 2004).  Homozygous lines are used 
in fitness studies as transgenics are maintained as homozygotes in the laboratory in order 
that rearing is easier as homozygosity negates the need for screening at every generation.  
It is the homozygous state that would be released into the field should the transgenic be 
used as part of a control strategy because introgression of the transgene into the wild type 
mosquitoes in the field would be more efficient (Li et al., 2008).  Hitchhiking effects of 
recessive, yet potentially deleterious, alleles present near the insertion site may only be 
noticeable in homozygous lines.  Therefore if multiple transgenic lines carrying the same 
transgene are generated and made homozygous, the line displaying the greatest fitness can 
be selected for use (Li et al., 2008).  Thus it is unsurprising that various studies into the 
fitness of transgenic lines compare wild type (control) lines with transgenic lines in the 
homozygous state especially for those lines considered ready for release as part of a control 
program in the field (Bargielowski et al., 2011).  However, several studies highlight the 
effect of inbreeding on fitness (Koenraadt et al., 2010; Li et al., 2008) which can be 
reduced by out crossing to a wild type strain.  Comparisons made between transgenic lines 
and wild type controls in terms of fitness parameters are therefore more likely to indicate 
that any differences observed between these lines are due to the effect of the transgene and 
not inbreeding.  Li et al. (2008) also suggest that it is the introduction of competition which 
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causes a reduction in transgene allele frequency in mosquito populations as homozygote 
populations are stable over many generations.  However, introduction of wild type alleles 
causes a dramatic loss of transgene alleles which could indicate that transgenic males are 
less able to compete with wild type males for females (Li et al., 2008).  When released into 
a field situation, which is the ultimate goal of transgenic mosquito creation, any transgenic 
mosquito in both homozygous and hemizygous form has to be able to successfully 
compete with their wild type counterparts in order that the control program is effective.  
Diaz et al. (2011) model the population dynamic effect of the introduction of a genetically 
modified mosquito into a wild type population, based on well-documented epidemiological 
data.  The authors conclude that it is the relative fitness of the resulting hemizygotes which 
is crucial for the success of the release thus highlighting the need for extensive studies into 
the reproductive fitness of transgenic mosquitoes destined for release (Diaz et al., 2011).  It 
was therefore concluded that the fitness studies conducted here would compare the wild 
type strain to transgenic lines in their hemizygous state.  Bargielowski et al. (2011) report 
that the differences between the transgenic line and wild type seen in their fitness studies 
may be due to a difference in genetic background.  Therefore, for the experiments 
described here, the wild type control was the host strain from which the transgenics were 
created.  From evidence shown here, it seems likely that the use of hemizygote transgenic 
mosquitoes removes certain confounding factors highlighting differences between wild and 
transgenic lines that are caused by the effect of transgenesis itself. 
 
4.4.2. Larval mortality 
Statistical analysis of mean larval mortality showed that there was no significant difference 
between control and transgenic lines.  The striking result from investigation of this fitness 
parameter is that, on average, 9% of KIL larvae die prior to reaching pupation compared to 
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only 3.2% and 5.6% respectively for EV3P and EV3M.  Although not a statistically 
significant result, biologically it is interesting as two out of three independent experiments 
follow this pattern.  Although experiment 2 does not show a greater average loss of KIL, it 
does indicate a larger variation within this line between replicates thus suggesting that it is 
KIL which is more prone to larval mortality.  Furthermore, all three experiments indicate 
similar losses of transgenic larvae in each experiment.  It is unlikely that possession of the 
Vida3 transgene confers a fitness advantage at the larval development stage when 
compared to a wild type strain.  Given that the difference observed is not statistically 
significant, it is more likely that it is caused by a small confounding factor not accounted 
for in the experimental design.  The study involved transferring 30 larvae from oviposition 
vessels to each replicate.  Oviposition vessels were all the same size and contained the 
same volume of water.  Cages from which the oviposition vessels were taken were set up 
with the same number of female and male mosquitoes in so that similar numbers of eggs 
would be laid into the vessels.  This was designed to ensure that each line was subject to 
the same density effects as L1 larvae hatch out.  However, it may be likely that either more 
females of the KIL line take a blood meal in the time offered, or fewer hemizygous larvae 
hatch out, or a combination of both, thus resulting in a greater density of L1 larvae in the 
wild type cage oviposition vessel.  This may result in these larvae being weaker and could 
account for the small yet universal increased larval mortality in the control line when 
compared to the transgenic lines.  It could be expected that a significant decrease in 
survival to pupation would decrease larval competition thus prompting eclosion to occur 
sooner.  Though significant differences between lines were not observed in this 
experiment, this does not mean that the slightly raised larval death levels in the KIL line 
would not have an effect on pupation.  However, this did not appear to be the case, perhaps 
because larval mortality was not high enough to affect pupation, or because age at pupation 
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is controlled mainly by factors other than density, such as genetics and temperature 
especially when density is already at relatively low levels (and food supplies plentiful), 
when compared to the likely situation in the field.  An. gambiae in the field are reported to 
be subject to larval mortality rates as high as 92-98% due to varying factors such as 
presence and/or absence of parasites, pathogens and predators within larval pools, inter and 
intra-specific competition and abiotic factors such as temperature and rainfall (Paaijmans 
et al., 2007; Kirby and Lindsay, 2009).  It is worth noting, however, that when considering 
only intra-specific (or intra-line) competition, higher larval mortality rates may lead to the 
production of larger, more fecund adult females and thus have no net fitness disadvantage 
(Koenraadt et al., 2010).  Mortality rates in this study are significantly lower than those 
encountered in the field as the factors affecting this parameter are not present in the 
laboratory.  This raises the question of how well laboratory-reared and field-released 
mosquitoes would actually survive, especially when in competition with field mosquitoes 
thus making it clear that for accurate modelling to be possible for releases, it would be 
necessary to take fitness studies out of the laboratory and into the field.   
 
4.4.3. Sex ratio 
There was no deviation from the expected 1:1 ratio of males to females in the control 
(KIL) line or in either of the hemizygous lines, EV3P or EV3M.  This suggests that 
presence of the Vida3 transgene did not influence the sex ratio of either of the hemizygous 
lines.  The transgene is known to be located on chromosome 3R, and is 2.5kb from any 
known gene (Meredith et al., 2011), therefore it would not be expected to distort the sex 
ratio. 
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4.4.4. Age at pupation 
There is no significant difference in female age at pupation between KIL, EV3P and 
EV3M when considering the pooled data.  This is true for comparisons between KIL and 
EV3P in all three independent experiments.  However, when considering each of the three 
independent experiments separately it can be seen that there are significant differences 
between age at pupation of female KIL and female EV3M.  In experiments 1 and 3, on 
average, KIL pupates sooner than EV3M but in experiment 2, it pupates later thus 
balancing out in the pooled data.  Furthermore, in experiments 1 and 2, there is a 
significant difference in age of pupation of females between the two hemizygous lines 
which is not then reflected in the pooled data set.  This is explained when looking more 
closely at the data which shows that the EV3P line pupates significantly later, on average, 
than the EV3M line in experiment 2 whereas in experiment 1, it pupates significantly 
sooner.  The variation seen between experiments may be due to conditions in the insectary 
changing between repeats which could not be accounted for, such as outside temperatures 
affecting the environment inside the insectary.  Anecdotal evidence suggests that, although 
insectary temperature and humidity are under control, there is certainly variation 
depending on ambient temperature outside.  It is clear that with each successive experiment 
there is a general increase in age at pupation for all genotypes, though pupation across all 
lines within experiments began on exactly the same day.  It‟s likely that external factors 
have influenced the timing of pupation, but have affected all lines to the same degree.  It 
remains possible that this has had an effect on the data, causing anomalies in the statistics 
when data is pooled, though this is only seen to affect females.  Given the slight 
inconsistency across experiments, it is most likely that pooled data reflects more accurately 
any differences observed between female age at pupation between lines, and so it can be 
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concluded that the presence of the transgene does not significantly affect female age at 
pupation. 
 When analysing pooled data, it is clear that there are significant differences in age at 
pupation between KIL and EV3M males and also between the two hemizygous lines, 
EV3P and EV3M.  There is no significant difference in age at pupation between KIL and 
EV3P males.  All three experiments exactly reflect these differences.  Mating in An. 
gambiae occurs in swarms composed of males which compete for arriving females.  These 
swarms seem to lack a female choice component thus placing more weight on male 
competition (Diabate et al., 2011).  Therefore, if males belonging to the EV3M strain take 
longer to reach pupation than wild type counterparts, this may have a negative effect on 
transfer of the transgene to subsequent generations.  Li et al. (2008) suggest that slower 
development of transgenic larvae delays the male mosquito in reaching sexual maturity 
which would have consequences when competing in the field with their wild type males.  
This means that EV3M may have a significant disadvantage in terms of fitness. What is 
interesting is that males from the EV3P line reached eclosion within a similar timeframe to 
those from the KIL line which could mean that the transgene, when maternally inherited, is 
impacting on genes which influence pupation.  The mechanism for this is unclear.  
Conversely, and although not observed in the hemizygous lines used within this study, 
transgenic lines which reach pupation sooner than wild type, a trait possibly under 
selection pressure in the laboratory when mass rearing, could incur a fitness disadvantage 
when away from laboratory conditions (Bargielowski et al., 2011). 
 
4.4.5. Wing length 
Wing length has been documented as a good indicator of body size for anopheline 
mosquitoes (Koella and Lyimo, 1996).  Furthermore, body size provides a good indicator 
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of the female‟s capacity for blood and therefore can affect fecundity (Lyimo and Takken, 
1993; Hogg et al., 1996).   Kirby and Lindsay (2009) showed that body size is related to 
development time in An. gambiae and An. arabiensis thus linking age at pupation to body 
size.  Their study shows that at higher temperatures, An. gambiae are smaller than An. 
arabiensis so their development time is quicker, although they develop too quickly to 
accumulate enough food to support pupation and therefore do less well than An. 
arabiensis.  Lyimo and Takken (1993) also report that a shortage of resources during 
development can have a detrimental effect on adult mosquitoes.  Using wing length as a 
measure of body size, their study indicated that the smaller mosquitoes (wing length of less 
than 3mm) hand-caught from the field in Tanzania, are more often pre-gravid than the 
larger females caught, and therefore are not fecund after a blood meal.  Instead they require 
two or three blood meals to complete their first gonotrophic cycle.  Further mating studies 
have shown that male An. gambiae will select larger females even when large numbers of 
males are competing for a smaller number of females thus suggesting that these females 
are picked due to their increased egg-carrying capacity (Okanda et al., 2002).  Implications 
of body size do not only affect females but can have a large effect on the mating 
competitiveness of male An. gambiae.  A study into sexual selection in mosquito swarms 
suggests that the most successful males were not the largest, but were of intermediate size, 
and these mosquitoes were six times more likely to achieve copulation with a female 
during one swarming event (Nghabi et al., 2008).  However, the study also showed that the 
largest males, which were on average 10% larger than intermediate-sized males and had 
two to four times more energy reserves, were 13% longer-lived than their intermediate-
sized counterparts (Nghabi et al., 2008).  Interestingly, within size groups, and consistent 
across the three size groups, males which mated were, on average, larger than those which 
did not mate (Nghabi et al., 2008).  The authors suggest three reasons for the success of 
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intermediate-sized males.  The first is that it is a trade-off between agility and lower energy 
reserves, and the second is that these males are closer to females in size, though the 
experiment was not designed to test for size-assortative mating.  The third reason being 
that males of this size cohort are mostly closely following the averages of natural sexual 
dimorphism for this characteristic.  However this would represent female choice as a 
mechanism behind mating behaviours within the swarm and much evidence suggests that it 
this is not the case with An. gambiae (Nghabi et al., 2008). 
Numerous experiments indicate that adult size plays an important role in reproductive 
fitness of An. gambiae.  It is therefore clear that this parameter is an important one and one 
which must be carefully considered when generating transgenics with a view to future 
release in control programs.  The study conducted here shows quite clearly that there is no 
significant difference between the size of wild type lines (KIL) and either hemizygous line 
(EV3P and EV3M) carrying the Vida3 transgene.  This is true of both males and females.  
Use of transgenic mosquitoes as part of a control program would involve the release of a 
large number of homozygous male mosquitoes.  It is these mosquitoes which would then 
have to out-compete wild type males for females.  Thus it would be important that 
homozygote males are of a similar body size, on average, to their wild type counterparts in 
the field.  Consequently it would be beneficial to include body size analysis of the 
homozygous EVida3 line.  Preliminary data shows that there is no significant difference 
between adult size of KIL and homozygous EVida3 (data unpublished). 
The correlation between body size of females and capacity for a blood meal also indicates 
that females of a similar size will take on board a similar infection when encountering 
infected hosts.  Infection with the malaria parasite has an effect on reproductive fitness of 
An. gambiae by reducing fecundity (Hogg and Hurd, 1995b).  In theory, a transgenic 
mosquito which will take a smaller blood meal, and therefore take on board a lower level 
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of infection (leaving aside fitness costs associated with smaller blood meals) than wild type 
females may be of benefit in terms of controlling disease.  However, it is likely that fitness 
costs associated with being smaller than wild type females may outweigh any benefits 
gained from being exposed to fewer parasites.  Furthermore it has been documented that 
infection levels in wild populations are maintained at very low levels with the average 
number of oocysts found on the midgut of field-caught infected mosquitoes being between 
1 and 3 (Dawes et al., 2009).  It is unknown whether this reflects the fact that those with 
high infection levels die and are thus not available for sampling (Lyimo and Koella, 1992), 
or whether it is due to other factors, such as the mosquito immune response.  However, 
these mosquitoes are likely to be better adapted at controlling natural infection with 
Plasmodium spp. than transgenic mosquitoes, and so even if they are exposed to higher 
parasitaemias in mammalian hosts, they are still likely to out-compete the transgenic line in 
terms of reproductive fitness.  
 
4.4.6. Adult longevity 
Analysis of pooled data shows that there are significant differences in longevity between 
KIL and hemizygous transgenic lines.  This is the case for both males and females 
although the differences do not follow the same patterns in both sexes.  When comparing 
longevity of females, there is no significant difference between KIL and EV3M but highly 
significant differences between KIL and EV3P and between EV3P and EV3M.  In both of 
these cases, it is the EV3P line which is, on average, the longest lived, out-living even the 
wild type line.  The difference between the transgenic lines, EV3P and EV3M is also 
reflected when comparing males, whereby EV3P is more long-lived than EV3M.  
Comparisons of KIL and EV3P males show that, as with females, it is the hemizygous 
strain which is, on average, the longer-lived, however the difference is less pronounced in 
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males.  In females, there is no significant difference in longevity between KIL and EV3M 
but in males, KIL invividuals live significantly longer on average.  Although levels of 
significance varied, all three experiments showed essentially consistent trends among both 
sexes when comparing wild type mosquitoes with transgenic hemizygous lines (Kaplan-
Meier longevity curves for independent experiments 1 to 3 are found in Appendix 7.3; 
Figs. 7.3.1-7.3.6).  In general therefore, it can be concluded that pooled data is highly 
representative of longevity in the three lines observed.  Results from the longevity study 
show that not only are there significant differences between wild type and transgenic lines, 
which might be expected, but also that there are significant differences between the two 
transgenic lines.  These differ only in the route of inheritance of the transgene, either 
through the male of female parent.  This was an unexpected result but one that was also 
evident from the data on age at pupation. 
Longevity of mosquitoes, or indeed any vector insect, is quite important in terms of its 
vectorial capacity.  The malaria parasite takes around 2 weeks to complete its life cycle 
within the mosquito host and become the infective sporozoite stage within salivary glands 
(Barillas-Mury and Kumar, 2005).  Female An. gambiae, to be an efficient vector of 
malaria, must live long enough for this life stage to be reached.  It is also beneficial to the 
mosquito to live longer, and therefore have the increased potential to undergo more 
gonotrophic cycles.  Indeed, a decrease in longevity has been targeted as a mechanism by 
which the vectorial capacity of Ae. albopictus can be reduced.  The aim was to reduce the 
lifespan of females so as they could still live long enough to reproduce, but not long 
enough to act as a vector of disease.  A species of Wolbachia (wMelPop), a natural 
symbiont of Drosophila, was transferred to the mosquito which then caused a significant 
shift in the age structure of the population of females towards those which are younger 
(Suh et al., 2009).  The authors do however, report that wMelPop reduces fecundity as well 
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as longevity, and causes a high embryonic lethality.  As such, it is less likely to spread to 
field populations of Ae. albopictus so its use as a control strategy is limited due to its 
association with such high fitness costs (Suh et al., 2009).  This highlights the need to 
ensure that any mosquito released into the field which would need to compete successfully 
with field populations is reproductively fit.  Longevity clearly forms part of this 
reproductive fitness; however the significance of longevity in mosquitoes in terms of 
fitness may differ between males and females.  In theory, females need to live longer than 
males in order to find a mate, copulate, feed and complete at least one gonotrophic cycle, 
which takes around 48 hours in An. gambiae.  Clearly more successful females will be 
those who can complete more than one gonotrophic cycle.  Males need to live long enough 
to successfully mate, which can occur with several females within a short period of time 
once they have matured, thus their theoretical life span requirement is shorter than for 
females.  Males may even have a competitive advantage if they mate many times earlier in 
life and so longevity may not be as important as in females.  However, there is evidence to 
suggest they have a limited mating capacity due to resource costs (Dao et al., 2010).  This 
means that the resources that males emerge as adults with would not be sufficient to allow 
them to find a reproductively successful number of females with which to mate and would 
thus argue for the advantage of increased male longevity.  Conversely, if males are less 
competitive, i.e. compromised in terms of reproductive fitness in other ways, perhaps 
because they take longer to pupate, and do not mate successfully early in life, clearly their 
reproductive fitness will also be compromised by having a reduced longevity.  A study 
looking at the comparative physiological fitness of free-living and laboratory-reared An. 
gambiae showed that free-living males had higher lipid stores than their counterparts, 
possibly due to a better quality larval diet than that provided in the laboratory.  
Incidentally, carbohydrate stores were lower in free-living male An. gambiae than in those 
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which were laboratory-reared, probably because sugar was available ad libitum to these 
mosquitoes (Huho et al., 2007).  The higher lipid content was expected to lengthen life 
expectancy of free living males as long-term survival is associated with high lipid 
abundance and larger body size (Briegel, 1990).  If presence of higher lipid reserves 
available from eclosion outweighs benefits of higher carbohydrate levels from sugars 
available post-eclosion, then field free-living males will have higher physiologically 
determined reproductive potential than their laboratory-reared counterparts (Huho et al., 
2007).  This adds further weight to the question as to whether greater longevity is truly 
important for male mosquitoes in terms of fitness.  It is known that carbohydrate stores in 
males are important to their ability to maintain flight and therefore impact on their ability 
to swarm.  There is evidence to suggest that in field caught mosquitoes these reserves 
increase in older mosquitoes therefore suggesting that reproductive fitness of males does 
not decrease with age (Huho et al., 2007).  The same study also indicated that the lower 
lipid content present in laboratory-reared males (which is linked to a shorter life span), 
may impact on fitness should longevity be an important parameter (Huho et al., 2007).  
Clearly, transgenic mosquitoes are laboratory-reared and therefore are likely to exhibit 
similar, if not greater, fitness deficits to those highlighted in this study comparing free-
living and lab-reared male An. gambiae.  Nghabi et al. (2009) showed that male An. 
gambiae of intermediate size were between six times more likely to achieve copulation 
than larger mosquitoes, however larger mosquitoes were consistently longer-lived than the 
intermediate-sized males.  The authors do suggest however, that although longer lived and 
larger males have more opportunity to mate over their life time, this may not offset the 
disadvantage their size confers (Nghabi et al., 2008).   
The study conducted here suggests that KIL males lived significantly longer than EV3M 
males but had a significantly shorter life span than EV3P males.  A comparison of 
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longevity between the two hemizygous line indicates that EV3P males are very 
significantly longer lived than those from the EV3M line.  Therefore it is hard to conclude 
that the presence of the Vida3 transgene has a detrimental effect on the longevity of An. 
gambiae males.  In terms of fitness of transgenic strains, a longer-lived male would be 
useful in terms of release, as the longevity may offset any reduction in competitiveness 
exhibited by the transgenic strains in mating swarms.  However female longevity also has 
to be considered since it is they which express Vida3 and which are the vector for 
Plasmodium spp.  Analysis of pooled data from longevity studies conducted here indicates 
that, whilst EV3P females are significantly longer lived than wild type (KIL) females, 
EV3M female longevity is not significantly different to that of the KIL line.  Again, and as 
with males, it is difficult to conclude that the presence of the transgene has a detrimental 
effect on the longevity of females, as there is a significant difference in longevity between 
hemizygous lines.  However it seems more likely that the presence of Vida3 in females is 
not detrimental in terms of longevity.  As discussed previously, it would actually be 
beneficial to cause an age shift in the female population towards younger mosquitoes as 
they would be less efficient vectors, especially when this is coupled with the anti-parasitic 
effect of Vida3 expression in the midgut of the females.  What is interesting about the 
longevity data is that although there appears to be a difference in longevity between 
hemizygous lines (which differ in the route of inheritance of the transgene), there is a 
difference in longevity when comparing males and females within lines only for EV3M.  If 
there is a genetic effect on fitness which is associated to a greater degree with maternal 
inheritance of the transgene, one may expect females to exhibit a greater fitness cost for 
longevity and other fitness parameters, than is apparent in males.  This is not the case in 
these studies, and in fact, the other fitness parameter where there is a clear difference 
between hemizygous lines is age at pupation.  With this parameter, it is also EV3M which 
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suffers a detrimental effect, with a longer time to pupation, but this difference is only 
apparent in males and not females.  The longevity study also shows that lifespan is reduced 
in males to a larger degree than in females when comparing EV3M line to KIL.  This 
suggests that although the Vida3 gene is inherited from maternal gametes, it is somehow 
affecting male progeny to a greater degree.  The mechanism by which this occurs is, at 
present, unclear. 
The longevity studies carried out here are very artificial and, although they do represent the 
maximum longevity potential of both male and female mosquitoes, they do not take into 
account the situation in the field.  Mosquitoes in these studies were not allowed to mate 
and females did not receive blood meals so consequently did not enter a gonotrophic cycle.  
As a consequence of this, females did not get the opportunity to express the Vida3 protein.  
Clearly these factors may indeed have a large impact on longevity of mosquitoes.  In the 
field, female mosquitoes come into contact with many pathogens, Plasmodium spp. being 
just one.  Up-regulation of the immune response to act against pathogens uses up valuable 
host resources and thus shortens the longevity of An. gambiae.  Studies have shown that 
disruption of the gene encoding SRPN2 which is itself a negative regulator of the PPO 
pathway involved in the melanisation response, can lead to an uncontrolled immune 
reaction killing female An. gambiae after reproduction but before Plasmodium reaches 
infective stages (An et al., 2011).  The melanisation response, however, is rarely observed 
in co-evolved Plasmodium-anopheline combinations due to evasion of the immune 
response by the parasite (Lambrechts et al., 2007).  This may have consequences, upon 
field release, for transgenic lines such as EVida3, known to melanise malaria parasites 
which have successfully evaded attack by the Vida3 molecule itself (Meredith et al., 2011).  
An up-regulated immune response via the melanisation pathway could be seen as 
advantageous, certainly when combined with expression of the transgene itself, in that the 
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knockdown effect on the parasite may be magnified.  This may in turn cause a reduction in 
average longevity of female transgenic mosquitoes released in the field as discussed by An 
et al. (2011).  This would be an ideal situation as it would allow for reproduction of the 
transgenic strains thus allowing the spread of the transgene through the population, whilst 
making them less susceptible to the malaria parasite, and generally increasing their 
immune response.  Laboratory-reared transgenic mosquitoes, when released into the field  
will encounter many more pathogens/parasites than when in the laboratory.  This may then 
initiate an up-regulation of the immune response, larger than that initiated in field 
mosquitoes in response to contact with parasites.  As a consequence, transgenic mosquitoes 
would require a larger amount of resources to allocate to this up-regulation.  This may 
cause a massive age shift in the population of female transgenic An. gambiae to a point 
where they were less likely to complete a gonotrophic cycle after an initial blood meal.  
Thus they would then be reproductively less fit than wild type counterparts and the spread 
of the transgene would be unsuccessful.  The fitness studies conducted here cannot provide 
a measure of this as mosquitoes were not blood fed, and consequently any fitness effects 
linked to feeding on either non-infected or infected blood cannot be measured.  Previous 
fitness studies have shown that as well as possessing no fitness burden when compared to 
wild type mosquitoes, females from transgenic lines expressing an antimalarial peptide 
(SM1) in the midgut were longer lived and more fecund than wild type when routinely fed 
on P. berghei-infected blood (Marrelli et al., 2007).  Furthermore, in cage experiments, 
transgenics gradually replaced non transgenics when maintained on infected blood.  This 
had not been seen before when similar cage experiments were performed as part of studies 
looking at fitness effects of transgenes (Catteruccia et al., 2003; Irvin et al., 2004; Moreira 
et al., 2004).  Although the activation of the innate immune cascade in mosquitoes is itself 
seen as a fitness-reducing occurrence (Ahmed and Hurd, 2006), Marrelli et al. (2007) 
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suggest that the observations of increased fitness from their experiments are due to the 
expression of a harmless immune peptide causing knockdown of the parasite prior to 
invasion of midgut epithelial cells and consequently prevention of the costly upregulation 
of an innate immune response.  Dawes et al. (2009) showed, by analysing death rates in 
cages fed on blood infected with varying densities of P. berghei ookinetes, that female An. 
stephensi mortality is not only age related, but is also infection-intensity related.  High 
death rates were seen in cages initially and were partly associated with blood feeding 
(Dawes et al., 2009). 
Dao et al. (2010) have shown that mating and reproduction affect longevity of An. 
gambiae.  Their study showed that longevity of females fed on blood and sugar was 
significantly higher than those fed on sugar alone, regardless of whether or not they were 
mated.  This suggests that in a laboratory environment where there is a reduced risk to 
blood feeding due to reduced exposure to pathogens and host response to a bite, blood 
provides more resources resulting in increased longevity.  However, mated females had 
reduced longevity when compared to virgin females if fed on blood and sugar thus 
suggesting a cost to females in mating, though the cost of reproduction in terms of 
longevity is ambiguous (Dao et al., 2010).  For male An. gambiae, the same study showed 
that exposure to females for 6 days resulted in a reduced longevity when compared to 
virgin males. In mated males, higher mortality was associated with smaller sized 
mosquitoes (Dao et al., 2010).  This may be due to these mosquitoes having fewer initial 
resources accumulated as larvae.  Forming mating swarms is thought to be costly to male 
mosquitoes, and therefore it is likely that longevity studies conducted in the laboratory, 
where males are exposed to females, are still not representative of the situation in the field.  
Clearly within a finite space such as a cage, swarming behaviour may not be as draining in 
terms of resources as they would be in the field as males are much more likely to come 
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across females without the same amount of time spent within swarms.  Therefore 
laboratory studies are likely to over-estimate male longevity.  In the fitness studies 
conducted here, males lived much longer than expected from general observations of stock 
populations within the same insectaries.  Indeed, anecdotal evidence suggests that females 
outlive males by a significant period of time.  There are two possible reasons for the 
observed increase in male survival between longevity-study males and stock males.  The 
first is that longevity study males were virgin males, and consequently did not use up 
valuable resources by mating.  The second is that stock males are routinely subjected to 
periods of around 18 hours where they have no access to sugar due to stock cages being 
starved to increase female blood-feeding.  It is expected that this causes significant male 
death in stock cages.  Longevity-study males, on the other hand, were able to access sugar 
and water ad libitum.  It is clear that fitness experiments whereby longevity of mosquitoes 
is measured as a fitness parameter need to take factors such as blood feeding and mating 
into account before they can be used as a true representation of a field situation. 
 
4.4.7. Conclusions 
In conclusion, from five fitness parameters measured in these studies, there is no clear 
evidence to suggest that possession of the Vida3 transgene has a significant overall effect 
on the fitness of the hemizygous transgenic lines.  Significant differences were seen 
between KIL and either of the hemizygous lines for some parameters such as longevity and 
age at pupation, but these were not consistent over both EV3P and EV3M lines, or between 
males and females.  Indeed some significant differences observed suggest that hemizygous 
lines showed increased fitness compared to the wild type KIL line.  Differences between 
EV3P and EV3M were observed and are difficult to interpret.  What is apparent is that 
fitness studies such as the ones undertaken here will not conclusively determine how 
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transgenic mosquitoes will fare if released in the field as part of an integrated control 
strategy when they have to compete successfully with the indigenous mosquitoes.  Factors 
such as the immune response to pathogens, including the target (in this case Plasmodium), 
mating behaviours and blood feeding/reproduction costs must be considered when 
conducting fitness experiments to get a better model for the field situation.  Nevertheless, 
preliminary laboratory fitness studies are essential prior to taking such trials to the field as 
it will enable an initial assessment of newly generated refractory transgenic lines.  
Assessment of both hemizygotes and homozygotes is also essential as it will be 
homozygote lines which are maintained in the laboratory and released, but hemizygotes 
which will be the first generation to have to compete throughout their whole life cycle with 
wild type mosquitoes. 
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Chapter Five 
5. General Conclusions 
The work undertaken here highlights the technical challenges inherent in the 
transformation of disease vectors.  The major malaria vector, An. gambiae, is a particularly 
demanding insect species to work with in a laboratory setting.  Genetic modification of this 
species with complex plasmids such as those used in Chapter 2 is time consuming and is 
without guarantee of a successful outcome, even when following a protocol that has been 
optimised to maximise survival and potential for genomic integration of the transgene.  
Use of RIDL technology in An. gambiae has not yet been documented and it may be that 
integration of particularly large plasmids into this species is inefficient in comparison with 
other species, such as Ae. aegypti and D. melanogaster.  A further consideration connected 
with the use of RIDL technology is the ability to mass rear the species concerned.  Rearing 
mosquitoes containing RIDL constructs requires these lines to be able to survive well, as 
larvae, in water containing tetracycline.  Investigations here provide evidence that rearing 
An. gambiae in such conditions is feasible, which was an initial concern for this species.  
Mass-rearing of Ae. aegypti has been successfully achieved with RIDL strains for the 
purpose of field trials (Derric Nimmo, unpublished data).  However, the logistics of rearing 
An. gambiae is different in that it is reported as a less robust system, and one more liable to 
population crashes.  It is possible to sex Aedes pupae using mechanical methods as there is 
a distinct size difference between male and females.  This size difference between sexes is 
also apparent in anophelines but is less marked, making mechanical separation more 
difficult.  In addition to this, anophelines are much more sensitive to the pressures of 
mechanical sorting, with a particularly high mortality rate amongst those which were 
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subject to this procedure (unpublished data).  Both the population suppression 
(encompassing RIDL) and population replacement approaches to mosquito control will 
ultimately rely on the ability to rear huge numbers of the target strain.  This makes it a key 
factor in the success of integrated control strategies releasing pre-established laboratory 
strains of genetically modified mosquitoes.  Without the ability to mass rear a transgenic 
strain the technology becomes redundant in terms of its viability.  Mass rearing of 
anophelines, as with Aedes, is possible.  Small scale release of sterile An. albimanus has 
previously been carried out in El Salvador causing suppression of the local population, 
although this was short-lived due to the effect of immigration (Reviewed by Benedict and 
Robinson, 2003).  For this to have been undertaken, An. albimanus had to be successfully 
mass-reared, producing millions of mosquitoes per week, thus proving mass-rearing 
feasible for anophelines (Nolan et al., 2011).  Since then, various laboratories have 
undertaken work to maximise the potential for mass-rearing of anopheline species for use 
in SIT programmes.  These have been both broad-ranging (Singh, 2007) and focused on 
parameters such as oviposition behaviour (Balestrino et al., 2010) and density-dependent 
effects (Gilles et al., 2011).  The Centre for Production and Infection of Anopheles 
(CEPIA) has been successful in mass-rearing both An. gambiae and An. stephensi (Thierry, 
2007).  This facility mainly rears anophelines for infection challenge experiments.  They 
are able to supply several different research institutes with between 2 and 3 thousand 
female mosquitoes per day reared following strict regimes to ensure reproducibility 
between experiments (Thierry, 2007).  Although not rearing transgenic mosquitoes, this 
facility proves that mass rearing of An. gambiae is possible and therefore allows for the 
possibility of using transgenic lines in future control strategies, with RIDL technology a 
viable option for anophelines. 
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Generation and subsequent characterisation of RIDL strains of An. gambiae would have 
resulted in the formation of further research questions associated with these lines regarding 
the effectiveness of the transgene and its sex-specific action, as well as the potential for its 
application downstream.  This would have been of particular interest given the prior 
generation (Fu et al., 2010) and large cage trials (Wise de Valdez et al., 2011) of a 
flightless RIDL strain of Ae. aegypti.  The inability to integrate the entire RIDL plasmid 
into the An. gambiae genome suggested that the size of the construct may affect efficiency 
of integration more in this species than with others.  This is further backed up by the 
inability to integrate other large constructs successfully.  However the microinjection 
protocol used here did allow for integration of a single piggyBac element, containing only 
a marker gene and associated 3xP3 promoter, which also suggests that the failure to 
integrate complete plasmids is due to their size and possible deleterious effects of the genes 
they encode.   
Failure to produce a novel transgenic resulted in a change of emphasis for the 
investigations presented here.  The EVida3 transgenic line generated by our laboratory had 
already been characterised, and the lines‟ ability to knockdown the murine malaria P. 
yoelii nigeriensis documented (Meredith et al., 2011). However, there remained a great 
deal of questions regarding the production and action of the synthetic Vida3 peptide in vivo 
and its effect on the mosquito itself.  This was both in terms of its interaction with the 
immune system and also fitness costs associated with production of Vida3.  The work 
presented here takes steps to further our understanding of the biology of transgenic An. 
gambiae by investigation of both blood feeding habits and reproductive fitness parameters.  
There are many aspects of mosquito biology which need to be assessed in a laboratory 
before the long term goal of release can even be considered. 
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The multiple feed studies described here support the conclusions of Meredith et al. (2011) 
in terms of the ability of Vida3 to reduce parasite burden when expressed in the midgut of 
the transgenic line.   However the effect is not the zero-sporozoite phenotype required for 
any mosquito to be deemed as truly refractory, as only one developed oocyst would 
produce enough sporozoites to allow the mosquito to become infective.  Furthermore, these 
investigations into the effects of multiple blood-feeding on Vida3 action indicated that the 
Vida3 peptide cannot cross the midgut epithelium and thus its effects on the Plasmodium 
parasite cease once the parasite invades midgut cells.  A multi-compartmental approach 
would therefore be necessary to provide a more thorough attack of the parasite within the 
mosquito host.  This would be achieved by driving expression of an AMP by means of a 
different promoter such as anopheline antiplatelet protein (AAPP) promoter which is 
salivary-gland specific (Yoshida and Watanabe, 2006).  Driving expression of Vida3 in 
both the midgut and salivary glands may further reduce the likelihood of the parasite being 
able to complete its life cycle within the mosquito thus blocking the transmission cycle and 
increasing the efficacy of the transgenic strain.  Previous studies have shown that field 
populations of anophelines will take a further blood meal within one gonotrophic cycle 
(Briegel and Horler, 1993).  Laboratory studies have also managed to illustrate this 
(Nirmala et al., 2005).  In terms of this study, it was thought likely that too many females 
may refuse the second blood meal in the laboratory.  Thus to have enough dissected 
females for a statistically powerful test it would have required the initial number of females 
feeding on the mouse to exceed the amount ethically recommended.  This meant that 
although conclusions can be drawn about the inability of the Vida3 peptide to cross the 
midgut epithelium, it is impossible to determine whether a second blood meal, within one 
gonotrophic cycle and therefore relatively shortly after the initial feed, would have a 
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greater knockdown effect purely due to the action of the Vida3 peptide on the parasite than 
when mosquitoes are fed only once within one cycle.   
However, other conclusions can be drawn from these investigations into effects of multiple 
feeding.  Studies here show a trend in line with those conducted by Lopes et al. (2007) in 
that a second (naïve) blood meal, given 3 days post infection, increases infection intensity.  
This could be due to the increased resources available to the parasite, but could also be 
attributed to the mosquito directing the resources from this blood meal away from an 
immune response and towards egg production.  The second feed given was non-infective 
and as a consequence, would not instigate such a large immune response as the first feed 
and parasites present already may not initiate any further peaks in immune activity.  This 
theory is corroborated by the observation of increased egg production in the second 
gonotrophic cycle when compared to the first in both lines E and EVida3.  Interestingly the 
study also indicates a cost to the mosquito of production of Vida3 peptide as EVida3 is less 
fecund than line E when given an infected feed. 
Further studies are required to examine the effect of second blood feeds (of varying 
immune and infection status) either with or between gonotrophic cycles.  These 
experiments, with appropriate controls, would go some way towards ascertaining how 
these parameters affect infection within transgenic strains, such as EVida3, and how 
infection and production of novel immune peptide affects fecundity.  More work is also 
required so that a consistent, reproducible system can be established for feeding peptides 
along with infected blood to mosquitoes in order that experiments such as the dose-
dependent curve experiment can be carried out effectively. 
Investigations conducted here into the general reproductive fitness of the transgenic line 
were carried out due to the observed effect of Vida3 production on fecundity highlighted 
by the multiple feeding experiments.  Reproductive fitness is an important consideration 
 276 
when assessing the feasibility of using transgenic mosquitoes generated and bred in the 
laboratory  as part of an integrated population replacement (or indeed suppression) 
strategy.  For this control strategy to be effective, released transgenic mosquitoes must be 
able to compete effectively for mates with the wild type population and be capable of 
producing and laying good-quality, viable egg batches.  Modification of mosquito biology 
and/or physiology brought about due to gene disruption cause by transgenesis or associated 
inbreeding could compromise the ability of a transgenic line to compete effectively with 
wild type field mosquito populations.  Clearly this would have a detrimental effect on 
release of transgenics as a reliable and effective control strategy.  The investigations 
presented here concentrated on analysis of five parameters of fitness in studies similar to 
those conducted previously (Moreira et al., 2004; Li et al., 2008; Amenya et al., 2010; 
Bargielowski et al., 2011).  Three out of five parameters measured (larval mortality, sex 
ratio and wing length) showed that there was no associated fitness cost with presence of 
the Vida3 transgene.  However, both age at pupation and longevity highlighted interesting 
differences between wild type (KIL) mosquitoes and the hemizygous transgenic lines, 
EV3P and EV3M. 
When considering age at pupation, the overall effect of the transgene is seen in males only.  
In females, there was no significant difference between KIL and either of the hemizygous 
lines.  However, EV3M males pupate significantly later than both KIL and EV3P males.  
Increased age at pupation is generally considered a disadvantage in terms of reproductive 
fitness, especially with regard to competitiveness of male mosquitoes.  Data generated by 
longevity studies shows, overall, a significant increase in longevity for both males and 
females of the EV3P line when compared to KIL.  However, it cannot be concluded from 
this that the presence of Vida3 confers a fitness advantage, for two reasons.  The first is 
that this increased fitness of a transgenic line is apparent only in one fitness parameter, and 
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it is possible that increased longevity may not be totally advantageous to a mosquito in 
terms of reproductive fitness.  The second is that the EV3M line does not corroborate these 
results by exhibiting increased longevity when compared to KIL.  Longevity data for the 
EV3M line are more consistent with data generated from assessment of age at pupation.  In 
both cases (if decreased longevity is taken to confer a fitness cost to the mosquito), EV3M 
males exhibit a greater fitness cost in comparison to their male KIL counterparts.  Genetic 
mechanisms behind these differences between hemizygous strains and between sexes 
within the EV3M strain are unclear.  Since the Vida3 transgene is autosomal, but 
differences are seen between reciprocal crosses and between sexes in one particular 
hemizygous cross, then it appears possible that such differences are due to inbreeding 
impacting on functionality of the X chromosome.  Analysis of the EVida3 line in its 
homozygous state should give rise to further evidence corroborating this hypothesis.  
Therefore, as all X chromosomes are affected in a homozygous line, the fitness costs in 
relation to age at pupation and longevity should be more pronounced in the homozygous 
line.  Anecdotal evidence, from working with stock populations in the insectary suggests 
that, in general, homozygous lines pupate later than other stock lines within the insectaries, 
although this has not been stringently measured.  It would also be expected, (assuming a 
cumulative effect), that, within the homozygous lines, females would be more greatly 
affected as opposed to males in the hemizygous state.  This is because females possess two 
copies of the X chromosome, both of which would be affected, and males have only one.  
Laboratory fitness studies fall into one of two categories.  The first is analysis of life-table 
parameters, and the second is competitiveness (Scolari et al., 2011).  The studies 
undertaken here look only at a comparison of life-table parameters between a wild type 
laboratory strain (KIL) and the hemizygous EVida strain.  Only when both categories are 
studied in full can the real fitness cost associated with presence of the Vida3 transgene be 
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gauged and more relevant fitness studies carried out in the field.  Currently the 
competitiveness of the EVida3 strain is under assessment (Douglas Paton, personal 
communication).  Further studies into fecundity are also necessary to complete life table 
analysis with regard to reproductive fitness indices.  Given the reports of a transgenic line 
exhibiting a fitness advantage over wild type laboratory strains when fed on infected blood 
(Marrelli et al., 2007), it would be ideal to (re)assess certain life-table parameters, such as 
longevity and fecundity, when maintaining EVida3 on both infected and non-infected 
blood.  This would be an ideal next step in examining fitness parameters in the laboratory. 
 
There are still a great many unanswered questions in terms of researching the genetics and 
biology of transgenic insects which must be addressed prior to taking such insects into the 
field.  It is likely that conclusions drawn from any investigations into a particular 
transgenic line will not be applicable across all lines generated.  However, investigations 
carried out here are both relevant and necessary in furthering our understanding of the 
biological interactions of transgenic insects. 
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Chapter Seven 
7. Appendices 
7.1. Appendix I:  Detailed, adapted and modified methods 
Protocol for transformations into bacterial cells 
The protocol uses XL10 Gold Ultracompetent cells (Agilent Technologies, Santa Clara, 
USA) and is adapted from , and therefore differs slightly to, the manufacturer‟s protocol. 
 Turn water bath to 42oC 
 Pre-chill required number of 14ml BD Falcon polypropylene round-bottom tubes 
on ice (one tube per experimental transformation) 
 Take one tube (150μl) of cells and thaw on ice 
 Add 4μl of the β-ME mix provided with this kit to the cells.  Swirl the tubes gently 
and incubate the cells on ice for 10 minutes, swirling occasionally 
 Whilst the cells are incubating, add 2μl of each ligation reaction into chilled 
Falcons and leave on ice (only 0.5μl is required if transforming from a Miniprep) 
 Divide competent cells between appropriate number of Falcon tubes (must be a 
minimum of 10-13μl cells per tube (when transforming from Minipreps only 5μl of 
competent cells are required).  Ensure cells are placed on DNA droplet in Falcon 
tubes 
 Mix cells gently and keep on ice for ≥ 30 minutes. 
 Heat shock cells at 42oC for 30 seconds (timing of this is critical) 
 Incubate the tubes on ice for 2 minutes 
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 Add 200μl of transformation medium to each tube and incubate the tubes at 37°C 
for 1 hour with shaking at 225-250 rpm 
 Plate ≤200μl of the transformation mixture on LB agar plates containing the 
appropriate antibiotic and incubate the plates at 37°C overnight 
o When plating cells transformed from Minipreps, 50μl of transformation 
mixture is plated, and when plating cells containing the pJet vector, 100μl is 
plated out.  All plating is undertaken in hood using aseptic techniques 
 
Protocol for preparation of genomic DNA from 10 mosquitoes 
The protocol uses Puregene DNA Isolation Kit (Gentra Systems, Minneapolis, USA) and is 
adapted from, and differs slightly to, the manufacturer‟s protocol. 
Cell Lysis 
 Place a 1.5ml centrifuge tube containing 500 μl Cell Lysis Solution on ice 
 Add 10 headless adults (0.5-2.0mg) to the chilled Cell Lysis Solution and 
homogenise thoroughly using a microfuge tube pestle. Place the sample back on ice 
until next step 
 Incubate the lysate at 65°C for 15 minutes 
RNase Treatment 
 Add 2.5μl RNase A Solution (4 mg/ml) to the cell lysate 
 Mix by inverting the tube 25 times and then incubate at 37°C for 15-60 minutes 
Protein Precipitation 
 Cool the sample to room temperature 
 Add 165μl of Protein Precipitation Solution to the RNase A-treated cell lysate 
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 Vortex the tube vigorously for 20 seconds to mix the Protein Precipitation Solution 
uniformly with the cell lysate.  Place the sample on ice for 5 minutes 
 Centrifuge the tube at 13,000-16,000 x g for 3 minutes.  The precipitated proteins 
form a tight pellet 
DNA Precipitation 
 Transfer the supernatant containing the DNA (leaving behind the precipitated 
protein pellet) to a 1.5 ml centrifuge tube containing 500μl 100% isopropanol (2-
propanol).  Mix by inverting gently 50 times 
 Centrifuged the solution at 13,000-16,000 x g for 5 minutes 
 Remove the supernatant and leave the tube to drain on clean absorbent paper. Add 
500μl of 70% ethanol and invert the tube several times to wash the DNA pellet. 
 Centrifuged at 13,000-16,000 x g for 1 minute. Then carefully pour the ethanol off. 
 Invert the tube and drain on clean absorbent paper and allow to air dry for 10-15 
minutes. 
DNA Hydration 
 Add 50μl of DNA Hydration Solution to the pellet. 
 Re-hydrate the DNA was by incubating the sample for 1 hour at 65°C or overnight 
 at room temperature. 
 Store the DNA at 4°C. For long-term storage, store DNA at -20°C or -80°C.  
 
Generation of transposase mRNA 
For the experiments described, transposase mRNA was produced by reverse-transcription 
of the transposase coding sequence in the plasmid, OX3081 (Oxitec Ltd. UK).  
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Transposase mRNA was generated using mMESSAGE mMACHINE T7 Ultra and 
MEGAclear Kits (both from Applied Biosystems/Ambion, Texas, USA) with 
modifications to the manufacturers protocols. 
Clean gloves, filter tips and dedicated „RNase free‟ reagents were used throughout.  All 
1.5ml and 0.5ml microcentrifuge tubes used in this protocol are individually sealed tubes 
which are guaranteed RNase/DNase-free. (Safe-lock Tubes, Biopur standard, Eppendorf) 
Linearisation of the plasmid (OX3081) 
 Generate an endotoxin-free maxiprep of OX3081 plasmid to ensure starting 
material is of optimal quality 
 Linearise 25μg of OX3081 plasmid by digestion with 5units of XbaI within a 100μl 
volume reaction and incubate at 37°C for one hour 
 Run a (0.5μl) sample of the digest on a 1% TAE gel after one hour to check the 
degree of cutting by comparing linearised plasmid to uncut plasmid (allow the 
reaction to continue while the gel is running) 
 When the plasmid is totally linearised, terminate the reaction according to 
mMessage protocol 
I. Add 1/20 volume of 0.5M EDTA 
II. Add 1/10 volume of 5M NH4OAc (as included in kit) 
III. Add 2 volumes of ethanol (use RNase-free EtOh) 
 Mixed the reaction well and chilled at -20°C overnight 
 Pellet the DNA by centrifugation for 15 minutes at maximum speed 
 Remove the supernatant, re-spin the tube and remove any traces of residual 
supernatant by means of a fine-tipped pipette 
 Re-suspend the pellet in 25μl of water (nuclease-free) from the Ambion kit 
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 Assess the yield of the linearised DNA plasmid and store at -20oC prior to in vitro 
transcription of mRNA 
Transcription Reaction 
Manufacturer‟s instructions include a TurboDNase Step and Poly(A) tailing step.  Both of 
these steps were not included in the protocol followed here as they are unnecessary.  The 
coding region within the plasmid contains a polyadenylation coding sequence. 
 Assemble the reaction in a 1.5ml microcentrifuge tube 
 Vigorously vortex the 10xT7 reaction buffer and the T7 2xNTP/ARCA solution 
until both are completely in solution and spin briefly to ensure reagents are 
collected in bottom of the tube 
 Add the components of the reaction in the order they are listed below 
Amount   Component 
to 20μl   Nuclease free water (use water supplied with Ambion kit) 
10μl    T7 2xNTP/ARCA 
2μl    10xT7 Reaction Buffer 
1μg    Linear template DNA 
2μl    T7 Enzyme mix 
 Flick the tube was gently to mix then briefly spin to collect reaction mix at bottom 
of tube. 
 Incubate the reaction for 2hours at 37°C 
 Remove 2.4μl of the reaction to run on a RNase-free 1% TAE agarose gel to assess 
RNA quality.  Remove a further 1μl of the reaction to run on a RNase-free 1% 
TAE-agarose gel to asses RNA quality  after MEGAclear Clean-Up.  Remove a 
fsecond 1μl sample to quantify using the NanoDrop (1 in 500μl dilution) 
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Recovery of the RNA 
Follow Ambion MEGAclear kit protocol with following notes/steps 
 Make up 1ml of fresh wash solution in a microcentrifuge tube (800μl Ethanol: 
200μl Wash Conc.). Make the wash fresh each time, immediately prior to use 
 Pre-heat a heating block at 65-70 °C for RNA elution step 
 Bring the RNA sample up to 100μl volume with elution solution, then mix gently 
but thoroughly 
 Add 350μl of Binding Solution Concentrate to the sample and again, mix gently by 
pipetting 
 Add 250μl of 100% ethanol to the sample and mix gently by pipetting 
 Apply the sample to the filter 
 Insert a filter cartridge into 1 of the Collection/Elution tubes supplied 
 Pipette the RNA mix onto the filter cartridge then centrifuge for 1min at 13,000rpm 
 Discard the flow-through was discarded 
 Apply 500μl of the fresh wash solution to the filter and centrifuge for approx. 50 
seconds at 13,000rpm until it is eluted as before in the tube 
 Repeat with a second 500μl aliquot of wash solution 
 Discard the wash solution and spin the filter again for 1 minute to remove any last 
traces of wash solution 
 Follow RNA elution Option 1 of the Ambion protocol 
o Place the filter cartridge into a new Collection/Elution tube 
o Apply 50μl of elution solution to the centre of the filter cartridge.  Close the 
tube-cap and incubate in a heating block at 65-70°C for 10 minutes 
o Recover the eluted RNA by centrifuging for 1minute at room temperature at 
13,000rpm 
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o Maximised RNA recovery by repeating the elution step with a second 
aliquot of 50μl of Elution Solution..  Collect the eluate was collected into 
the same tube 
Precipitation of the RNA 
 Pre-chill the centrifuge to 4oC 
 Prepare 500μl of 70% ethanol (per reaction) and chill at -20°C 
 Add 1:10 volume of 5M Ammonium Acetate (NH4Ac) to the purified RNA to the 
sample 
 Add 2.5 volumes of 100% ethanol. Mix the sample well and incubate overnight at -
20°C 
 Spin the supernatant at maximum speed for 15 minutes in a pre-chilled 4°C 
centrifuge 
 Carefully remove and discard the supernatant 
 Wash the pellet with 500μl 70% fresh cold ethanol, centrifuge again and remove 
the 70% ethanol 
 To remove the last traces of ethanol, quickly re-spin the tube and any remove any 
residual fluid with a fine-tipped pipette. 
 Air-dry the pellet overnight at room temperature 
 Re-suspend the pellet in 15μl RNase-free water (from Ambion kit). 
 Remove 2μl for analysis: 
o Use 1ul for quantification by using NanoDrop. 
o Run a very clean TAE-RNA gel (Section 7.1.4) of 1μl of the sample. Run 
samples with Formaldehyde Load Dye in 3:1 ratio as specified in the 
mMessage mMachine protocol alongside any sample removed and stored 
from earlier in the protocol.  Run gel at ~70mV for ~1 hour. 
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RNase-free agarose gels 
When possible, all in vitro transcribed mRNA was checked on a 1% TAE agarose gel to 
check both quantity and quality of RNA produced.  Quality of transcribed mRNA was of 
utmost importance given its downstream application within microinjection techniques.  
Therefore, 1% TAE-agarose gels were made following standard procedure but with several 
adaptations to ensure they remained as RNase-free as possible to avoid denaturing of RNA. 
 Make up 1 x TAE using Molecular Grade water in individual RNase-free Falcon 
tubes 
 Make up 1% agarose in RNase-free Falcon tubes using TAE made as above 
 Clean the gel tank out by soaking in 1% SDS (made using Molecular Grade water).  
Soak combs and dams in 1% SDS as well 
 After soaking for approx. 1 hour, rinse gel tank, combs and dams with 70% ethanol 
(made again using Molecular Grade water).  Allow the tank to dry out prior to use. 
 Load the gel and run as soon as possible after pouring and cooling 
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7.2. Appendix II:  Solutions 
 
10% Glucose solution for feeding mosquitoes 
 Dissolve 100g glucose in 900 ml distilled water. 
 Add streptomycin/penicillin (Sigma-Aldrich, Poole, UK) to a concentration of 
0.28%. 
 Adjust volume to 1L with distilled water. 
 Filter sterilise before use. 
 
Water-saturated Halocarbon Oil 
 Approximately 10ml of Halocarbon oil 700 (Sigma-Aldrich Company Ltd, Dorset, 
UK) is contained in a sterile 30ml universal plastic tube with approximately 4ml of 
sterile water.. 
 The tube is inverted a number of times and then ready for use. 
 
10x microinjection buffer 
 50mM KCl 
 1mM NaPO4 
 pH 7.2 
 
Stock solution of Tetracycline water (3mg/ml) 
 To 1L distilled water add: 
o 3g Tetracycline powder 
 Mix until dissolved 
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 Aliquot into 50ml tubes and freeze (tetracycline degrades in sunlight so ensure 
powder and stock solutions are kept in the dark) 
 
Tetracycline water for rearing mosquitoes (0.03mg/ml) 
 Defrost 1 aliquot of stock tetracycline solution 
 Dilute in a total of 5L of distilled water 
 This will be enough for 5 standard rearing trays 
 
Luria Bertani (LB) broth (1L) 
 To 800ml of distilled water add: 
o 10g Bacto-tryptone. 
o 5g yeast extract. 
o 10g NaCl. 
 Stir until the contents have dissolved entirely then adjust pH to 7.5 with NaOH. 
 Adjust volume to 1L with distilled water. 
 Sterilize by autoclaving. 
 
LB Agar Recipe Luria Bertani (1L) 
 To 800 ml distilled water add: 
o 10g Bacto-tryptone 
o 5g yeast extract 
o 10g NaCl 
 Adjust pH to 7.5 
 Add 15g Agar. Melt agar into solution in the microwave. 
 Adjust volume to 1L with distilled (or milipore) H2O. 
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 Sterilize by autoclaving. 
 Cool until warm to touch (approximately 50°C). At this point add antibiotics to the 
 LB Agar. 
 Add ampicillin to 100μg/ml concentration or kanamycin to 50μg/ml. 
 
Orange loading dye, 6x 
 10mM Tris-HCl, pH7.5 
 50mM EDTA 
 10% Ficoll 400 
 0.4% OrangeG 
 
10% SDS (1L) 
 To 900ml distilled water add: 
o 100g SDS 
o Heat to 68°C 
o pH to 7.2 with HCl 
 Adjust to 1L with distilled water 
 
SOC broth (1L) 
 Add the following to 900ml of distilled water. 
o 20g Bacto Tryptone. 
o 5g Bacto Yeast Extract. 
o 2ml of 5M NaCl. 
o 2.5ml of 1M KCl. 
o 10ml of 1M MgCl2. 
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o 10ml of 1M MgSO4. 
o 20ml of 1M glucose. 
 Adjust to 1L with distilled water. Sterilize by autoclaving 
 
TAE 50x Buffer (1L) 
 242g Tris Base 
 57.1ml Glacial acetic acid 
 100ml 0.5M EDTA, pH8.0 
 Adjust to pH7.2 and bring the final volume to 1 litre with distilled water 
 
1x PBS buffer (1L) 
 Dissolve the following in 800ml distilled H2O. 
o 8g of NaCl 
o 0.2g of KCl 
o 1.44g of Na2HPO4 
o 0.24g of KH2PO4  
 Adjust pH to 7.4. 
 Adjust volume to 1L with additional distilled H2O. 
 Sterilize by autoclaving 
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7.3. Appendix III:  Kaplan Meier longevity curves illustrating 
longevity data for independent experiments 1-3 
 
 
Graphs for experiments 1-3 follow on subsequent pages 
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Figure 7.3.1 (previous page):  Kaplan-Meier survival curves to compare longevity of 
the control (KIL) line with two hemizygous transgenic lines using data from 
Experiment 1 
Graphs A-D show female survival data and graphs E-H show male survival data.  Graphs 
A and E show survival curves for all three lines included in the experiment.  Graphs B-D 
and F-H compare the survival curves for each combination of pairs of lines for female and 
male mosquitoes respectively.   
All survival data was analysed using the log-rank (Mantel-Cox) test and significance levels 
are displayed on each graph (**, p < 0.001; *, p < 0.05; ns, not significant). 
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Figure 7.3.2 (previous page):   Kaplan-Meier survival curves to compare longevity of 
males and females for each line using pooled data from Experiment 1 
A) Survival curve comparing male and female longevity in the control (KIL) line; B) 
Survival curve comparing male and female longevity in the hemizygous transgenic EV3P 
line; C) Survival curve comparing male and female longevity in the hemizygous transgenic 
EV3M line.  
All survival data was analysed using the log-rank (Mantel-Cox) test and significance levels 
are displayed on each graph (ns, not significant).  
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Figure 7.3.3 (previous page):  Kaplan-Meier survival curves to compare longevity of 
the control (KIL) line with two hemizygous transgenic lines using data from 
Experiment 2 
Graphs A-D show female survival data and graphs E-H show male survival data.  Graphs 
A and E show survival curves for all three lines included in the experiment.  Graphs B-D 
and F-H compare the survival curves for each combination of pairs of lines for female and 
male mosquitoes respectively.   
All survival data was analysed using the log-rank (Mantel-Cox) test and significance levels 
are displayed on each graph (***, p < 0.0001; not significant). 
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Figure 7.3.4 (previous page):   Kaplan-Meier survival curves to compare longevity of 
males and females for each line using pooled data from Experiment 2 
A) Survival curve comparing male and female longevity in the control (KIL) line; B) 
Survival curve comparing male and female longevity in the hemizygous transgenic EV3P 
line; C) Survival curve comparing male and female longevity in the hemizygous transgenic 
EV3M line.  
All survival data was analysed using the log-rank (Mantel-Cox) test and significance levels 
are displayed on each graph (**, p < 0.001; ns, not significant).  
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Figure 7.3.5 (previous page):  Kaplan-Meier survival curves to compare longevity of 
the control (KIL) line with two hemizygous transgenic lines using data from 
Experiment 3 
Graphs A-D show female survival data and graphs E-H show male survival data.  Graphs 
A and E show survival curves for all three lines included in the experiment.  Graphs B-D 
and F-H compare the survival curves for each combination of pairs of lines for female and 
male mosquitoes respectively.   
All survival data was analysed using the log-rank (Mantel-Cox) test and significance levels 
are displayed on each graph (***, p < 0.0001; not significant). 
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Figure 7.3.6 (previous page):   Kaplan-Meier survival curves to compare longevity of 
males and females for each line using pooled data from Experiment 3 
A) Survival curve comparing male and female longevity in the control (KIL) line; B) 
Survival curve comparing male and female longevity in the hemizygous transgenic EV3P 
line; C) Survival curve comparing male and female longevity in the hemizygous transgenic 
EV3M line.  
All survival data was analysed using the log-rank (Mantel-Cox) test and significance levels 
are displayed on each graph (***, p < 0.0001; **, p < 0.001; ns, not significant).  
 
